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ABSTRACT
MUSCAT, R. BEHAVIOURAL MICROANALYSIS OF DOPAMINE AUTORECEPTOR 
FUNCTION.
Low doses of DA agonists are presiued to act by stisulating DA 
autoreceptors on the sona/dendrites and axon teralnals of DA 
neurons. Low doses of aposorphine reduced food Intake, in a 
■icrostructural analysis paradigm, by reducing both the time 
®P®Dt feeding and the rate of food ingestion. The reduction of 
eating time was shotm to result from the stimulation of DA 
autoreceptors located on the cell bodies and dendrites of the 
mesolimbic DA system. The reduction of eating rate however, 
appeared to result from the activation of axon terminal DA 
autoreceptors. The significance of this dissociation is discussed 
Id relation to the mechanisms through which presynaptic DA 
receptors on the same neuron may subserve different behavioural 
functions.
The observation that apomorphine administration resulted in a 
selective manipulation of the- mlcrostructural parameters of 
feeding, was then used to assess the action of antidepressant 
drugs on DA autoreceptor function. In both normal and chronically 
stressed rats, chronic antidepressant treatment failed to alter 
the sensitivity of DA autoreceptors. However, on withdrawal, the 
sensitivity of cell body DA autoreceptors appeared reduced, as 
apomorphine no longer in any way influenced the time spent 
feeding in the microstructural paradigm. The Implications of 
these findings are dlscusssed in relation to the hypothesis that
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CHAPTER 1
DOPAMINE AUTORECEPTORS
1.1 DOPAMINE
Dopaain* (DA) was first recorded in the CNS as early as the 
end of the 1950 *s (Montagu 1957) and soon localized 
intraneuronally (Carlsson et al, 1962). Shortly thereafter a 
deficit of DA within the CNS was suggested to be the underlying 
cause of Parkinson's disease (Homykiewicz 1966). However, it was 
not until 1971 that DA was considered as a neurotransaitter in 
its own right within the CNS and not just a precursor of 
noradrenaline (Ungerstedt 1971a). Following the observation 
that DA systeas are well represented in the brain, the 
•l*ct*'ophysiologlcal, blocheaical, pharaacologlcal and 
behavioural properties of this systea were soon forthcoaing. 
Bunney's group deaonstrated that DA neurons have firing rates 
of between 1 and 9 spikes per second, action potentials with an 
initial positive segaent followed by a proalnent negative 
phase and frequently a late positive coaponent. in
addition, a nuaber of DA cells fire In what has coae to be 
known as characteristic bursting fashion (Bunney et al, 1 9 7 3). 
Homykiewicz (1973), deaonstrated that the caudate nucleus and 
the putaaen contain the highest concentration of DA within 
the brain, followed by the nucleus accuabens, substantia 
nigra, globus pallidus and the aaygdalold coaplex. The aain 
aetabollte of DA in these brain regions is hoaovanillic acid 
(HVA) and soae 80% of DA and HVA is found within the basal 
ganglia. In addition, it seeaed that there were two receptor
subtypM for DA, naa«l, 01 or 02 (KoJsablan and Calna 1979) ;
«tiBulation of 01 racaptors raaulta in an incraase in the 
activity of adanylata cyclaaa (cAMP) whila stiaulation of tha 02 
racaptor doas not activata cAMP but aoaatiMs inhibits it (Onali 
at al, 1981).
Carloson (1975), also noted that a particular 
characteristic of DA systeas was that they possessed 
autoregulatory receptors. These autoraceptors are to be found 
presynaptically on axon tarainals of DA neurones and also on 
the soaa and dendrites of the cells of origin. Soaatodendritic 
autoraceptors regulate tha firing of DA neurones whereas the 
taminal autorecaptors saaa to be involved in tha control of 
DA synthesis and its release. Stiwilation of these receptors 
by DA agonists results in a suppression of both the electrical 
conduction along DA neurones and iapulsa induced release of 
endogenous DA (Roth 1979). In behavioural terms this leads to 
reduction in, for exal^>le, locomotor behaviour, which is in 
direct contrast to an increase in activity which observed 
following the stimulation of postsynaptic DA receptors by DA 
agonists (Costall et al, 1980).
1.1.1 Anatomy of DA systems
The catecholamine neural systems emanate from a series 
of cell bodies in the brainstem that were designated Al to A12 by 
Dahlstrom and Puxe (1964). Of these cell groups A9, AlO, and 
A12 are dopaminergic. They give rise to the nigrostriatal,
Msoliabic, and tubarclnfundlbular pathways raspactivaly, and 
thasa mymfmm hava baan ra-classifiad to includa tha wall 
aatablishad cortical DA projactions (Llndvall and Bjorklund 
1974, 1978). Thara ara, additionally, dopaninarglc intemeurons 
in tha brainstaa, suparior carvical ganglion (S.I.F. calls), 
ratlna, olfactory bulb and carotid body. It is possible that 
additional dopaainargic structuras will ba idantiflad in tha 
futura.
Tha nigrostriatal DA systaa is now ona of tha aost 
widely studied pathways in tha brain. Tha A9 call group which 
9 Ìvas risa to it, is located in tha zona coapacta of tha 
substantia nigra. Thasa ara larga aultipolar calls which sit on 
tha dorsal aspect of tha substantia nigra. It can ba seen that 
tha large calls in question hava aultipla idantatlons in tha 
nudai and a vary proalnant golgi apparatus. Tha dendrites extend 
into tha zona reticulata where they ara surrounded by nerve 
endings many of which ara gabaargic. Tha axons of thasa proceed 
rostrally in a proainant pathway that ascends in tha lateral 
hypothalaaus just dorsalataral to tha sadlan forabrain bundle. 
They enter tha crus cerebri at tha sidhypothalasic level, 
intermingle with tha nyallnatad fibres in tha internal capsule, 
and than fan out through tha globus pal Ildus to enter tha caudate 
and putaman (Moore and Bloom 1978). Tha fine structure of tha 
pathway has baan further consolidated by studies of 
axoplasmic flow. 3(H) dopamine injected into the substantia 
nigra is well transported to nerve endings in the caudate
putoMn (SlMon et al, 1979).
The naxt aost proninent tract is the aesoliabic pathway. 
These AlO cell bodies extend Medially froa A9, foraing a cap over 
the interpenduncular nucleus. It has been estiaated that there 
are soae 27-29,000 cells in the VTA of the rat (Halliday and Tork 
1985, 1986) of these 18,000 (>70%) Stained for tyrosine
hydroxlase (Swanson 1982) irtiich for the rat is the
greatest aidbraln concentration of DA (Geraan et al, 1983). 
The axons ascend together with the axons of the 
nigrostriatal dopaaine systea following a slightly aore aedial 
course. They do not enter the crus cerebri but continue in a 
rostral direction just dorsal to the aedial forebrain bundle to 
Innervate liable structures such as the nucleus accuabens, 
olfactory tubercle and possibly the aaygdaloid coaplex and the 
hlppocaapus. Further analysis of the dopaaine pathway to the 
nucleus accuabens has established that fibres sweeping along 
aspect of the nucleus accuabens separate into a 
nuaber of branches, the aost abundant of which runs dorsally 
and rostrally into the deep layers of the frontal cortex 
(aPFC). A second branch turns dorsally above the corpus 
callosua and aoves caudally to innervate the anterior liable 
cortex. Another branch Innervates the septua and reaaining 
portion give terainals to the olfactory tubercle, (Lindvall and 
Bjorklund 1974). Additional evidence for aesollablc projections 
has cone froa Siaon et al, (1979), using HRP (retrograde) and 3H 
leucine (anterograde) procedures to aap the DA projections fron
th« VTA. They have sumrized their findings as follows;
1) DA projections to regions rich in DA terainals, eg, nucleus 
accunbens,
2) DA projections to regions suspected of containing DA teminal 
regions, eg, locus coerulus, and
3) DA projections to regions not known to contain DA tereinal
regions, eg, supraoptic nucleus and anterodorsal thalaeic
nucleus.
Recently, Oades and Halliday (1987), have suggested that the 
efferent projections of the VTA can be divided sore
systeeatically into five subsytess;
1. The nesorhoabencephalic projection to the cerebellum and the 
inferior olive.
2. The nesodlencephalic pathway to the thalamic and hypothalamic 
nuclei.
3. A small but significant mesostrlatal pathway to the anterior 
striatum.
4. The Msollmbic projection to the nucleus accumbens, tuberculum 
olfactorium, lateral septum and the interstiatal stria 
terminalls. Mesollmbic projections also serve the amygdaloid 
nuclei, olfactory nuclei, entorhinal cortex and the hippocampus.
5. The mesocortlcal pathway projects to the prefrontal, 
o*i>itofrontal and cingulate cortices.
Finally, the tuberoinfundlbular dopamine system has cell 
bodies A12 located within the arcuate nucleus of the 
hypothalamus. These cells innervate the external layer of the
■•dlan «iin«nc«.
1.2 BBHAVIOORM. rONCTIOMS OF DOPAMIWE SYSTEMS
Dasplt* th« vast aaoimt of lltaratura available on the 
behavioural functions of the nigrostriatal and nesolisbic
dopasine pathways, they have yet to be fully understood. One of 
a nusber of controversies yet to be resolved is whether 
the Msolisbic pathway is specifically Involved in locomotor 
activity and the nigrostriatal system in the complex 
stereotyped behaviour which involves sniffing, biting,
licking and head movements which predominate after large doses 
of Dk agonists, eg am>hetamlne (Randrup and Munkvad 1967; 
Schiorring 1979). A nusber of studies have demonstrated that 
local injection of amphetamine into either the nucleus accunbens 
or the caudate nucleus results in increased locomotor activity by 
the former and stereotyped behaviour by the latter (Creese and 
Iversen 1974; Costall at al, 1972; Jackson at al, 1975; 
Nakanjuola at al, 1980). Some of the motor behaviours 
with the caudate-putamen nuclei are also observed 
following the stimulation of the D1 receptor found in this 
area and typically take the form of oral and facial
dyskinesias (Rosengarten at al, 1983). In addition, the 
behaviours elicited by the stimulation of different 
dopaminergic brain loci may be antagonized by the specific DA 
antagonists, eg haloperidol, (Kelly et al, 1975;
J•'•**^ ***^  1975). However, others have suggested that
the wide variety of behaviours recorded are only different
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aspects of the saee behavioural repetoire which thus isplies 
that different behaviours are not necessarily Mediated by
dopasine systeas, (Kafetzopoulos 1986; KoMcinidis 
and Anisaan 1980, 1981).
One aodel sees the prlaary function of DA systeas as 
controlling the rate of behavioural output, independently of the 
aotivatlonal deteralnants of behaviour, which in turn supports 
the view that both the nigrostriatal and aesoliabic DA systeas 
are Involved in the behavioural stiaulation resulting froa the 
adainistration of a^hetaaine (Lyons and Robbins 1 9 7 5),
Consequently, dopaaine syteas appear to be involved with a 
general behavioural activation, as adainistration of da 
agonists, eg. aaphetaaine, results in an increase in open- 
field locoaotion, activity and a nuaber of unconditioned
behaviours (Kelly et al, 1980). However, as suggested above, 
aaphetaaine-lnduced locoaotion seeas to be dependant on the 
integrity of the aesoliabic rather than the nigrostriatal DA 
thus behavioural activation aay be independent of the 
type of aotor aro\isal underlying stereotypy (Kelley and Stinus 
1984) .
In recent years considerable attention has been focussed 
on the question of whether the aesoliabic DA system constitutes 
a "reward pathway". Anlaals will self-adainister DA receptor 
agonists but not agonists that have been shown to interact with 
other neurotransaitter receptor populations if trained to press a 
lever in the process (ICSS). In particular the D2 and the Dl
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receptor subtype sees to be involved as adsinistratlon of 
sulpiride, a specific D2 receptor anatagonist and SCH23390, the 
specific D1 receptor antagonist, increased lever pressing in the 
less paradigs (Nakajisa and Mackenzie 1986; Woolverton 1986).
Wise and colleagues first noted that animals on neuroleptics 
show extinction like behaviour when placed in a self stlnulation 
situation (Fouriezos and Wise 1976), or while responding for food 
reinforcement (Wise et ai; 1978a,b). Gallistel et al, (1982), 
were also able to demonstrate that this effect of
neuroleptics was not due to the motor debilitating effects 
drug as changing the environment resulted in a 
reinstatement of responding-to baseline levels. Benlnger and 
Freedman (1982), also using a two-task procedure observed 
extinction like behaviour with lever pressing following pimozide 
but no such effect in the motorically demanding wheel-runing 
paradigm. These findings argue against the notion that dopamine 
receptor blockade results in a severe motoric handicap and
support the idea that DA systems are primarily involved in
the rewarding aspects of behaviour supported by positive 
reinforcement (Wise 1982).
However, the assumption that neuroleptic pretreated animals 
behave as if they were undergoing extinction has not been 
validated experimentally, if anything the studies reported to 
date demonstrate quite the reverse of what is predicted from such 
a hypothesis. Animals on neuroleptics appear to mimic the 
behaviour of animals undergoing extinction as both show
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raductions in rasponse ratas. Howavar, transfering fron 
neuroleptic pratraatMnt to extinction produces an increase in 
response rates (Beninger 1982; Mason at al, 1980; Tonbaugh at al,
1980). These observations would suggest that DA sytens are not 
directly involved in the reward processes associated with 
positive reinforcenent and thus do not support the anhedonia 
hypothesis, in addition, DA antagonist treataent and extinction 
do not seen to be functionally equivalent processes and therefore 
such conparisons should not be used as evidence to inplicate DA 
systems in reward. As a result of such findings it has been 
suggested that the nesolinbic DA systen is in fact responsible 
for the activating effects • rather than the hedonic inpact of 
positive reinforcement (Mogenson 1982,- Salanone 1986).
DA systems however, are also implicated in feeding and 
drinIcing behaviour making studies using food and water reward 
to interpret. However, the specificity of the DA 
systems in feeding behaviour have also been called into question.
(1978), has argued that DA systems in the perlfomical 
area of the hypothalamus are responsible for a satiety 
response, in that administration of DA to the PFH resulted 
in a dose dependent suppression of food intake. Indeed, a
"'“***^ oi neuroleptics including pimozide totally attenuated
the reduction in food intake caused by DA and amphetamine. 
However, systemic administration of DA antagonists also 
resulted in a reduction of food consumption. This effect has 
been interpreted as a non-specific action of DA antagonists, as
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destruction of the nigrostrlatal pathway following 6-OHDA 
administration also results in aphagia (Ungerstedt 1971b). Based 
on these findings it appears that the nigrostriatal DA 
pathway nay mediate the arousal and motor component of feeding 
(Strieker and Zigmond 1976), whereas the hypothalamic DA 
mechanisms provide direct stimuli for terminating this 
behaviour. The DA receptor subtype within the perifomical 
hypothalamus appears to be of the D2 subtype which inhibits AC 
activity; the D1 agonist SKF 82526, did not in any way alter 
the effects of D2 agonists on AC activity (Carruba et al, 
1985). This system of dopaminergic fibres also appears to be 
devoid of autoreceptors (Carruba et al, 1985). In contrast to 
the effects of DA agonists • on feeding behaviour, intracerebral 
administration of dopamine increases water consumption (Poat et 
al, 1980; Setler 1973). It is also well established that 
dopamine receptor antagonists reduce the consumption of water 
(Block and Fischer 1975; Grupp 1976; Rowland and Engle 1977; 
Sumners et al, 1979). These data suggest some involvement of 
central M  mechanisms in the control of drinking responses but 
appear to be well less defined than the DA system involved in 
feeding behaviour.
nie problem with DA mediated behaviours seems to be one of 
interpretation. Heuroleptic drugs suppress rewarded behaviour. 
However, the majority of paradigms used to study these effects 
require an active output of behaviour, and activating, hedonic, 
and rate effects become difficult to separate. However, a number 
of paradigms have now become available in which it is possible
14
to look at tha contributiona of tha DA syataas in raward. One 
paradlga dascrlbad by Harmstaln (1961, 1971) axploits the 
■atchlng lav, in which tba strength of tha rasponea is directly 
relatad to tha raward received. In this case animals press a 
lever for food or water reinforcement, while in the paradigm 
used by Gallistel, animals press a lever for electrical 
stimulation. The number of responses can Jse plotted against the 
total number of reinforcements obtained in each paradigm and 
the curve obtained is sigmoid in shape. The motor parameter in 
the equation essentially sets the asyiq;>tote of the curve while 
the reinforcer efficacy is that value which maintains half 
maximal responding. The indirectly acting DA receptor 
agonist, a^>hetamine, increased the reinforcing value of the 
food reirard and elelctrical stimulation. Pimozide, however, in 
addition to decreasing reinforcement efficacy also reduced 
motor capacity in a dose dependent manner (Gallistel et al, 1982; 
Galliwtel and Karras 1984; Heyman 1983; Winner et al, 1987a). 
In the place location paradigm, tdiich consisted of a box whose 
)iloor consisted of three rectangular wire mesh panels, 
haloperidol reduced motor activity compared to controls but not 
the time spent on the panel which contained the food dish 
(Salamone 1986). The minimal motor requirements demanded by such 
a task would first of all suggest that DA antagonists do not 
impair all reinforced behaviours and secondly, DA antagonists do 
not bl\int the hedonic impact of food reward. However, in a two- 
bottle test in which animals had equal access to a bottle 
containing sucrose and one holding water, DA receptor anatgonlsts
15
reduced the coneuaption of sucrose but increased that of water 
(Towell et al, 1987a). It say be said that the motoric 
requirements of this paradigm are also minimal and reducing DA 
function resulted in a reduction in the rewarding properties of 
the sucrose solution. In that DA antagonists cause adipsia, the 
increase in water consiuq;>tion cannot be said to result from a 
direct involvement of the physiological mechanisms involved in 
drin)cing (see al>ove).
From a theoratical standpoint, it may be impossible to 
■•parate out the motoric and rewarding components of goal 
directed behaviour and the fiinction of DA systems within this 
framework, as DA systems seem to be involved in Incentive 
related motor activity. Thus treatments that reduce DA activity 
also interfere with performance in schedule induced or 
reinforcer induced behaviours (Keehn et al, 1976; Wallace et 
al, 1983). A general statement of the functional significance 
of DA pathways within the brain may simply be that they 
modulate motor output in relation to stimulus-related 
activation (Salamone 1986). Animals receiving neuroleptic 
P*'«treatment show a progressive deterioration of responding on a 
number of schedules (Salamone 1986; Winner et al, 1987a) but 
return to base-line responding when treatment has ceased 
(Flbiger et al, 1976).
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1.3 PRBSYHAPTIC M  RECEPTORS
In contrast to tha locoaotor atiwulant affacta of OA agonlata 
at high doaaa, tha noat notabla and noat raportad finding 
in tha bahavioural litaratura following tha adniniatration of 
low doaaa of DA agoniata la tha auppraaaion of locomotion in 
rata and nica (Coatall at al, 1981; Di Chiara at al, 1976; 
StrontK» 1976). Thia affact ia baliavad to arise from the 
stimulation of prasynaptlc DA racaptors which results in tha 
inhibition of DA synthesis and ralaasa (Famabo and Hambarger 
1971; Starke at al, 1978). However, a number of problems have 
arisen with regard to tha role of DA autoracaptora in tha 
reduction of locoaotor behaviour and DA aynthasls. Apomorphlna 
and a number of other DA agonists also interact with 
noradrenergic receptor aystaas and it is racognlaad that sedation 
may also result from tha stimulation of alpha 2 racaptors. 
Indeed, one study raportad that soma DA antagonists ware 
affective in reversing apomorphina-lnduced sedation while others 
ware not (Sumners at al, 1981) and in another study, DA 
antagonists ware totally Inaffactlva (Costall at al, 1980). In 
addition to tha problems associated with tha findings that DA 
agonists may have affects on other naurochamical systems is tha 
guastion of whether DA autoraceptors are actually present 
on tha call bodies and terminal regions of DA systems.
Opposition to the very presence of this receptor subtype has 
come from Laduron (1981), who has put forward tha theory of 
"Partial Occupancy" to explain the biphasic action of apomorphine
17
****^ •'•urol^ptic druQS* li a high dos* o t an axoganous 
■ubstanca is appliad tha occu{>atlon will ba relativaly hoaoganous 
so that all racaptors will ba raachad by tha drug. In contrast, 
at lowar dosas tha disposition of tha drug should occur randomly 
and this will rasult in only a faw raceptors occupiad by tha 
ia. a partial occupation of tha racaptors. Low dosas of 
a naurolaptic " would laad to a partial occupation of 
postsynaptic OA racaptors which would rasult in an slight 
incraasa in DA synthasis through a positiva faadback loop. As 
graat majority of tha OA racaptors are not blocked, 
tha alavation of DA ralaasa will elicit hyparmotility. Moreover, 
it is possible that such a concept could similarly explain 
tha sedative affects observed with low dosas of apomorphina. 
However, it is difficult to reconcile this hypothesis with tha 
biochemical findings (sea below). Also, kainic acid lesions of 
tha naostriatxim, which destroy tha feedback pathways, fail to 
inhibit tha affects of low dosas of DA agonists on tha synthasis 
of DA (Bannon at al, 1980).
A second alternative, tha "rauptaka" hypothesis has bean put 
forward to explain tha inhibition of DA synthesis by DA
agonists and tha biphasic effects of these drugs. It has been 
proposed that under normal conditions DA synthasis is partly 
inhibited by tha transmitter newly taken up following the 
ralaasa into tha synaptic cleft. Thus if the dopamine 
concentration in this area increases the amount of the 
transmitter uptake will also increase with the result that DA
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synthasls will be Bor* lnhiblt«d. On the contrary, if DA in the 
synapse decreases, the amine uptake will be proportionally 
reduced with the consequent disinhibition of DA sysnthesis 
(Cerrito et al, 1981). In addition, it has also been 
reported that DA agonists are highly hydrophobic and thus 
readily cross the presynaptic aeabrane to inhibit the enzyme 
machinery (tyrosine hydroxylase) responsible for the synthesis 
of dopamine. However, in synaptosomal preparations apomorphine 
inhibits DA synthesis at concentrations substantially lower than 
those needed to inhibit soluble tyrosine hydroxylase (Bltran and 
Bustos 1982). Furthermore, addition of the DA uptake inhibitors 
cocaine or benztroplne to.the preparation failed to inhibit 
apoBorphlne-induced reduction of DA synthesis. Demarest (1983), 
reported that amphetamine did reverse the reduction in 
dopamine synthesis by apomorphine in the striatum and the nucleus 
accuabens. This finding could be taken to support the reuptake 
However, it is also possible that amphetamine reduced 
the intracellular concentration of DA with the result that DA 
synthesis was increased by a reduction in end product inhibition.
Electrophysiological evidence unequivocally supports the 
findings that DA autoreceptors are present on the soma and 
dendrites of DA neurones. Microiontophoretic application of DA 
agonists to the cells of origin of both the nigrostriatal and 
mesollmbic pathways results in a cessation of impulse flow along 
these neurones (Groves et al, 1975; White and Wang 1984). In 
addition, amphetamine, applied systemically, inhibits cell
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firing in th* striatun as wall as in the substantia nigra 
wharaas haloparidol anhancas call firing in both thase areas 
(Grovas at al, 1975). Carlsson and Lindqvist (1963), put 
forward a nauronal feedback loop hypothesis to explain these 
systemic affects. However in the nigrostriatal system, while 
ablation of the feedback pathways with kainic acid did change 
the pattern of firing of nigral cells, this could not be 
explained simply by the removal of the inhibitory GABA input on 
to these calls (Doudat at al, 1984). In addition, tha finding 
that nigral calls are sensitive to DA and are inhibited by 
DA antagonists (Bunnay and Aghajanian 1973; Grace and Bunney
1983) damonstratas that thase cells clearly possess dopamine 
receptors, which apparently are some 10 to 100 times more 
sensitive to DA agonists than are postsynaptlc DA receptors 
(Sklrboll at al, 1979).
Tha presence of DA autoraceptors has also bean established 
on dendritic projections of nigral DA neurones. Gaffen (1976), 
using slices of rat nigra from the zona reticulata, in which 
cell bodies are absent, demonstrated that DA was released into 
the preparation by raising the external potassium 
concentration. Cheramy (1981), reported that the release of DA 
from dendrites was involved in the self-regulation of DA 
cells as well as in the release of naurotransmittars in nigral 
affarants fibres and the regulation of the activity of non 
dopaminergic calls.
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Autoreceptors on the cell bodies and dendrites of the 
Besoliabic OA system have slBllarly been reported to respond to 
DA agonists, %rhlch Inhibit lapulse flow in these neurones, 
whereas agonists of other classes exert weak or no effects at 
all (White and Wang 1984). The presynaptlc OA receptors in the 
sesoliMblc pathway also appear to be more sensitive to DA 
agonists than autoreceptors located in the substantia nigra, 
perhaps because the Besollsbic DA system seems to lack the 
well defined long loop feedback pathways found in the 
nigrostriatal DA system (Walker 1986). In addition, neurons 
projecting from the VTA to the prefrontal or anterior 
cingulate cortex have faster mpontaneous firing rates than DA 
projections to the caudate and the accumbens. These neurons are 
insensitive to both rate and synthesis suppressant effects of 
DA agonists which would liQ>ly that these projections lack 
autoregulatory mechanisms on their soma or terminal regions 
(White and Wang 1984).
1.4 PHABMACOLOGY OF DA RECEPTORS
The classification of subpopulations of DA receptors has 
been the subject of a number of controversies. Two subtypes of DA 
receptors were initially defined by the observation that one 
population were coupled to adenylate cyclase while the second 
were not (Kebablan 1978; Kebabian et al, 1972). These two 
receptor subtypes were first refered to as alpha and beta 
(Kebablan 1978), but in order to avoid confusion between 
these receptor subtypes and those found on noradrenergic
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terminals Kebablan and Caine (1979), suggested the D1 and D2 
terminology. The occurrence of two receptor subtypes for DA has 
also been Inferred from behavioural and the electrophysiological 
evidence, except that these receptors have k>een labeled 
excitatory or inhibitory ie OAe and DAi (Cools and van Rossun 
1976; Cools et al, 1976; Cools and van Rossum 1980). It would 
appear that postsynaptlc D1 receptors defined by Kebabian and 
Caine correspond to DAi, as application of D1 receptor agonists 
results in hyperpolarisation, whereas stimulation of postsynaptic 
receptors results in depolarization and consequently 
correspond to OAe (Grace and Bunney 1983; Marling 1981; Marling 
and Mull 1980). Costall and Naylor (1981), referred to these two 
subtypes of DA receptors as DAI and DA2, but subsequently this 
terminology has been used to differentiate the peripheral DA 
«■•«•Ptor subtypes from those occurlng centrally (Goldberg and
Kohll 1983). Careful analysis of agonist/antagonlst actions 
of these peripheral receptors has shown that R-sulplride 
potently antagonizes the DAI mediated renal vasodilation,
whereas it is ineffective in blocking the Dl' mediated DA
■<^i»>l*tion of adenylate cyclase (Spano et al, 1979) while 
opposite effects have been reported for a number of ergot 
derivatives (Kebabian et al, 1978). However, with the 
emergence of very specific agonist and antagonist drugs of the 
two receptor subtypes it is possible that the peripheral and 
central receptor subtypes will eventually be shown to be
identical (Goldberg et al, 1985).
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H»i* classification of DA racaptors has baan a subjact of 
intansa dabata sinca Laduron (1981), proposad that thara is only 
a singla typa of DA racaptor whila Saasan (1980), suggestad 
four subtypas. At tha sonant tha ganaral viawpoint is that 
thara ara two subpopulations of DA racaptors, D1 and D2; one 
possibla raason for tha prolifaration of siibtypas is the 
diii«rsnt conditions under which racaptor binding studies are 
carried out in various laboratories (Ivaraan 19 8 3). m  
addition, a nusbar of models have baan put forward that assuse 
that racaptors can exist in at least two conformations. Tha Monod 
modal suggests that tha transition from one state to tha next 
depends on binding with tha ligand in a concerted process whereas 
Kohland suggests tha involvement of a sequential process (Kaiser 
and Jain 1985). Tha four subtypas according to these models 
could therefore represent high and low affinity states of Dl and 
D2 receptors (sea Chapter 5).
Prasynaptic DA racaptors present on tha soma and dendrites 
oi the masollmbic and nigrostiatal systems appear to resemble the 
D2 subtype in many respects. Khan applied iontophoratically to 
tha zona coi^wcta, DA and a number of DA agonists Including 
apomorphina causa dose related suppression of the firing of these 
calls. Tha affects of these agonists is reversed by the selective 
D2 racaptor antagonist sulpiride and zatidollna but not by SCH- 
23390, tha specific Dl racaptor antagonist (Freedman and Woodruff 
1986). White and Wang (1984), reported that DA was the most 
effective exogenous agonist to inhibit the firing of these DA
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call* and ttaa apaciflc D2 racaptor antagonist, sulpiride, 
coaplataly blockad tha rata supprassant affacts of DA and DA 
agonists (but not thosa of GABA). Sisilar obsarvations have 
baan aada whan axoganous DA agonists hava baan applied to 
dendrites in tha zona reticulata. Again, the suppression of 
firing rates was reversed by antagonists of the D2 subtype but 
not by thosa reported to have D1 racaptor affinity (Gessa and 
Marau 1984). It has also baan daaonstratad that Dl 
racaptor antagonists fail to bloclc tha responses nediated by 
eg. aponorpbina, (aaasis ,tha inhibition of prolactin release 
and hypotharaia) that are dependant on tha Integrity of 
postsynaptic D2 receptors (lorio at al, 1983). The behavioural 
evidence though scant, also supports tha suggestion that 
prasynaptic DA receptors are of tha D2 subtype (see Chapter 
5) in that sulpiride but not SCH-23390 reversed 
aponorphina's inhibitory affect on locoaotion (Cuomo et al, 
1986). Finally, tha pharamacological evidence would seem to 
support tha hypothesis that l>oth call body and axon terminal DA 
autorecaptors are of tha D2 racaptor subtype as both have 
rather higher affinities for D2 agonists and antagonists. In 
terms of tha behavioural function of these receptors there is 
no evidence (prior to the present study) to suggest a separate 
function for each receptor: stimulation of either cell body or 
axon terminal autoreceptors by DA agonists results in sedation 
(Costall et al, 1981).
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1-4.1 Bloch— leal aapact« of tha atlaMlatlon of DA autoraceptors 
Tha rata lialtlng stap in tha blosynthasis of DA is tha 
convarsion of tyroslna by tyrosina hydroxylasa to L-DOPA 
(Blaschko 1957); following tha atlanilation of tarainal 
autoracaptors it has baan obsarvad that tyrosina hyroxlase 
activity is raducad (Nowyc)cy and Roth 1978). In contrast,
alactrical stiwilation of tha nigrostriatal pathway leads to 
an incraasa in tha synth— is of DA following a change in the 
kinetic properties of tyrosina hydroxylasa. Stiaulatlon 
results in an Incraasa in tha anzy—  affinity for the pteridlna 
co-factor and substrate and a decrease in the affinity for DA 
(Murrin at al, 1976). In addition, Murrln and Roth (1987), have 
reported that maxiaal stisulatlon of the nlgro-neostriatal 
fibr—  results in an increased synthesis of DA, which in turn 
could be raducad by DA agonists that interact with axon tarsinal 
autoracaptors. Tha abolition of neuronal firing by
h— Isaction or traat— nt with Gasaa-butyrolactone (GBL) also 
results in an Incraasa in tha synthesis of DA, as seasured by 
tha accuBulation of its precursor DOPA (Carlsson 1975; Nowyc)cy 
and Roth 1978; Roth at al, 1983). Again, in this sodel, DA 
agonists ware found to depress synthesis tdtereas DA antagonists 
reversed this affect.
However, tha role of DA autoracaptors in the release of DA 
has been'questioned since it has baan observed that changes in 
the release and synthesis of DA do not follow the sane tine 
course (Westfall et al, 1976). In addition, the initial
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•xp*rla«nts (Farnabo and Haid>argar 1971), in which it was 
daaonatratad that naurolaptics incraaaad tha stimilation-inducad 
ralaaaa of Oh idtila apoBoxphina had tha oppoaita effacts, 
hava subsaquantly not baan confirmad (Raitari at al, 1978). Tha 
usa of in vivo tachniquas could hava causad this anbiguity as 
alactrically invo)cad Oh ralaasa nay ba raducad by a nusbar of 
manipulations such as tha stimulation of postsynaptic OA 
^•captorm and call body autoracaptors in addition to tha 
•Simulation of axon tarminal autoracaptors. In rat caudata 
slicas, alactrically avokad ralaasa of DA was inhibitad by DA 
agonists whila DA antagonists incraasad tha ralaasa of DA 
(^Sllla at al, 1982a). it is of intarast that spontanaous 
ralaasa of DA was not affactad by apomorphina, haloparldol or 
calcium fraa Ringar; howavar, tha alactrically avokad 
ralaasa of OA was affactad by thasa compounds (Starka at al, 
1978). It would appaar that tha calcium dapandant ralaase of DA 
following alactrical stimulation is modulatad by prasynaptic DA 
racaptors but calcium indapandant ralaase alicitad by amphatamina 
is not (Arbilla at al, 1982b; Kamal at al, 1981). Similarly, in 
rat striatal mllcas it has baan shown that apomorphine fails to 
inhibit spontanaous ralaasa of OA but it did block the 
iosm«tlon of labelled DA (Bitran and Bustos 1982).
Roth at al, (1983), hava put forward a tentative model in 
which it is envisaged that stimulation of DA autoraceptors by 
apomorphina reduces tha influx of calcium leading to a reduction 
in OA ralaase along with protein carboxymethylation of
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calBodulln. Th* Mthylatad calaodulln raducas tha affinity of 
tyrosina hydroxylaaa for ptarldina and tyrosina and incraasas 
Ita affinity for DA; aa a consaquanca, DA synthasls la 
inhibitad. Daatructlon of dopamine neurons by 
intraventricular 6-hydroxydopamina (6-OHDA) Inhibits 
apomorphina affacta on carboxynathlation (Roth at al, 
1983) as wall as haloparidol induced release of DA (Blaha and 
Lane 1984; Foml and Nleoullon 1984); however, in the 
lesloned rat amphetamine enhanced DA release. The evidence 
to date would suggest that axon terminal autoreceptors are 
indeed Involved in the synthesis and calcium dependent release 
of DA though the precise mechanisms through which these 
molecular events are brought about still await resolution.
1.4.2 Behavioural consequences of DA autoreceptor stimulation
The consistent behavioural observation following the 
administration of low doses of DA agonists is hypokinesia 
(Costall et al, 1980; Dl Chlara at al, 1976; Strombom 1976) 
which is also apparent following blockade of dopaminergic 
transmission with neuroleptic drugs (Beninger 1983). The 
former is assumed to reflect a selective stimulation of 
presynaptlc DA receptors while the latter is assumed to occur 
following the blockade of postsynaptic DA receptors. However, 
with increasing doses of DA agonists stimulation of 
postsynaptic receptors also occurs resulting in locomotor and 
stereotyped behaviour (Kelly et al, 1975). The effects of 
autoreceptor stimulation by low doses of apomorphine are
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by 02 but not 01 receptor antagonists (Cuomo et al, 
1986; Stable and Ungerstedt 1986) but the stimulatory 
effects of this drug are reversed by non-specific DA receptor 
antagonists (Serra et al, 1983).
Apomorphine and 3-PPP have been used in the clinic as 
potential antipsychotic agents to some good effect (Tamminga et 
*1» 1978; 1983). The predominant feature arising from the use of 
such compounds was the reduction in extrapyramldal side effects, 
relative to classical antipsychotic agents, and the lack of 
effect on serum prolactin levels (Brown and Campbell 1984). 
Neuroleptic administration in animals typically causes catalepsy 
as well as a suppression -of conditioned avoidance responding 
(CAR). It has been pointed out that these effects of 
neuroleptic drugs correlate well with their clinical potency 
(®8l<l8**«rini 1980) and are dependent on the Integrity of the 
nlgrostriatal OA system (Carlsson 1978). The effects 
can be attenuated by pretreatment with anticholinergic agents 
(Baldessarinl 1980; Carlsson 1978). The Increase in 
striatal OA ttimover following haloperidol administration is also 
blocked by pretreating with scopolamine (Anden 1972). However, 
very low doses of DA agonists, unlike neuroleptics, do not 
inhibit CAR, which could be related to the minimal effects of 
these agents on extrapyramidal motor functions (Ahlenius and 
Hillegaart 1986).
Interpretation of the effects of low doses of DA agonists on 
positively reinforced operant tasks is not entirely
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straightforward. Apoaorphine rsducss responding in a CRP schedule 
by 30% at a dose of 60ug. However at 30ug no such effects are 
detected in the CRF paradiga but deficits are obtained in fixed 
interval schedules. In addition, apoaorphine showed enhanced 
reductions in elevated fixed ratio schedules which in turn is 
concordant with the anhedonia hypothesis based on the law of 
effect (see above). That these effects can be explained by the 
siaple notion that DA agonists reduce locoaotor activity in rats 
is refuted by the observation that apoaorphine spared renewal 
of responding caused by food delivery but abolished responding 
reinstated by secondary reinforceaent (Camoy et al, 1986). bow 
doses of DA agonists have also been reported to iapair responses 
to novelty (Misslin et al, 1984). These findings would iaply that 
low doses of DA agonists reduce or blunt the iapact of incentive 
stiauli leaving prlaary reinforceaent intact. Such a view would 
seea to be consistent with the position that DA systeas are 
involved in the activating effects of rewarded behaviour ie, 
incentive activation (Bindra 1974, 1978), rather than with reward 
per se.
Increases in yawning behaviour in rats has been observed 
following the adalnistration of low doses of apoaorphlne (Gower 
et al, 1984; Stable and Ungerstedt 1984). However, the location 
of the DA systea involved in the yawning response has been 
questioned, as has the receptor subtype, as SCH-23390 attenuated 
the yawning response evoked by apoaorphine in both control 
and reserpine pretreated rats (Morelli et al, 1986).
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It has b««n suggastsd that OA systeas aay be lapllcated in 
the etiology and expression of anxiety (Taylor et al, 1982) since 
low doses of aposorphine sees to be beneficial in the sanageaent 
of certain states of anxiety associated with psychotic conditions 
seen in schizophrenics. However, low doses of neuroleptics have 
also been reported to relieve anxiety related syaptoas in 
neurotic (Finnerty et al, 1976) and chronically anxious patients 
(Rogerson and Butler 197l)_. The aniaal literature also fails to 
distinguish between OA agonists and antagonists: both low doses 
of apoaorphine and neuroleptics produce anxiolytic effects 
in the conflict paradiga (Hjorth ot al, 1986; Merlo Pich and 
Saaanin 1986). However, once again the exact identity of 
neuronanatoaical locus through irtiich these agents exert 
their anxiolytic like actions is lacking but the aechanisa of 
action underlying neuroleptic-induced Increases in punished 
responding does appear to Involve central serotonin neurons 
(Leysen et al, 1978).
1.5 DA MfO DEPRESSION
catecholaaine hypothesis of depression (Schildkraut 
1965), suggested a reduction in the levels of the 
neurotransaltter noradrenaline rather than adrenaline or 
dopaaine, in critical areas within the central nervous systea 
(CMS). This hypothesis proved to be very attractive in that it 
could explain a nuaber of pharaacological phenoaena that result 
following the aanipulation of noradrenergic systeas. Reserpine 
which depletes noradrenergic terainals of NA, was used in the
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of hypor^onalon also inducad severa daprasslon in a 
nuabar of patlants. In contrast, aonoasina oxidasa inhibitors 
usad to traat tubarculosis, incraasa lavals of NA and ware found 
to produca an alavation in aood (Loonar at al, 1957). in 
addition, aaphataaina which anhancas tha ralaase of NA froa 
prasynaptic tarainals, was also affactive in elevating aood in 
noraal volunteers (Lasagna at al, 1955). The finding that the 
lavals of tha aajor _ aatabolite of KA, 3-aathoxy-4-
hydroxyphanyglycol (MHFG) ware low in deprasslvas (Mass 1968), 
further supported tha hypothesis of a reduced NA function in 
depression.
However, a nuaber of anoaalias began to appear with respect 
to drugs that supposedly reduce NA function and thus in theory 
should exacerbate daprasslon. Alpha-aathyl-para-tyrosina (AMPT) 
inhibits tha conversion of tyrosine to dlhydroxyphanylalanine 
and thus reduces NA levels, did not cause depression 
(Mendels and Frasier 1974). In addition, Goodwin (1972), noted 
that in patients reported to be suffering froa depression 
following reserplne pretreataent were actually not depressed but 
were sedate and lethargic. In contrast, aaphetaaine which 
Increases NA has not been shown to be an effective 
antidepressant. However, little aention was aade of the fact 
that;
1. the evidence for NA also Inadvertantly supports a reduction in 
DA levels,
2. depression aay be biocheaically heterogenous.
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The dopaaine hypothesis of depression becase prevalent 
following the observation by Randrup in 1975, that in sone 
depressed patients HVA levels were abnormally low. HVA is the 
■ajor Mtabolite of DA and its presence in cerebrospinal fluid 
(CSF) is thought to mainly originate from DA turnover in the CMS. 
The majority of studies to date have reported a reduction in the 
concentration of HVA in depressed patients (Bankl 1977; Mendels 
et al, 1972; Papeschl and McClure 1971; Bowers et al, 1969) but a 
ntimber of studies have found no difference in HVA levels in 
depressives and normal controls (Berger et al, 1980; Subramanyam 
1975). The latter inconsistency may have resulted from the 
transport of HVA out of the CSP. This problem may be remedied by 
administering probenecid, which blocks the removal of acid 
metabolites out of the CSF; studies using this technique have 
reported a decreased HVA accumulation in sone or all 
depressed patients (Bowers 1972; van Praag et al, 1973; Sjostrom 
1973). Low HVA levels in the CSF following probenecid 
pretreatment in patients with marked psychonotor retardation, is 
probably the most firmly established finding in the biochemistry 
of depression (Hillner 1985).
1.6 ^  AMD AMTIDBPPBSSAMTS
For a number of years the possibility that antidepressants 
increase DA function was neglected, as it was believed that 
tricyclic antidepressants act by inhibiting the uptake of NA and 
5-HT but not of DA (Carlsson 1970). This belief cane to be 
questioned following the observation that antidepressants are
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*®**^^**® in the treatment of Parkinsons disease
(Randrup at al, 1975), which results from a depletion of 
nigrostriatal Dk (Homykiewicz 1966). Subsequently it was 
demonstrated that antidepressants do in fact inhibit DA uptake 
weakly and this effect was also demonstrated by 
some antidepressant drugs that do not block neuronal uptake of 
HA or 5-HT (Hytell 1978).
Antidepressant effects are usually seen following two to 
three weeks of treament so the acute effects of these drugs 
(which now appear to include a weak inhibition of DA uptake) may 
be ruled out as the mechanism of clinical action. A number of 
studies have reported that antidepressants may Increase DA 
function by increasing the synthesis of DA (Leonard and Kafoe 
1976; Sugrue 1980). However, only mianserin slightly increased DA 
content, while a number of antidepressants ai^ ECS did not have 
any effect on DA levels (Evans et al, 1976; Sugrue 1980). In 
addition, turnover of DA %ras unaffected by chronic treatment with 
a numiMr of antidepressant drugs (Sugrue 1980).
However, a considerable literature demonstrates an 
increase in the responsiveness of postsynaptic DA receptors 
following chronic antidepressant treatment. Chronic treatment
with tricyclic antidepressants and the atypical
antidepressants mianserin and Iprindole produced an enhanced 
response to apomorphine and amphetamine-induced locomotor 
behaviour (Serra et al, 1979; Spyraki and Fibiger 1981; Maj et 
al, 1984a,b; Martin-Iverson et al, 1983; Willner and Montgomery
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1981). These responses are believed to result fros the 
■tinulation of aesollabio postsynaptic OA receptors (Moore and 
Kelly 1978), the results suggest that chronic antidepressant 
treataent either increased the affinity or the nuaber of these 
receptors (see below). in addition, soae studies have reported 
that repeated antidepressant treataent also caused an Increase 
in the responsiveness of postsynaptic DA receptors in the 
nlgrostrlatal DA systea^ as aaphetaalne and apoaorphine 
stereotypy were found to be increased following chronic 
treataent with a variety of antidepressant drugs (Hillner and 
Montgoaery 1981; Millner et al, 1984). However, these findings 
are less well supported as a' nuaber of studies have failed to 
deaonstrate any enhanceaent of the stlaulant-lnduced stereotyped 
behaviour with chronic antidepressant pretreataent (Dellna-Stula 
and Vassout 1979; Maj et al, 1979; Spyra)ci and Fibiger 1981).
The biocheaical evidence however, does not support an 
increased responsiveness of postsynaptic DA receptors. A nuaber 
of studies have failed to show any Increase in DA receptor 
binding in the striatua or for that aatter, in the accuabens, 
with the specific ligand 3H haloperidol following chronic 
antidepressant treataent (Martin-Iverson et al, 1983; Tang and 
Seeaan 1980; Tang et al, 1981; Hillner 1983). Subsequently, it 
has been suggested that the sensitization of DA receptors may 
depend on the anticholinergic properites of antidepressant drugs 
in that antidepressants with negligible affinity for the 
cholinergic receptor subtype did not potentiate DA agonist
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induced behaviour« (Martin-Iverson et al, 1983). This promising 
hypothesis has now lost mosentun as in three other studies the 
•ntidepressants used in the above study did potentiate DA- 
dependent behaviours (Amt at al, 1984; Maj et al, 1984a,b). 
However, as results from receptor binding studies sees to vary 
fro« one laboratory to another it say be premature to rule out an 
increased sensitivity of postsynaptic OA receptors following 
chronic treatment with antidepressant drugs on this evidence 
alone. The behavioural evidence would also seen to support this 
view as sulpiride, an atypical neuroleptic, reversed the 
antidepressant effect on immobility in the Porsolt test in rats 
(Borsinl et al, 1984; Pulvlrentl and Samanln 1986). Central 
injection procedures would also suggest that the nucleus 
accumbens is involved in this effect as intracranial 
administration of sulpiride to this area resulted in similar 
findings (Cervo and Samanin 1987)..
1>6«1 Antidepressants aiwl presvnaptic DA receptors
While an increased response to OA agonists following chronic 
antidepressant treatssnt suggests a postsynaptic site of action, 
these data are also open to an alternative explanation: a 
reduction in the sensitivity of presynaptic DA receptors. The 
toning dotm of the inhibitory effects of autoreceptor stimulation 
by endogenous DA would in effect Increase DA synthesis and 
release. Following acute administration of the antipsychotic drug 
molindone, increases in DOPAC have been reported while low doses 
of apomorphine were ineffective in reducing these levels (Conway
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and Uretsicy 1983). In addition, tha doses of molindone used in 
this study correlate well with those that enhanced amphetamine- 
induced stereotypy.
Serra et al, (1977), reported that following chronic but not 
acute treatment with Imipramine, amitriptyline and mianserin the 
sedative effects of a low dose of apomorphine were abolished. 
Subsequently, this effect was confirmed using a variety of 
antidepressant agents which included nomifensine ( a specific DA 
uptake inhibitor), doxepin (Zebrowska-Lupina and Kozyrska 1980), 
KAO Inhibitors (Chlodo and Antleman 1982) and ECS (Serra et al, 
1981). The electrophysiologlcal evidence also seemed to support a 
reduction in the sensitivity of presynaptlc DA receptors 
following chronic antidepressant treatment, as the reduction in 
DA cell firing following apomorphine was found to be attenuated 
(Qiiodo and Antelman 1980). The biochemical evidence however, %ras 
equivocal. An Increase in DA synthesis which should result from a 
reduction in the sensitivity of DA autoreceptors was observed by 
Serra et al, (1979), and Holcomb et al, (1982), following chronic 
treatment with antidepressant drugs. However, no Increase in DA 
synthesis was observed following ECS, which did block the 
sedative effect of apomorphine (Färber et al, 1983).
In addition, Holcomb et al, (1982), using the GBL model to 
assess the inhibition of DA synthesis by apomorphine following 
the cessation of Impulse flow, reported that chronic treatment 
with a typical or an atypical antidepressant did not change the 
response to apomorphine. A number of studies have also failed to
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observe any changes in the sedative effect of aposorphine after 
chronic treataent with antidepressant drugs or ECS (Ehlers et al, 
1983; Spyraki and Fibiger 1981). The finding that antidepressants 
increase DA cell firing has also been found wanting in that two 
studies found no change in the aposorphlne-induced inhibition of 
DA cell firing following chronic antidepressant pretreataent 
(NacNelll and Gower 1982; Welch et al, 1982). It is difficult to 
draw any definite conclusions froa these studies in relation to 
the effects of antidepressant drugs on DA autoreceptor 
sensitivity.
The problea of assessing the role of DA autoreceptor 
sensitivity in the apparent potentiation of dopaalnergic 
function by antidepressants is coapounded to soae extent by 
aethodological liaitations. The aaj or technigue used to identify 
changes in DA function is that of a potentiation of DA agonist 
induced behaviours, which aay result either froa a reduction in 
the sensitivity of presynaptlc DA receptors or tram an increase 
in the sensitivity of postsynaptic DA receptors. This aethodology 
therefore cannot deteraine with certainty the site of action 
through %rtxich antidepressants aay exert their effects on DA 
systeas. In earlier experlaents in this laboratory (Towell 1984), 
presynaptic DA receptors were assayed by the effects of low doses 
of apoaorphlne on food intake in rats. As will l>e deaonstrated 
below (Chapter 5), apoaorphine anorexia provides a aethodology 
which does differentiate between subsensitive presynaptic DA 
receptors and supersensitive postsynaptic DA receptors.
37
Lik« «arllar studlM of DA auterocoptors, the initial
axpariMnts on the effacts of chronic antidepressant treatsent on 
apoaoridiine anorexia also proved inconclusive. In the first 
•xp^rieent, the evidence for DA autoreceptor subsensitivity 
during chronic DMI treatnent was at the best equivocal; in a 
second experinent, in which aponorphine was applied centrally, 
there was no evidence for this effect. Nevertheless, in both 
experinents, a reduction^ in DA autoreceptor sensitivity was 
apparent following the withdrawal from chronic treatiMnt with the 
tricyclic antidepressant DMI (Towell 1984). In view of the 
potential clinical immrtance of antidepressant effects on DA 
•y*teaas and the advantage • Of this particular technique for 
studying these interactions (Chapter 2), the present experinents 
were carried out in order;
1. To establish the eechanises of apoeori>hine anorexia.
reevaluate the effect of antidepressants on DA autoreceptor 
function.
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CHAPTER 2
APCTIORPHIME ANOREXIA
Aa notad in Chapter 1, low dosaa of DA agonists, such as 
apoBorphlna, stisulats prssynaptlc DA racaptors (Carlsson 1975), 
and Inhibit tha synthasis and ralaasa of DA (Hjorth at al, 1982), 
which results in behavioural sedation. High doses of aposorphina, 
however, stimiate behaviour, by an interaction with postsynaptic 
DA receptors in the nucleus accusbens and strlatiw, which 
produces locosotor activation and stereotyi>ed behaviour 
(Kakanjoula at al, 1982; Kelly at al, 1975). The phanucological 
evidence related to the behavioural effects of low doses of 
apoBorphine is soMwhat controversial. Nhile s o m  studies have 
found that ap«M>rphine-induced sedation was blocked by 
neuroleptic drugs (Di Chiara et al, 1976; Montanaro et al, 1982), 
others have failed to antagonise aponorphine induced sedation 
with neuroleptics (Costali at al,1980) or have reported that sose 
neuroleptics were effective but others were not (Sunner at al,
1981). These data in turn would suggest that the pharMcologlcal 
and behavioural effects of a sedative dose of aposorphine M y  be 
heterogenous. However, all these studies used locosotor activity 
to monitor aposorphina Induced sedation and in this paradlgs it 
is very difficult to fractionate motor activity into Maningful 
and reliable behavioural components. Workers in this laboratory 
therefore decided to examine the sedative effects of apomorphine 
in a different paradigm that does lend itself to behavioural 
mlcronanalysis.
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2.1 MICROSTBUCTUfcAL AHALYSIS OF FEEDING BEHAVIOOR
Both food deprived and non-deprived aninals eat in discrete 
(Richter 1927), and it is possible to analyse feeding 
behaviour by Measuring the nueber of seals taken, eeal sise, seal 
duration, inter-eeal intervals and the average rate of eating 
during eeals. Within aeals, short bouts of eating are separated 
by episodes of other behaviours such as rearing and asbulation 
(Blundell 1981). So in addition, certain intra-Meal parameters 
can be assessed, such as the number, size and duration of, eating 
bouts. The relationship between bouts of eating and non-eating 
activities can also be assessed. Thus a drug may reduce food 
intake by either affecting the" physiological mechanisms involved 
feeding or by enhancing non-nutrional behaviours between 
eating bouts and disrupting feeding behaviour during a meal. The 
intrameal parajipters are often called microstructural parameters 
of eating.
Osing this methodology, Blundell and Latham (1980), reported 
that the anorectic agents, ami^ietamine and fenfluramine, had 
affects on the microstructural characteristic of 
eating. Both drugs reduced consumption by reducing the time spent 
eating, but paradoxically, amphetamine increased the rate of 
consumption whereas fenfluramine reduced the rate of food intake.
^^bding demonstrates that the method employed is able to 
reveal different behavioural actions of anorectic drugs, and 
also implies that different modifications in the microstructure 
of eating may be related to the drugs varying actions on
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particular naurochealcal systeu. in fact Blundell and Lathaa 
(1980), deaonstrated that at equlpotant doses, fenfluraaine 
hypophagia was antagonized by the serotonergic antagonist 
aethergoline but not by piaozide, a dopaaine receptor antagonist, 
while the reverse was true of aapheteusine anorexia.
The aajorlty of aicrostructural studies of feeding behaviour 
have relied on observers to record Aether the aniaal was eating 
or not (Blundell and Lathaa 1978; Cooper et al, 1979, 1980a,
1980b). Two probleas are inherent in this procedure:
1. Subjective observation aay result in drug effects that are 
distorted by artefacts of an inaccurate decision:
2. Observational analysis is both tlae consuaing and labour 
intensive.
*** aethodology, first used to analyze song patterns
in zebra finchs (Slater 1974), and subsequently applied to 
feeding (Hlep)ceaa 1971; Burton et al, 1981; Winner and Towell
1982) showed that changes between feeding and other behaviours 
aay be deduced by exaainlng the teaporal distribution of feeding 
responses. The technique used to do this is log survivor analysis 
of the distribution of inter-response tines (iRTs).
2.1.1 THE IRT METHOD
The theory behind log survivor analysis is that the frequency 
of IRTs is nade up of a ntiaber of underlying Poisson 
distributions, each associated with a behaviour having a constant 
probability of expression. The problea with IRT analysis is to 
resolve these discontinuities reliably. Such a aethod is
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Available in tbe technique of log survivor analysis;
45 eg pellets (Abels anieal nutrient pellets), which are of 
uniform bite size are used to aa)ce it possible to record the 
time of all bites. Proa this Information it is possible to 
calculate inter-response times (IRTs) and plot the frequency 
distribution of IRTs. The IRT distribution for values ranging 
between 1 and 36 sec is bell shaped with a long trailing tail 
(Fig 2.1A). IRT mode values are usually in the range of 4 to 8 
sec and at IRT values of greater than 12 sec there are a 
significant reduction in responses trtilch is the reason for the 
the long tail in the 36 sec distribution. Hie frequency 
distribution of IRTs can l>e transformed to a survivor plot, which 
shows the frequency of IRTs longer than any given time period. A 
log transform of this function results in a log survivor plot, 
from trtiich reliable estimates of the time spent feeding may be 
deduced. A straight line on a log survivor represents a single 
Poisson function and so any discontinuity can be visualised as 
changes in the slope of the log survivor function. A 
"brealqpoint" may then be Identified (Pig 2.IB). The break point 
provides a "bout criterion" %rhich is then applied to decide 
trhether a particular inter-response interval is within or between 
eating bouts.
It is assumed that bouts of eating occured at IRTs shorter 
than the brealqwint whereas other behaviours such as ambulation 
were associated with IRTs longer than the brea)cpoint. Log 
survivor curves are therefore constructed for each subject and 
for every experimental session following which the breakpoints
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Fig. 2.1
A: The frequency distribution of Inter-response times for a typical subject, 
and tWe the survivor transform, which shows the proportion of the frequency 
distribution lying to the right of each point In the frequency distribution.
N Is the number of responses In each Is IRT bln and p(S) is the percentage of 
survivors.
B: Three typical log survivor functions. The uppermost curve Is the log 
transform of the survivor function shown in A; for clarity, the other two 
examples are displaced down by one log unit. The breakpoint in each curve Is 
marked by an arrow.
Winner and Towell 1982.
«3
ar* dataralnad and parasatars of aatlng tlaa and anting rata are 
than deduced.
In order to verify that changaa apparent in eating rate in 
the nicrostructural paradigm are not artefacta of the method 
eiq>loyed, the frequency dietribution of iRTa can be plotted. A 
reduction in the rate of consumption should be readily visualized 
by a shift to the right in the distribution curve and an increase 
in the median IRT whereas an increase in eating rate should 
result in a shift to the left in the IRT frequency distribution 
and a decrease in the median IRT. ^pomorphine reduces eating rate 
as calculated by the log survivor method (Hillner at al, 1985), 
and also caxises a rightward shift in the descending limb of the 
distribution curve «Aich results in an Increase in the median 
IRT. Amphetamine in contrast Increases eating rate and causes a 
leftward shift in the IRT distribution. (In this case the 25th 
percentile was used to measure the shift in the ascending limb of 
the distribution as this parameter proved to be more sensitive to 
these changes than the median lRT.)(Towell at al, 1987b).
Prior to the work of Towell (1984), the log survivor method 
had only previously been used to analyse twenty-four hour feeding 
patterns (Booth 1972; Booth and Pain 1970; Burton et al, 1981). 
Apomorphlne has a short duration of action (Burkman et al, 1974; 
Kaul et al, 1961), it was therefore necessary to determine 
whether log survivor analysis could also be used to analyse 
brief (thirty minute) feeding seseions. The assumption that iRTs 
shorter than the breakpoint represent eating within a bout,
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«Aillst IRT« graatar than tha braalq;>olnt raprasant aatlng batwaan 
bouta, waa validatad by c<Mq>aring raaulta obtainad with log 
aurvlvor analyaia and with thoaa obtainad through diract 
obaarvation (Willnar and Towall, 1982). AniMla wara filaad, and 
obaarvad to apand long parioda aating, diractly facing tha food 
tray and only moving to taka a furthar food pallat; it was 
poaaibla to idantify fr<» tha film thoaa intar-raaponaa intarvals 
in which bahavioura othar than aating (raaring, grooming and 
walking) occurad. Eatimationa of aating tima by tha log survivor 
mathod diffarad froa thosa obtainad from diract obsarvation by 
only 2.1%. Tha valuas of aating rata wara avan closar (1.3%). Tha 
astimation of tha numbar and langth of bouts was lass accurata 
with arrors in axcass of 40%. Howavar, it is likaly that a 
proportion of tha gaps notad on tha film wara wrongly
catagorisad, sinca at vary short intarvals thasa usually 
consistad of a singla raar or turn by tha rat, both of which ara 
compatibla with continuad aating. Whan tha vary short gaps (<lo 
sac) wara axcludad from tha calculation, tha discrapancy in tha 
and langth of bouts, though still markad, was considarably 
raducad (25% and 23% raspactivaly). In conclusion, tha mathod 
dascribad producad vary accurata astlmatas of aating rata and 
aating tima and raasonably accurata astimatlons of tha langth of 
aating bouts and tha intarvals batwaan thasa bouts of faeding.
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2 .2  MICROSTRUCTORAL ANALYSIS OF APMiORPHIME ANOREXIA
As notsd abovs, DA agonists hava blphasic affacts on 
locoBotor activity. Low dosas produca sadation, but at highar 
dosas, locosotor stimulation bacoaas apparant (Costall at al, 
1980, 1981) Carlason 1975). Tha sadatlva affacts of aponorphina 
•ra baliavad to rasult from an intaraction with prasynaptic DA 
racaptors on call bodias and axon tarminals (Skirboll at al, 
1979; Sokoloff at al, 1980j Hjorth at al, 1982), tihila tha 
activating affacts rasult from tha stimulation of postsynaptlc DA 
xacaptors (Rally at al, 1975; Kababian and Calna 1979). Howavar, 
Willnar at al, (1985), raportad that apomorphina raducad total 
food intaka monotonically at all dosas tastad (Fig 2.2). 
Nicrostructural analysis showad that apomorphina raducad tha rata 
of oonsui^>tion and tha tima spant anting at all dosas tastad. 
Nowavar, at low dosas (<0.1mg/kg) apomorphina raducad total 
anting tima by raducing. tha langth of anting bouts, %rtiaraas at 
high dosas (>0.1 mg/kg) apomorphina raducad anting tima by 
incraasing tha latancy to initiata faading and tha langth of gaps 
batwaan faading bouts. Navarthalass, daspita thasa diffarancas 
batwaan tha actions of prasynaptic and postsynaptic dosas of 
Apomorphina, tha monotonio dosa rasponsa curva raisas tha 
guastion of whathar tha raduction in faading by low dosas of 
apomorphina raally doas rasult from tha stimulation of 
prasynaptic DA racaptors.
Tha affact of apomorphina on anting tima was assumad by 
Hillnar at al, (1985), to ba madiatad primarily by DA call body 
autoracaptors in tha masolimbic systam, sinca tha affact could be
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APOMORPHiNE DOSE-RESPONSE
300
a. 100-
Total
0 .04 .08.16.32.64 
Dose (mg/kg, s-c)
Fig. 2.2 Star* show dlffarencea t«tw«an control and apoaoxphlne.
On* star p<.03, t*»o atara p<.01, Oiraa atara p^.OOI.
Wfillner ct al, J98S.
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reliably elicited by epoaorpbine infueione in the VTA. However, 
thia finding is not conclueive evidence that apoeorphine acts in 
the VTA after syataeic adeinistration. One of the sain objectives 
of this thesis was resolve this problem iuuud>iguously (see 
section 2.4).
A further problem with respect to the effects of apomorphine 
on the nlcrostructural parameters was the finding that 
neuroleptics reversed the apomorphlne-induced reduction of eating 
time but not of eating rate (Winner et al, 1985). A second 
objective was therefore to resolve the mechanism by idiich 
apomorphine reduces the rate of eating.
Talcing the apomoridiine-induced reduction in eating time as a 
measure of DA cell body autoreceptor function, Towell (1984), 
reported that in two out of five tests during chronic treatment 
with the tricyclic antidepressant DNZ, aposorphine failed to 
reduce food intake. This finding would tend to support the 
observations of Serra et al, (1979), that chronic antidepressant 
treatment reduced the sedative respense of apomorphine on 
locomotor activity. This, in turn would suggest that one of the 
mechanisms of by which antidepressants exert their effects is by 
reducing the sensitivity cf presynaptlc DA receptors. However, in 
a second experiment, no changes in the anorexic effect of 
apomorphine applied directly to the VTA were detected during the 
course of chronic treatment with DMI (Towell 1984). In both 
experiments (le, using both peripheral and central administration 
of apomorphine) a reduction in the apomorphine response was
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obMrvsd during withdrawal froa chronic antidaprassant traataant. 
Thia laplias that OA autoracaptors ara aubsanaitlva only during 
withdrawal, and calls into question tha assuaptlon that 
reductions in tha sensitivity of prasynaptic DA receptors
contribute to tha affects of antidaprassant drugs. A third 
objective of this thesis was therefore to reevaluate the effects 
of chronic antidepressant pretreatnent on DA autoreceptor 
function following a conclusive resolution of the sechanisas by 
which low doses of aponorphine reduce eating tlae.
2.3 M  EVALPATIOM OF VARIABI^ IHTBRVAL OPERAMT RESPONDING ^  A 
POTENTIAL EXPERIMENTAL TOOL
An Initial experiaant was carried out to examine whether 
variable Interval (VI) responding could )»e used as an 
eiqperiaantal tool in place of continous reinforceaent (CRF). The 
schedule used was a VI of 30 secs. VI schedules have four 
potential advantages over CRF:
1. The schedule generates steady states of responding asking it 
very aaenable to study the affects of apoaorphine on rate.
2. It is possible to introduce a nuaber of different coaponents 
within the schedule and thereby generate aore coaplex 
experiaental designs.
3. Satiation results auch aore slowly with these schedules so it 
is also possible to run longer sessions.
4. The schedules are cost effective, in that the nuaber of 
pellets consuaed in a session is considerably less than that in 
the CRF paradiga.
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2.3.1 METHOD 
Subjects
Adult sale Lister hooded rats (Olac, Bicester, Oxon) weighing 
250-350g were used. They were housed in pairs under conditions 
of controlled tesperature and hualdity, on a 12 h light-dark 
cycle (08.00-20.00 h light). Animals were maintained on 21-h food 
deprivation, with free access to food between 14.00 and 17.00 
hours daily, and water available at all times. Behavioural 
testing was carried out between 10.00 and 14.00 hours.
An;>aratus
Bight identical operant test chambers (Campden Instr. Ltd., 
London), enclosed in sound .attenuating cubicles, were fitted with 
the right lever only. Recording of lever presses and delivery of 
food pellets were achieved by means of an on-line digital 
co^Miter (Acorn System IV), whi<di %ras programmed in Onlibasic, a 
language designed for the on-line control of behavioural 
experiments (Fray 1981). IRT's, were also recorded using a 
Cromemco Z2 microcomputer and thus the IRT frequency distribution 
for each animal receiving each treatment could be determined.
Procedure
Pharmacological studies were not initiated until all animals had 
achieved a steady state of responding, which required between 30 
to 40 sessions. The duration of the teat session was 30 min. Drug 
treatments were presented in a counterbalanced order, with a 
minimum of two drug-free days between tests. One group of animals 
(n>12) received four doses of apomorphine: 0, 0.04, 0.06 and 0.08
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■g/lcg; a furthar group (n-12) recaived four dosas of pimozide: 
0, 0.3, 0.45 and 0.6 mg/kg.
All injactions wara mada in a volume of 1 ml/kg. Apomorphine 
HCl (Sigma) was dissolved in 0.02% ascorbate as an antioxidant, 
and Injected subcutaneously in the scruff of the neck lo min 
p i^ io r to test sessions. Pimozide (Janssen) was dissolved in 
minute quantises of glacial acetic acid and made up to the 
required volume with distilled water and injected 
Intraperitoneally 2 h prior to test sessions, impropriate vehicle 
solutions were used for control injections.
2.3.2 RESULTS
The effects of apomorphine and pimozide on the total number of 
^••ponses and the total number of reinforcers recorded in the 30 
minute session are shown in figure 2.3A. Jm<>»orphlne reduced the 
total number of responsed at 0.04mg/kg, (P(l,33) - 16.9,
p<0.001). However, with increasing doses of apomorphine there was 
no further reduction in response output. The reinforcement 
density was similarly reduced by ^;>oaorphine at all doses tested 
P(l-»33) “ 6.2, p<0.05). The reduction in response output by
*P«*®*phine was reflected in a reduction in the number of the 
shorter Intervals in the IRT frequency distribution; the 
preponderance of the longer IRT's resulted in a significant 
increase in the median IRT (Fig 2.3B; min P(l,33) - 5.2, p<0.05). 
Again, however, there was no further Increase the median IRT with 
Increasing doses of apomorphine.
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In oontrast to apoaorphin«, plaozld« r«duc«d rat* dosa- 
dapandantly (Flg 2.3A: F(l,33) - 26, 46.9, 89.4, P<0.001). Excapt 
t o r tha lowaat dosa tastad, pinosida alno raducad tha total 
nuabar of pallata obtainad in tha tast saaslon (Fig 2.3A: F(l,33) 
” 16.7 and 68.7, p<0.001). Piaozlda also causad a dosa 
dapandant incraaaa in tha nadian IRT (Fig 2.3B: F(l,33) - 5.7,
6.5, 19.1, p<0.05, 0.05, 0.001).
Aponoridilna and plmozlda producad vary sinllar changas in 
raspondlng, ralnforcaMnts and tha nadian IRT at tha lowast dosa. 
Howavar, tha hlghast dosa (doubla tha lowast in both casas), 
tha affacts of piaosida vara signiflcantly graatar on all thraa 
■aasuras (Fig 2.3A,B: F(l,33) - 89.4, 68.7, 19.1, p<0.001).
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ig. 2.3
EFFECTS OF APOHOBPHIIiE AND PIMOZIDE ON 
VAEIABLE INTERVAL PERFORMANCE (VI 30)
O— —O
S3
2.3.3 DISCPSSICMt
In thin «xpnriMnt administration of aponorphina and 
pimoaida in tba varlabla Intarval achadula caused a conconittant 
reduction in responding and the number of reinforcements obtained 
in a session. In other words, apomorphlne produced similar 
behavioural deficits to those seen following neuroleptic 
administration in positively reinforced tasks. However, the 
effects of pimozide increased dose-dependently while those of 
apomorphina did not. If it is assumed that the doses of 
apMorphine used in this study selectively stimulated presynaptic 
DA receptors. Interpretation of the results is relatively 
straightforward. Stimulation of DA autoreceptors reduces DA 
availability in the synaptic terminal irtiile pimozide reduces DA 
efficacy by blocking postsynaptlc DA receptors. Therefore, 
following maximal stimulation of DA autoreceptors, increasing 
doses of DA agonists do not result in further reductions in 
responding (floor effect), whereas, increasing doses of DA 
antagonists further inhibit endogenous DA from activating 
postsynaptlc DA receptors resulting in greater reductions in 
response malntainance. The results of the present experiment are 
fully consistent with this formulation. However, it is important 
to note, that the effects of apomorphlne in the CRF paradigm were 
rather different: increasing doses of apomorphlne, notably from
0.04 to 0.08 mg/kg, resulted in further reductions in food 
intake. The effect of apomorphine in the CRF paradigm appears 
to be more coiq>lex and therefore it nay be unwise to use VI 
schedules to attempt to elucidate the effects observed in CRF
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•xp«rÍMnts.
A furthar problui Im c o m s  apparent on axaaination of tha log 
survivor curvas for VI and CRF schsdulas. Tha curvas raprasantad 
(Fig 2.4), ara typical for animals parfoming in thasa two 
procaduras. In tba CRF paradigm a changa in tha slopa of tha 
curva is aasily visualisad at IRT valúas of lass than 16 sac 
(approx), wharaas in tha VI curvas a changa is obsarvabla at IRT 
valúas of graatar than 16 sac. Using tha braaJcpoint than to 
daduca tha timas spant aating (CRF) or lavar prassing (VI) it 
bacomas apparant that tha animals rasponding in tha CRF paradigm 
did so for intarvals ranging batwaan 700-1600 sac, whila in tha 
VI paradigm animals raspondad for 1700 to 1800 sac. In tha 
miorostructural paradigm tha animals wars abla to obtain as many 
food palista as thay daslrad and tharafora spant mora or lass tha 
first half of tha sassion at tba tray door, whila in tha rast of 
tha sassion thay carriad out a variaty of diffarant bahavlours 
(grooaiing, rasting, ambulation), intarsparsad by occasional 
visits to tha tray door. Tbs animals parforming undar tha VI: 30 
schadula spant most of tha sassion lavar prassing for food as tha 
maximum numbar of palista availabla was only 60. This axplanation 
would account for tha obsarvatlon that tha braa)q;>oint in tha VI 
procadura cannot ba usad, to distinguish batwaan bahaviours other 
than rasponding, to calculate an accurate astimata of tha time 
spant lavar prassing. Tha usa of tha breakpoint method however, 
demonstrated that rasponding in tha VI schadula was continous 
throughout tha sassion. Tha VI schedule would then be the
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V I CRF
rig. 2.4 «urviyor function, for VI (variable interval) on the left
a ^ r r ^  breakpoint is markedby an arrow. The end time under the arrow denotes the time spent lever
S ^ n ^ f f e d i n ^ V i  "" this denote* the time
irthe M  iiS'se.sion responses that occurred after the breakpoint
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appropriât* tool to us* if on* only want*d to invostigat* the 
*ffacts of apoMorphin* on rat*. W* did, indead, find that a 
variaty of naurolaptics failed to attenuate the aponorphine 
response with the exception of sulpiride (results not shown) a 
specific 02 receptor antagonist (Jenner at al, 1978; Montanaro at 
al, 1982). However, for reasons outlined above, the VI 
procedure cannot demonstrate changes in the time spent lever 
pressing as lever pressing was continous throughout the 
Given that the affect observed during antidepressant 
withdrawal, in th* CRF paradigm, was an attenuation of
eating time, VI schedules cannot be used to investigate th* 
mechanism by which antidepressants produce such an affect.
2.4 OBJHCTIVBS OF PRESENT WORK
For th* reasons described above, th* CRF paradigm was used in 
all subsequent *;q>*rim*nts. Chapter 3 contains a detailed 
description of th* methods used in these studies.
■n»* first objective was to resolve th* neurotransmitter 
■y*t*m* involved in th* apomorphine-induced reduction* of eating 
time and eating rat* (Chapter 4).
Having demonstrated that these reductions were in fact a 
consequence of th* stimulation of central DA receptors, the 
second objective was to examine th* relative contribution of pro 
and postsynaptic DA receptor systems to th* apomorphin* response 
(Chapter 5).
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Given that ap<»orphine may Interact with preaysnaptic DA 
receptors, the third set of experiments made use of intracranial 
injection procedures to investigate the exact location and the 
relative contribution of these receptors to the apomorphine- 
induced reductions in eating time and eating rate (Chapter 6).
Finally, having established the receptors responsible for the 
apomorphine responses, two important points were addressed in 
Chapter 7 with respecit to the mechanism of action of 
antidepressant drugs.
D®«» chronic antidepressant treatment unequivocally reduce DA 
autoreceptor sensitivity (and thus increase in DA output) ?
2. If so, is this effect relevant to the clinical actions of 
antidepressant drugs ?
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CHAPTER 3 
GENERAL METHODS
This chapter gives an account of tha ganaral aathods used in 
subsaquant axparinants; additional details ara included where 
necessary in later chapters.
3.1 SXreJECTS
Male lister hooded rats (NIMR, Mill Hill or OLAC, Bicester) 
weighing aiq>roxiaately 300-400 g at the start were used in all 
experinants. They were individually housed under conditions of 
controlled tajqperature and humidity, on a 12 h light-dark cycle 
(09.00-21.00 light). Animals were maintained on 17-21 h food 
deprivation and fed with standard laboratory diet (Dixons, Hare, 
• At the end of daily testing animals were given access to 
food pellets for 3 h. Hater was freely available in the home cage 
at all times.
3.2 APPARATOS
Eight identical operant chambers (Ca^;>den Instr. Ltd., 
London), from which the levers had been removed, were progreuuied 
to deliver a 45 mg food pellet (Larkhall Labs. London), idienever 
the perspex food tray door was pressed, subject to the constraint 
^Aat presses spaced less than one second apart were ineffective. 
The house and tray light were illumunated continously, and the 
chambers were housed in individual sound-attenuating boxes with 
smoked perspex viewing windows. Each response on the tray door 
was logged (to the nearest 0.1 sec) by a Cromemco Z2 
microcomputer, which output the time of each response on a visual
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display unit (VOO), and subaaquantly producad a listing of 
rasponsa tiaas and Intar-rasponsa tiaas (IRTs), an IRT fraquancy 
distribution and a log survivor function (saa balow).
3.3 DBDGS
Ilia following drugs wars usad in axpariaants dascrlbad in 
this thasis; datails of dosas and tiaas of adainistratlon can ba 
found in tha ralavant chaptars:
Aaitriptyllna hydrochlorida (Harck, Sharp and Dohaa, Hoddesdon, 
Harts): axpariaant 7.1.
(•••)-Aiqihataalna sulphata (Salth Klina and Franch, Welwyn 
Cardan City, Harts): axpariaant 5.3.
Mioaozphina hydrochlorida (Slgaa, Poola, Dorset): all
axpariaants.
Dasipraaina hydrochlorida (Ciba, Horshaa, Sussex): axpariaants
7.1 and 7.2.
Doaparidona (Janssen, Hantaga, Oxon): axparlaant 4.1.
Dopaalna hydrochlorida (Sigaa, Poola, Dorset): axpariaant 4.1. 
Natargollna (Paraitalia, Milan): axpariaant 4.2.
Mianserin hydrochlorida (Baachaa, Epsoa, Surrey): axparlaent 7.1. 
Naloxone hydrochloride (Slgaa, Poola, Dorset): axpariaant 4.2. 
Pargylina hydrochlorida (Sigaa, Poola, Dorset): axpariaant 4.1. 
Pbantolaaina aasylata (Cll>a, Horahaa, Sussex): axpariaant 4.2. 
PiMosida (Janssen, Wantage, Oxon): axpariaants 2.3 and 4.3.
(♦/•")“Pr^ranolol (Sigaa, Poola, Dorset): axpariaant 4.2. 
SCH-23390 (R-(+)-8-chloro-2,3,4,S-tatrahydro-3-aathyl-5-phanyl-
lH-3-bansazapina-7-ol) (Scharing Corp. Kenilworth, New 
Jarsay): axpariaant 5.2.
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Soopolaaln* by«lrobroBid« (Slgaa, Pool«, Dorsat) : «xporlMnt 4.2. 
(V~)~Sulplrld« (Dolagrang«, Paria): «xparlaanta 4.3, 5.2, 6.1, 
6.2A and 6.2B.
Tatrabanasina (Rocba, Ifalwyn Cardan City, Harts): «xpariaant 5.1. 
Yohiabina hydrochlorida (Sigaa, Pool«, Doraat): «xpariaant 4.2.
i^poaorphina vas dissolvad in 0.02% ascorbate as an 
antioxidant; sulpiride, piaoxida, doaparidone and tatrabanazine 
ware dissolvad in ainuta quantities of glacial acetic acid and 
aada up to the required voluaa with distilled water; SCH-23390 
was dissolvad in physiological saline; all other drugs were 
dissolvad in distilled water. Apoaorphlna, SCH-23390 and 
y<^iabin« war« adainistarad subcutaneously in the scruff of the 
n«c)c; all other drugs war« adainistared intraperitoneally. All 
systaaic injactioits war« aada in a voluaa of l al/)cg with the 
exception of doaparidona which was injected at 2 al/kg. 
Intracranial (i.c.) adainistration procaduras ware used in son« 
axparlaants; full details are given in chapters 6 and 7.
3.4 HISTOLOGY
At the and of axparlnants 6.1, 6.2 and 7.1, aninals were
parfusad under sodiun pentobarbital (100 ag/kg i.p.) with
bufferad foraalin and thair brains were rapidly ranoved and 
stored in 10% foraalin for approxiaataly 5 weelcs. The brains ware 
then blocked in 20% galatlna and stored for a further 5 weeks. 
Prosan 100 alcron «actions war« prepared using a nlcrotone (HSE, 
Loixlon) and stained with crasyl fast vlolat in order to verify 
cannula placeaents nicroscopically using the atlas of Pellegrino
61
and Cushaan (1967).
3.5 PROCBDORB
Anlaala wara tralnad to prass tha perspax tray door in order 
to racaiva a 45 ag food pallat, under a schedule of continous 
relnforceaant (CRF). Experlaents were usually run on six days of 
each week (Non-Sat). Sessions were of 30 ain duration and 
following 3-4 weeks (18-24 sessions) of training all aniaals 
achieved asy^f>totic parforaanca. In general, in each axperiaent 
all aniaals received drug traataants in a counterbalanced order 
with a ainiaua of two drug-free days between tests and (where 
•wiaals were re-used) a ainiaua of seven days between successive 
studies. The exceptions were two studies in Experiaent 4.2 and
experiaents in Chapter 7, in which separate groups of aniaals 
ware tested under each drug condition. Following the achleveaent 
of asyaptotic performance 30 ain sessions were run on test days; 
on intervening days, 10 ain test sessions were usually run. 
Apoaorphlne (0.05ag/kg) was used in the aajority of studies with 
the exception of those desribed in Chapter 7 in which 0.06 ag/kg 
was adainistered to ensure a consistent and reliable reduction in 
eating tlae as well as eating rate.
3.6 MICROSTRUCTORAL ANALYSIS
The frequency distribution of inter-response times (iRTs) 
between the taking of successive pellets, can be transformed to 
a survivor function, which shows the number or the proportion of 
IRTs greater than any given IRT. A logarithmic transforaation of 
the proportions produces a log survivor function. The log
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■urvivor function falls off stsaply ovsr IRT ranges that occur 
with high frsqusncy, and ths initial fall is in a straight line 
(indicating an underlying Poisson distribution). Usually the 
slope changes sharply to a shallower slope, enabling a brea)cpolnt 
to be identified easily. A snail proportion of log survivor 
curves do not have a clean brea)qpoint which is easily detectable. 
To aid identification of the brealq;>oint, grouped log survivor 
curves were constructed for each treatnent condition, which 
defined a region in the log survivor curve %rtiere the breakpoint 
was likely to occur.
Following the identification of the breakpoint, the 
following parameters of feeding were calculated:
1. The number of bouts (B), which is equal to the number of gaps 
(l.e. intervals longer than the brea)q;>oint) plus one.
2. Bating time (T), which is given by the total of all IRT's 
smaller than the brealqpoint.
3. The length of eating bouts, which is given by T/B.
4. Bating rate: Since the tine taken to eat the final pellet in 
each bout is neither known nor Included in the calculation of 
eating time, the local eating rate is given by (N-B)/T (where N 
is the total number of responses), rather than by N/T. An eating 
rate of 0.1 pellets/s is equivalent to 0.27 g/min.
In order to confirm the authenticity of changes in eating 
rate derived by log survivor analysis, the raw data were also 
examined directly, by constructing IRT frequency distributions 
for each of the treatment conditions. A reduction in eating rate
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■•an« that each pallat takas a longar t i M  to consuM and this 
should ba raflactad by an incraass in tha ssdian irt. 
Aposorphina was found to raduca sating rata in tha 
aicrostructural paradigm and accordingly incraasad tha madian IRT 
(Willnar at al, 1985).
3.7 STATISTICAL ANALYSIS
Following tha calculation of tha sicrostructural parasatars 
of faadlng as dascribad abova, tha data wars subjactad to 
•***ly*i* varianca, supplaaantad whara appropriata by tasta of 
sim>la sain offsets and planned comparisons. It was occasionally 
nacassary to usa non-paramatric tasta, idian tha varianca in tha 
data was Inhonoganous.
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CHAPTER 4
APOMORPHIMB ANOREXIA; A PHARMACOLOGICAL CHARACTERIZATIOH
Earlier «xperlMnts have suggested that apoeorphine-induced 
anorexia Bay involve two distinct components. Low doses of 
apoBorpbine in the Bicrostructural paradign reduced food intake 
by decreasing both the time spent eating and the rate of food 
ingestion (Mlllner et al, 1985). The typical neuroleptic drug 
haloperidol and the atypical neuroleptic thioridazine both 
bloclced the effect of aMorphine on eating time, and
administration of apcamridiine directly into the ventral tegmental 
(VTA) selectively reduced eating time. By contrast, eating 
rate was unaffected by neuroleptic drugs, or by apomorphine 
infusions into the VTA. On the basis of this evidence, it was
concluded that the reduction of eating time by apomorphine was
*>y “  autoreceptors in the VTA. However, the reduction 
of eating rate by apomorphine appeared to be mediated by a 
different mechanism.
The three e;q>eriments described in this chapter were
designed to elucidate the pharmacological basis of this effect. 
The first experiment investigated the possibility that in part 
apoBori^ine anorexia might be mediated peripherally: the actions 
Peripherally acting DA agonist and antagonist, DA and 
do^ridone, were examined, as well as their interactions with 
apomorphine. The second experiment examined whether a range of 
antagonist drugs at receptors for neurotransmitters other than 
dopamine could attenuate the reduction in eating rate induced by
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apoaorphlm; th« drugs studied wsrs antagonists at ali^a 1 , alpha 
2 and beta adranorscaptors, plus an antisuscarinic drug, a 
■•>^'tonargic antagonist and an opiate antagonist, in the final 
axpariMnt the affect of neuroleptic drugs on aposorphine 
anorexia was re-exaained, by challenging aposorphine with two 
additional neuroleptic drugs, pisozide and sulpiride.
4.1 METHODS
A total of 128 rats weighing 300-350 g were used in these 
e]q;>eriaents (48 NIMR, 80 Olac). Consumption of 45 mg food pellets 
was measured between 10.00 and 14.00 h in modified operant 
chambers as described in Chapter 2; food was freely available in 
the home cage from 14.00 te 17.00 h. Microstructural parameters
calculated for pellet feeding sessions as described in 
Chapter 3.
Drug doses and pretreatment times were as follows:
Apomorphlne (0.05 mg/kg) and dopamine (l.o mg/kg), lo min; 
phentolamine (l.o mg/lcg), 20 min; yohimbine (l.o mg/kg), 25 min: 
Pargyllne (15 mgAg)> propranolol (5.0 mg/kg), naloxone (1 . 5  
■g/isg), scopolamine (0.05 mg/kg) and domperidone (5.0 mg/kg), 30 
min; met|kergoline (2.0 mg/kg) and sulpiride (5.0 and 7.5 mg/kg),
60 min; pimozide (0.3 and 0.4 mg/kg), 120 min.
Appropriate vehicle solutions were used for control Injections.
In Experiment 4.1 the effects of apomorphine, DA, the 
monoamine oxidase inhibitor pargyline, and domperldone were 
tested in sixteen animals, using eight different drug
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coabinations; full details are shown in Pig. 4.1. in the first 
P«rt of Bxperiaent 4.2, separate groups of anlaals (n-12) were 
tested under four conditions: aposorphlne, yohiabine, both drugs, 
control. One week later, the study was repeated using the sane 
aniaals substituting aetergoline for yohinblne. In the second 
Experiaent 4.2, apoaorphlne was challenged with 
phentolaaine, naloxone and scopolanine in one group of aniaals 
(n-16) and a further group_ (n>16) were used to test the effect of 
propranolol. In all four studies each anlaal was tested under all 
four drug conditions. In Bxperiaent 4.3, the sane design was used 
to test the effect of piaoride (n-16) and sulpiride (n»l6). The 
e:q>erinent was repeated at t%ro' doses of each drug.
4.2 RESULTS 
Bxperiaent 4.1
Apoaorphine significantly reduced the total nuaber of 
pellets consuaed during the half-hour test session, (Pig 4.1A: 
14.4, p<0.001). This effect was brought about
P^taarily by a reduction in the rate of pellet consuaption 
(Pig 4.1C: (F(l,105)^16.3, p<0.001); there was also a reduction
in the tlae spent eating, though this change did not reach 
significance, (Pig 4.IB; (P(l,105)- 1.71, M.S.)). The peripheral 
DA antagonist doaperidone did not in itself change perforaance on 
any of the three aeasures (aax P(l,l0S)-2.83, H.S.), and also 
failed to attenuate the effects of apoaorphine. In fact, the 
effect of apoaorphine was greater following doaperldone pre- 
treataent (Pig 4.1A-C): food consuaption (P(l,105)»ii.3, p<0.0l)
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and anting tina (P(l,105)-18.1, p<0.001) wera significantly lower 
altar apoaorphina and doaparidona than aftar apoaorphine alone.
Pargyline did not significantly alter any of the three 
aeasures (aax F(l,105)-1.0, H.S.), but DA adainistered in the 
presence of pargyline produced a significant anorectic effect, 
(F(l,105)-38.1, p<0.001). However, unlike apoaorphine anorexia,
DA anorexia was caused pradoainantly by a reduction in eating 
tiaa, (F(l,105)—30.8, p<d.001), in addition to a reduction in
eating rata, (F(l,105)-12.3, p<0.001). Doaparidona pretreataant
coiVl«taly ravarsed the anorexic effect of dopaaine on all of the 
aicrostructural paraaeters (Fig 4.1A-C: total pellets,
F(l,105)-12.9, p<0.001; . tiae, F(l,105)-5.4, P<0.05; rate,
F(X,105)—8.9, P<0.05). In contrast, apoaorphine pretreataent
resulted in a further reduction in the total nuaber of pellets 
consuaad (F(l,105)-35.4, p<0.001), consequent on a considerable
reduction in both eating rata (F(l,105) -16.6, p<0.001), and
eating tiaa (F(l,l05)-20.7, p<0.00l).
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Pig. 4.1 A: Total food intake; B: eating time; C: eating rate. Values
ReAna and standard error. VEH, vehicle; APO, aponorphine; DOH, donperidone; 
PARC, pargyline; DA, dopamine. APO, APO/DOH, DA and DA/DOH columns have been 
cross hatched to facilitate visual inspection of the figure.
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Experiment 4.2
Total food intake was significantly reduced by
pretreatnent with five of «le six antagonists: (Fig 4.2:
phentolamine (24% reduction: F(l,30)-27.5, p<0.00l), naloxone 
(30% reduction: F(l,30)-45.6, p<0.001), scopolamine (5 4%
reduction: F(l,30)-48.8, p<0.001) and metergoline (17%
reduction: F(l,44)-8.4, p<0.01)). The reduction in food intake
resulted from a reduction in time spent eating (Fig 4.3), in the 
case of phentolamine (F(l,30)-31.3, p<0.001), naloxone
(F(l,30)-24.4, p<0.001) and scopolamine (F(l,30)-6.2, p<0.05),
the rate of eating (Fig 4.4) was also significantly reduced by 
scopolamine (F(l,30)-25.8, ' p<0.00l) and met)ièrgoline
(F(l,44)-19.6, p<0.001).
Daspite these changes in baseline performance, none of 
the six antagonists significantly modified the actions of 
apomoxphlne. Yohimbine did partially attenuate the reduction of 
food intake, but this change did not reach statistical 
significance (F(l,44)-2.9, M.S.). As in experiment 4.1
apomorphine did not significantly reduce eating time in these 
studies (Fig 4.3). Effects of apomorphine on eating rate are 
shown in Fig 4.4. In all six studies, apomorphine substantially 
reduced eating rate (min F(l,30)-14.6, p<0.001); but in no case 
was this effect significantly attenuated by pretreatment with a 
potential antagonist (Interaction: max F(l,15)-3.3, N.S.).
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In order to quard against any unforeseen artefacts in the 
technique used to calculate eating rate, the effects of the six 
drugs were exaained further by inspection of the raw data prior 
to log survivor analysis. The IRT frequency distribution curves 
for apoaorphlne/propranolol study are shown as an illustration 
(Fig 4.5). The reduction of eating rate by aposorphine is 
reflected in a reduction in the nuaber of shorter IRTs and a 
shift to the rig^t in_the IRT frequency distribution. The 
pr«Pond«r*nce of longer IRTs causes a significant Increase in 
tbs aedian IRT (F(l,30)-24.3, p<0.001). The failure of
propranolol to restore eating rate is confirmed by the fact that 
the propranolol/aposorphine- 'curve is very similar to that of 
alone, and by the lack of effect of propranolol on 
tbe median IRT (interaction: F(l,15)-1.3, K.S.). Similar data
were obtained with the other five antagonists, (max F(l,44)>3.4, 
M.S.).
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Fig. 4.5 Inter responae Ciae (IRX) frequency dlacribution for feeding responses 
in I sec Ciae bins, following Che adainistreeion of aponorphine and/ or 
propranolol. Arrows show the sadian IBT in each condition.
75
ExperlMnt 4.3
Both dosM of plaozld« (0.4 t  0.3 mg/kg) substantially 
attanuated ths anorexic response to aposorphine, (Fig 4.6A; 
interaction: F(1,15)-8.1, p<0.01), and ( Fig 4.6A: interaction:
y(l»15)“6.37, p<0.02). At 0.3 mg/kg, pieozide alone had no effect 
on any eeasure, but pisozide reversed the effect of apoeorphine 
on food intake (Fig 4.6A: interaction: F(l,iS)-8.l, p<0.0l) and 
eating rate, (Fig 4.6C: interaction: F(1,15)-10.7, p<0.005); in 
this experiment apomorphine did not significantly reduce the 
spent eating. At 0.4 mg/kg, pizmzide administered alone 
significantly reduced total food intake (F(l,30)-16.7, p<0.0i),
by reducing both eating time.(7(1,30)>5.9, p<0.05), and eating
(^(1»30)"7.2, p<0.05). In this experiment, apomorphine
reduced both eating time and eating rate; pimozide reversed both 
of these effects (apomorphine/pimozide interactions: eating tine 
P(l,15)-8.1, p<0.01; eating rate F(l,15)«5.3, p<0.05).
Both doses of sulpiride (5.0 « 7.5 mg/kg), vrtien administered 
alone caused a s m II reduction in food intake which just reached 
significance at the lower dose used, (Fig. 4.7A: F(l,30)-4.2,
p<0.05). Again, however, apomorphine failed to reduce food intake 
in sulpiride pretreated animals, (Fig 4.7A: interactions: 
F(l,15)“9.5, p<0.01 and F(l,15)-9.3, p<0.01). Apomorphine did not 
significantly reduce the time spent eating in these 
•xp*fiBents. In both experiments, sulpiride reversed the 
apomorphine-induced reduction of eating rate, (Fig 4.7C: 
interactions: F(l,l5)-4.8, p<0.0S and F(l,15)=8.4, p<0.01).
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For both drugs, reversal of the effect of apomorphine on 
eating rate was conflraed by analysis of the IRT frequency 
distributions. As In Bxperluent 4.2, the sedlan IRT was
significantly Increased by apouorphlne; this effect was blocked 
by both doses of pluozlde (Interactions: Fig 4.6D: F(l,1S)-16.7, 
p<0.001; F(1,1S)>4.8, p<0.5) and by both doses of sulpiride
(Interactions: Fig 4.8D: F(l,15)-8.2, p<0.01; F(l,l5)-20.2,
p<0.002).
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Fi(. 4.6 Effects of epoaorphine and piaoside (left 0.4, right 0.3 ag/kg) 
on A: total food intake; B: eating tiaa; C: eating rate; D: aedian IRT. 
Values are aeans. CON, control; APO, apoaorphine; white circles, control; 
black circles, piaozide pretreataant.
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on A: total food intake; B: eating tiae; C: eating rate; D: median IRT. 
Values are swans. CON, control; APO, apoaorphine; white circles, control; 
black circles, sulpiride pretreataent.
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4.3 DISC088I0M
In «xpnrlMnt 4.1, adnlnistratlon of a low dosa of
•Po*o*T>*»ina raducad food intaka, nainly by raduclng the rata of 
food oonsiuq;>tlon. Dk alao producad an anoraxic rasponea but this 
was nainly attributabla to a raduction in tha tina spent eating. 
Ok does not cross tha blood brain barrier and tha resulting 
anorexia nay be a consequence of tha stiaulation of peripheral Dk 
«^•captors present in the gastrointestinal system (GIT). 
Involvanant of dopaaina receptors in this system has been 
P®*t*^hted for the inhibitory effects of dopamine on gastric acid 
secretion in dog and man, (Valenzuela at al, 1979). Dopamine 
receptors in the GIT nay also be involved in the inhibition of 
gastric emptying (Brockaert , 1979). However, the evidence 
•vailable for the localization of Ok receptor systems within the 
GIT is not at all conclusive and furthermore there is evidence 
that the inhibitory effect on gastric motility following Dk 
administration nay be reversed by the ali^a and beta adrenergic 
phentolamlne and propranolol (Brocicaert at al,
1984). In addition, it is apparent that there are species 
differences as well as regional differences within the same 
animal, with respect to the localization of peripheral Dk 
receptor populations, (Costall et al, 1982).
Many substances that affect the gastrointestinal system also 
act on the chemoreceptor trigger zone (CTZ) in the lower brain 
stem. Therefore, Dk anorexia may alternatively be mediated by an 
action in the area postrema (Borrison 1974; Borrison and Wang
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1951), within which lies th* CTZ. Bweaus* the CTZ lies outside 
the blood brain barrier it is often difficult in in-vivo studies 
to exclude an effect on thim structures, even for substances 
that do not cross the blood brain barrier.
Nhatever the precise site of action of DA, it is clear 
that in addition to the difference in their nicrostructural 
characteristics aposorphine and DA anorexia are anatonically 
distinct. The periidierally acting OA antagonist donperidone, 
which, like OA, does not cross the blood brain barrier (Laduron 
and I^ysen 1979) was effective in reversing DA anorexia but 
actually enhanced apoeorphine anorexia. These data argue 
strongly that both coi^tonents of aponorphine anorexia, the 
reduction in eating tine and the reduction in eating rate, are 
nediated by central nechanisns.
Bxperinent 4.2 exanined the possibility that the effects of 
*Po*Aorphine on eating rate night be nediated by one of six non-DA 
realtor systens. In the first instance the alpha 2 noradrenergic 
antagonist yohinbine was tested, as there are a nunber of stiidles 
in which the sedative effects of aponorphine were attenuated by 
alpha 2 antagonists, (Oelbarre and Schnitt 1973; Sunners et al, 
1981). Yohlnbine did tend to antagonise the reduction in food 
intake produced by aponorphine, though in this study this effect 
was not significant. In an earlier experlnent (not reported in 
detail) a larger dose of yohinbine (0.2 ag/kg), which reduced 
baseline performance, did appear to antagonise the effect of 
aponorphine on eating tine. However, in neither of these
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experiments was there any antagoniss of the effect of apomorphine 
on eating rate. Thera is some evidence that yohisbine may also 
Interact with DA autoreceptors (Scatton et al, 1980; Van Oene et 
al, 1984), though the apoaorphine-induced reduction in mouse 
climbing behaviour which is believed to result from the 
stimulation of DA autoreceptors was not reversed by yohimbine 
(Costall et al, 1984).
At high doses, some of the behavioural effects of 
apomori^ine are mediated by alpha 1 receptors (Maj et al, 1971,
1977); however the ali^a 1 antagonist phentolamine was 
ineffective in reversing the reduction of eating rate, at a dose 
that reduced feeding wh«ui given alone. The beta antagonist 
propranolol also failed to attenuate the apo^rphine reduction in 
food intake, at a dose which did partially antagonize amphetamine 
anorexia in the same paradigm, (Winner and Towell 1982).
The possible contribution to apomorphine-induced sedation of 
cholinergic, serotonergic and opiate systea», either directly or 
via modulation of dopamine activity is uncertain. In studies 
frtiich investigated locomotor activity, cholinergic intemeurons 
in the caudate nucleus appear to be postsynaptic to DA neurons, 
and administration of cholinergic antagonists have been shown to 
abolish haloperidol catalepsy, (Costa 1977). However, in the 
nucleus accumbens it would appear that the cholinergic input has 
a modulatory effect on the circuit initiating locomotor activity 
since carbachol, a cholinergic agonist, increased dopamine 
stimulated locomotion (Jones et al, 1981). In order for both
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dopaaine and carbachol to increase locoaotion there would have to 
be at least one inhibitory intemeurone in the circuit for 
locoaotor activity between these synaptic inputs (Jones et al, 
1981). In addition to a cholinergic input to the nucleus 
accuabens, a serotonergic input aay also be Involved, as 
serotonin abolished dopaaine stiaulated locoaotion (Costall et 
al, 1976). There are no intrinsic 5-HT intemeurons in the 
accuabens and thus this input is assuaed to be froa the aidbrain 
raphe (Costall et al, 1976; Geyer et al, 1976). In addition, a 
preferential action of low doses of aaphetaaine on 5-HT systeas 
within the nucleus accuabens aay account for the inhibitory 
effect of aaphetaaine on locoaotor activity (Hussey et al, 1983). 
Opiate receptor systeas are also present in high concentrations 
in the aesoliablc brain regions (Snyder 1978); enhephalinergic 
nexirons terminate presynaptically on nlgrostrlatal and aesoliabic 
dopamine nerve terminals, and apparently regulate the release 
of Dh via activation of opiate receptors on the DA nerve 
terminal, (Pollard et al, 1977, 1978; Costall et al, 1978). 
The opiate antagonist, naloxone, has been found to potentiate 
metha^ihetamine stereotypy as well as abolish haloperidol 
catalepsy, (Balsara et al, 1984).
Despite this evidence of interactions between DA and ACh, 5- 
HT and enkephalin, in the present study, the auscarinic, 
■•rotonergic and opiate antagonists, scopolamine, nethergoline 
and naloxone all failed to reverse apomorphine anorexia, at 
behaviourally active doses.
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In an earlier report (Hlllner et al, 1985), it was 
deaonstrated that haloperidol and thioridazine abolished the 
apoaorphine-induced reduction of eating tine but had little 
effect on the apoaorphine-induced reduction of eating rate. The 
final experlaent in this chapter however, showed that the effect 
of apoaorphine on eating rate was in fact blocked by two 
additional neuroleptics, piaozide and sulpiride. Piaozide blocked 
all the effects of apoaorphine, both at a dose (0.4 ag/kg) which 
itself substantially reduced feeding, and also at a dose (0.3 
ag/kg) which had alniaal effects on baseline perforaance. Siailar 
considerations apply to sulpiride. Sulpiride slightly reduced 
food Intake but subsequent qxperiaents confined that sulpiride 
blocked all the anorectic effects of apoaorphine, under 
conditions in %rtiich sulpiride itself had no significant effect on 
feeding (see caiapter 6).
Piaozide and sulpiride are relatively specific eurang DA 
®**bagonists. Piaozide has no other significant receptor 
interactions at aoderate doses (Finder et al, 1976). Sulpiride 
has soae affinity for alf^ 2 receptors (Montanaro et al, .1982), 
but the lack of effect of yohiabine on eating rate rules out an 
interaction with alpha 2 receptors as an explanation for this 
effect of sulpiride. It aay therefore be concluded that, like the 
effect of apoaorphine on eating tiae, the reduction of eating 
rate by apoaorphine is also aediated by central DA receptors. 
However, it is clear froa the evidence reviewed earlier that the 
receptors responsible are anatoaically distinct from the cell
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body autorocoptors in th* VTA that appaar to madiata tha affact 
of apoaori^lna on aatlng tima. Tha hypothasia now antartainad and 
axaminad in tha following chaptars, in that tha affacta of 
apomorphina on anting tima and mating rata may ba madiatad by 
diffarant populationn of contrai DA racaptora.
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CHAPTER 5
y**^^*^**^*^^ awatomical iocalizatiom op apctiorphine anorexia
It has baan suggastad that tha raduction in aating tiae 
following systaaic apoaorphina aay rasult froa tha stiaulation of 
DA racaptora in tha VTA, as aating tiaa was salectivaly reduced 
by direct application of apoaori^ina to this area (Hillnar at al,
1985). In tha previous chapter it was shown that the reduction 
in aating rata following systaaic apoaorphina is also aediated by 
central DA receptors, nia location of tha DA receptors Involved 
in both of these affects has yat to be firaly astablishad but in 
view of tha avldanca reviewed in Chapter 1, tha hypothesis put 
forward is that tha site of action of low doses of apoaorphina is 
a prasynaptic one and tha DA receptor is of the D2 subtype.
Tha three axparlaants carried out in this chapter were done 
in order to establish:
1. Tha relative contribution of pra and postsynaptic DA receptors 
to apoaoxidaina anorexia.
2. Tha DA receptor subtype (D2/D1) involved in these effects.
3. The neuronal systea aediating the anorectic response to low 
doses of apoBorphine.
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EXPERIMENT 5.1: THE EFFECTS OF TETRABENAZINE PRETREATMEMT ON 
APOMORPHINE ANOREXIA
In princlpl«, it should be straightforward to distingiush 
pre-and postsynaptic effects of aponorphine, by destroying DA 
neurons, which should abolish any effects sedlated 
presynaptically, while sparing postsynaptic Mediated effects. 
Chesical lesions using 6-hydroxydopaaine (6-OHOA) (in cosblnation 
with dessethylialpraMlne -(DMI) to protect noradrenergic neurons 
(Breese and Taylor 1971)), have been used to good effect to 
establish the anatoMical bases of the effects of asphetsMlne: for 
exa^le 6-OHOA lesions of the nucleus accusbens abolished the 
loc<Motor response to a^^^gtasine, %fhile lesions of the striatus 
reduced am>hetamlne-induced stereotypy (Kelly et al, 1975; Koob 
et al, 1978; Nakanjoula and Ashcroft 1982). It has also been 
reported that 6-OHDA lesions of the eesolisbic neurons failed to 
attenuate the anorectic response to asphetamine (Koob et al,
1978) but lesions of the nigrostriatal systea did attenaute 
aaphetaaine anorexia (Joyce and Iversen 1984).
In preliminary e;q;>eriaents (not reported in detail) it was 
found that the effects on aposorphine (uiorexia following 6-OHDA 
lesions of either the nucleus accuidsens or the striatal complex 
were someidiat equivocal: the effects of apomorphine on eating 
tiw* were attenuated, but the effects on eating rate appeared to 
be unaffected (Muscat et al, 1985). Although lesions of this type 
result in a marked reduction in transmitter availability and a 
concomittant disruption of behaviour, animals are still able to
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perfora though ljq|>ovarlah«d, on a nuabar taska, auggaating that 
follovlng tha laaion tha ayataa ia atill oparativa. J^>proxlaataly 
60% to 85% raductiona in OA availability hava baan raportad 
following local adainiatration of 6-OHOA to tha nuclaua accuabans 
or tha caudata nuclaua (Kally at al, 1975; Taylor and Robbins
1986): in Parkinaoniaa, aotor diaordara only aoaatiaaa bacoae 
apparent following 90% daatruction of DA terainals (C a s s a  and 
Corsini 1981). A aajor problaa in interpreting results of this 
kind is tha davalopaant of suparaansitivty of postsynaptic DA 
•^•captors. DA agonists such as apoaorphina, at doses which 
inhibited behaviour in tha noraal aniaal, hava baan found to 
increase activity in tha 6-OHDA lasionad rat (Ungarstadt 1971b) 
*• • result of a 40 fold increase in tha sansitvity of
postsynaptic DA receptors to low doses of apoaorphine 
(Ungarstadt at al, 1978). m i s  affectively aaans that 6-OHDA 
cannot be used to confira prasynaptic affects of low doses
of apoaorphina.
As an alternative to 6-OHDA there are several agents which 
are able to induce tha disappearance of aainas froa their storage 
in the nerve tarainal. Raserpina is probably the aost
faailiar and widely used. This coapound causes a draaatic fall in 
aaina levels both in peripheral and central neurons within 
■•veral hours (Glowinski and Baldessarini 1966). However,
although recovery starts to take place within two days in the 
cell bodies, full recovery of aaine levels in nerve terainals 
takes several days (Shore 1972). It appears that reserpine aay
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act irravaraibly on vaslcular aanbranas; tha long tiaa course of 
recovery aay reflect the tiae of arrival of fresh-reserplne free 
vesicles provided by axoplasalc transport (Shore 1972).
Bensoquinolisines, on the other hand are a group of drugs, 
of irtiich tetrabenaslne is the best known, %rhich exert slailar 
amine depleting actions to reserpine (Pletscher et al, 1962). 
Tetrabenazlne (TBZ) is less potent than reserpine, not as long 
acting and is more selective for amine stores in the CHS (Howard 
et al, 1981) Quinn et al, 1959). In addition, tetrabenazlne 
causes a rapid depletion of amine stores probably by blocking 
uptake into storage granules. Of the three biogenic amines, DA 
appears to be most sensitive to TBZ. Reductions in DA levels are 
apparent within 15 min are still present 2 h later (Pettibone et 
al, 1984) and return to normal within 15 h (Pletscher 1968).
Sedative effects of low doses of apomorphine (<0.1 mg/kg) are 
believed to be mediated by presynaptlc DA receptors, while high 
doses are believed to act postsynaptically (Di Chiara et al, 
1976; Makanjoula et al, 1980; Kelly et al, 1975). It was 
therefore predicted that TBZ would abolish the anorexic effect of 
a low dose of apomorphine (0.05 mg/kg), but not those of a higher 
dose (0.15 mg/kg).
5.1.1 METHODS
16 rats (NIMR) weighing approximately 300g at tha start of 
the experiment, were tested between 15.30 and 17.00 h daily. The 
animals were trained to feed by pressing the door of the pellet
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**^ ®P******^  i** o*** of «Ight identical operant chaabers;
■icrostructural paraaetere of feeding were calculated as 
described in Chapter 2.
Drug treataents were presented in a counterbalanced order 
with a alniaua of two drug free days between tests. The duration 
of test sessions was 30 ain; on intervening days the session was 
10 ain. On experlaental days the aniaals were adainistered 
apoaorphlne (0, 0.05 or 0.15 ag/kg) lo ain prior to testing,
following pretreataent 2 h earlier with tetrabenasine (0, i.o or 
2*® ■9/itg), in a 3 • 3 factorial design. The dose of TBZ was 
selected on the basis of a prellalnary dose-response study: at 
higher doses than that used TBZ svibstantially reduced food 
consuaption (75% reduction at 4.0 ag/kg).
5.1.2 RBSULTS
Both low and high doses of apoaorphine significantly reduced 
food intake (Fig 5.1A: F(l,90) - 20.5, 54.1, p<0.001). The
reduction in consuaption brought about by the low dose of 
apoaorphine was predoainantly attributable to a reduction in 
eating rate (Fig 5.IB: F(l,90) » 15.5, p<0.001). Apoaorphine also 
reduced eating tlae: this effect was not statistically
significant (Fig 5.10: F(l,90) - 1.3, N.S.); there was, however,
a significant reduction in the duration of eating bouts 
(Fig 5.IE: F(l,90)-4.6, p<0.05). The anorexic effect of the high 
dose of apoaorphine was attributable to a reduction in the time 
spent eating (Fig 5.ID: F(l,90) - 12.6, p<0.00l); and also to a 
further reduction in the rate of pellet consuaption (Fig 5.IB:
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P(l,90) “ 14.3, p<0.001). At this do««, in addition to a dacraaaa 
in tha duration of aatin? bouta (Fig 5.1E: F(l,90)-ll.2, p<0.0l)
thara was also a non-significant incraasa in tha duration of gaps 
batwaan bouts (Fig 5.IF: F(l,90)-1.4, H.S.). At both dosas of 
apoaorphina tha changas in aating rata wara raflactad in an 
Incraasa in tha aadian IRT (Fig 5.2C: F(l,90) - 12.0 and 20.7,
p<0.001).
Tha lowar dosa of TBZ (l.Oag/kg) caused a slight but 
insignificant reduction in tha total nuabar of pallets consuaad 
(Fig 5.1A: F(l,90) “ 2.5, N.S.) which was attributable to a 
reduction in the rate of consuaption (Fig 5.IB: F(l,90) - 6.8, 
P<0.05). At this dose, TBZ failed to attenuate significantly any 
o t tha affects of tha low dosa of apoaorphina, but further 
accentuated the effects of tha high dosa (Fig 5.1A: F(l,90) -
60.8, p<0.001). This interaction was brought about by a further 
decreaent in the tiae spent feeding (Fig 5.ID: F(l,90) » 30.7, 
p<0.001) and tha length of aating bouts (Fig 5.1E: F(l,90)-18.0, 
p<0.001). TBZ did not however, altar tha affects of apoaorphina 
(0.15ag/kg) on aating rata or tha aadian IBT (Fig 5.1B,C: 
F(l,90) - 0.1, 0.4, M.S.).
The higher dose of TBZ (2.0ag/kg) significantly reduced 
pellet consuaption (Fig 5.1A: F(l,90) - 58.5, p<0.001), by 
reducing both eating rate (Fig 5.IB: F(l,90) - 51.9, p<0.001) 
and eating tlae (Fig 5.ID: F(l,90) - 13.8, p<0.001). At this dose 
of TBZ, the affects of the lower dose of apoaorphine (0.05 ag/kg) 
on pellet consuaption and eating rate were totally abolished
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(Fig S.1A,B: F(l,90) - 0.1, 0.1, H.S.). TB2 (2.0 Bg/lcg) also 
*^ii*h*d ths offsets of ths higher doss of aposorphine on eating 
rats and asdian IRT (Fig 5.IB and 5.2C: F(l,90) - 2.4, 0.1, N.S.) 
Hovsvsr, in ths presence of tetrabenazine (2.0ag/kg) the high 
dose of apoaorphina (0.15ag/kg) still reduced the total nuaber of 
pellets consuaed (Fig 5.1A: F(l,90) - 16.4, p<0.00l), by
reducing the tiae spent eating (Fig 5.ID: F(l,90) - 1 9 .1 ,
p<0.001).
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Fig. 5.I Effects of apoaorphiae and teCrabenazine on (A) total food intake;
(B) eating rate; (C) awdian IRT; (D) eating tiae; (E) bout length; (F) gap 
length. Values are saans and standard error. VEH, vehicle; APO, apoaorphine; 
TBZ, tetrabenazine. Open coluans, vehicle pretreataent; cross hatched coluans, 
apoaorphine (O.OS ag/kg) pretreataent; filled columns, apoaorphine (O.IS rag/kg) 
pretreatsant.
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5.1.3 DISCOSSIOM
Tb* lower dose of tetrabenasine used in this study failed to 
attenuate any of the effects of a low dose of apoeorphine. 
However, it nay be assueed that at this dose only partial 
disruption of DA teminal stores nay have occurred as 
tetrabenasine did not in itself reduce food intake in the 30 
minute session. In contrast, the higher dose of tetrabenazine 
(2.0mg/kg), did reduce food intake, but abolished the effects of 
the lower dose of apoeorphlne. In addition, tetrabenazine also 
prevented the rate reducing effects of the higher dose of 
apomorphine. It is unlikely that these effects of tetrabenazine 
were floor effects: in experiment 4.2, both scopolamine and 
metergoline caused reductions in eating rate comparable to that 
brought about by TBZ, but nevertheless, in the presence of 
apomorphine further reductions in eating rate were observed.
The fact that tetrabenazine abolished the effects of both 
low and high doses of apomorphine on eating rate, supports the 
hypothesis that these effects are mediated by presynaptic DA 
receptors. TBZ did not, however, block the reduction in eating 
time that ensued following the administration of the higher dose 
of apoanrphine. Indeed, both doses of TBZ enhanced this effect. 
These results suggest that the effects of the higher dose of 
apomorphlne on eating tine (though not on eating rate) M y  be 
mediated by postsynaptlc DA receptors. It is generally assumed 
that the sedative effects of a low dose of apomorphine (<0.1 
Big/kg s.c.) are mediated by presynaptic DA receptors while the
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EXPERIMENT 5.2: the effects of apomorphine on feeding
MEDIATED BY D2 W  ^  RECEPTORS ?
Kebabian and Caine (1979), proposed the subdivision of 
dopamine receptors into two classes, D1 receptors which are 
functionally linked to cyclic AMP and D2 receptors that are not. 
In addition, it was also observed that in sose cases 02 receptor 
stimulation results in the inhibition of cyclic AMP (Stoof and 
Kebabian 1984). Seaman (ld'80), suggested four classes of dopamine 
receptors, Dl, D2, D3 and D4 but it now appears that the D3 and 
D4 sites may be conformational states of Dl (Leff and Creese 
1983a, b) and D2 receptors (Caron et al, 1983; Grigoriadis and 
Seaman 1984, 1985; Sibley et al, 1982) respectively.
The idiaxmacological specificity of the rate reducing and time 
reducing effects of apomorphine may be further characterized 
by the administration of specific D2 and Dl receptor antagonists. 
As presynaptic DA receptors are presumed to be of the D2 subtype 
(Roth 1981), pretreatment with sulpiride, a specific D2 receptor 
antagonist (Jenner et al, 1978; Montanaro et al, 1982), 
should abolish the apomorphine-induced reduction in eating 
rate and this effect has already been demonstrated (experiment 
4.3). However, this effect of sulpiride does not distingiush 
pre- and postsynaptic sites of action. The ventral tegmental 
area, the site of origin of the DA fibres to the nucleus 
accumbens has been found to possess only D2 receptor site as no 
DA sensitive adenylate cyclase activity has been identified on 
DA neurons in this region (Bockaert et al, 1977; Phillipson et
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al, 1977). Howavar, D2 racaptor binding sltas hava also been 
daaonstratad in the nucleus acciubans (Jastrow at al, 1984), 
and in this stxxictura the D2 sites are located both pre and 
postsynaptically (Tassin at al, 1982). It is also apparent 
that in addition to D2 racaptor sltas, the nucleus accuabens 
also possess D1 racaptor sites identified by DA-stinulated 
adenylate cyclase (Horn at al, 1974), or by the binding of 
D1 ligands (Schulz at al, 1985), in particular the specific D1 
racaptor antagonist, SCH-23390 (Hyttal 1983; lorio at al,
1983). Howavar, unli)ca D2 racaptor sltas, all 01 receptor sites 
are located postsynaptically: 6-OHDA lesions reduced the binding 
of 02 racaptor ligands but did not affect 01 stlaulated adenylate 
cyclase activity (Creese and Snyder 1979; Crease at al, 1977; 
Schwartz at al, 1978), whereas kalnic acid lesions did not 
significantly altar binding of 02 racaptor ligands but 
substantially reduced 01 increases in cyclic AMP activity 
(Sokoloff at al, 1980). Following however, the two kinds of 
selective lesion (6-OHOA and Kainlc acid) of OA neurons, 02 
receptor binding was significantly reduced (Sokoloff at al, 
1980).
The specific 01 agonist SKF 38393 (Settler at al, 1978) has 
no marked stimulant affects (except for slight non-stereotyped 
sniffing, rearing and locomotion after high doses), but Induces 
turning after unilateral lesions to the nigrostrlatal pathway 
(Amt and Hyttell 1984) and Increases locomotor activity after 
6-OHOA treatment (Breese and Mueller 1985). These effects of SKF
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38393 ar« totally attanuatad following the adainistration 
of the specific D1 receptor antagonist SCH-23390 (Hyttel 1983; 
lorio et al, 1983). SCH-23390 also inhibited the actions of non- 
selective Oh agonists such as aaphetanine and apoaorphine; 
SCH-23390 abolished apoaorphine-induced stereotypy, 
aaphetaaine-induced stereotypy and aaphetaaine-induced 
hyperactivity (Christensen et al, 1984; lorio et al, 1983; 
Schulz et al, 1985). However, in spite of its specificy for 
01 receptors, it has also been observed that SCH-23390 
prevented the behavioural effects of selectively acting 02 
agonists, such as lisuride, pergolide and LY-17155, in noraal 
animals (Mailaan et al, 19»4). In animals which have been 
P>^*treated with 6-OHOh, alpha-methyl-para-tyrosine (AMPT), or 
reserpine, SCH-23390 proved to be ineffective in reversing 02 
receptor mediated behaviours. The explanation put forward for 
these effects of SCH-23390 was that 01 receptors in some way 
■•<li»te the consequences of postsynaptic 02 receptor 
■timulation in normal animals (Carlson et al, 1986) but 
following Oh depletion this mechanism becomes uncoupled (hmt and 
Hyttel 1985).
In order to determine the Oh receptor subtype involved in 
*P®*®n>hine anorexia, the present experiment examined the 
i**teractions of systemlcally administered apomorphine with the D1 
receptor antagonist SCH-23390 (Hyttel 1983; lorio et al, 1983) 
and the 02 receptor antagonist sulpiride (Hontanaro et al, 1982). 
On the basis of the literature reviewed, it was assumed that
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«ulplrld* would block roaponsM Mediated by pre- or posteynaptlc 
D2 receptors, whereas SCH-23390 would block any postsynaptlcally 
Mediated response.
5.2.1 METHODS
16 rats (NIMR) weighing 300-350g at the start of the 
experieent, were tested between 14.00 and 16.00 h, and allowed 
free access to food between 16.00 and 19.00 h. Following training 
to feed froM pellet dispensers, as described in Chapter 3, drug 
treatMents were presented in a counter-lsalanced order, with a 
MinisuM of two drug-free days l>etween test. The duration of the 
test was 30 Min and on intervening days the session length was 
usually 10 Min. All sixteen anisals were adslnistered systeslc 
apoMoridiine (0.05 Mg/kg sc) or vehicle, following pretreatsent 
with sulpiride (10 Mg/kg i.p.), SCH-23390 (0.0125 Mg/kg sc) or
vehicle (saline sc) in a 2 • 3 factorial design. Following the 
temlnation of the experiment. Measures of eating rate, eating 
time and other microstructural parameters were derived from log 
survivor analysis of the frequency distribution of IRTs, as 
decrlbed in Chapter 3.
Sulpiride %ras administered 1 hour before apomorphine 
Injections and SCH-23390 30 min before aponorphine injections. 
Doses of apomorphine and sulpiride were based on those used in 
previous experiments. The dose of SCH-23390 was selected on the 
basis of a preliMinary dose-response study: at doses higher than 
that used, SCH-23390 substantially reduced food consumption (45% 
reduction at 0.025 mg/kg; 70% reduction at 0.05 ng/kg).
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Data wara subjactad to analysis of varlanca, suppleaented 
«rhara ai^ropriata by tasts of slapla aain affects and planned 
comparisons. In addition, in order to analyse separately the 
interaction of apoaorphine with the two different drug 
treataents, after analysing raw scores, a second analysis was 
also carried out, on data obtained by subtracting each 
apoaorphlne score froa the appropriate control score.
5.2.2 RB8DLTS
Systeaic adalnistration of apoaorphine suppressed food intake 
(Fig 5.3: F(l,45) “ 65.4, p<0.001) by reducing both eating tiae 
and eating rate (Fig 5.3: F(l,45) - 11.3, p<0.01; 59.6, p<0.001, 
respectively). Apoaorphlne also significantly increased the 
aedian IRT (Fig 5.3: F(l,45) - 71.9, p<0.001). The effect on 
eating tiae %ras further analysed by coaputing the aean duration 
of feeding bouts, the duration of gaps between bouts of feeding 
and the initial latency; apoaorphine shortened the duration of 
feeding bouts (Milcoxon T(16) - 3.0, p<0.01), but the duration of 
gaps and the latency to initiate feeding did not change 
significantly (T (16) - 1.3 and 0.4, M.S.).
Sulpiride, by itself had no noticeable effects, while SO{- 
23390, by itself, significantly iapalred performance on all four 
aeasures (Fig 5.3: ain F(l,45) - 53.8, p<0.001). Pretreataent 
with sulpiride substantially reduced the effect of apoaorphine on 
food consumption, eating time, eating rate and aedian IRT (Fig 
5.3: apoaorphlne/sulpiride interactions: (F(l,30) - 13.6, 
p<0.001; 5.6, p<0.0S; 9.5, p<0.01; 19.8, p<0.001, respectively).
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However, none of the effects were reversed by SCH-23390. Indeed 
despite suppressing feeding by itself, SCH-23390 actually 
enhanced the suppressant effect of aposorphine on food 
consunption and eating tine, the effects of aposorphine on eating 
rate and Median IRT were unaffected by SCH-23390 (Fig 5.3: 
apoMorphine/SCH-23390 interactions, F(l,30) - 8.7, p<0.01; 8.0, 
P<0.01; 0.2, M.S.; 0.7, N.S., respectively). Sulpiride, but not 
SCH-23390, also reversed the effect of aposorphlne on bout length 
(F(l,30)- 6.7, 0.1, P<0.05; N.S., not shown).
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5.2.3 DISCUSSION
The results of the present study provide further evidence 
for an involvement of the D2 receptor subtype in the effects of 
systemic apomorphine on both eating rate and eating time. The 
reversal by the selective D2 receptor antagonist sulpiride 
(Jenner et al, 1978; Montanaro et al, 1982), but not by the D1 
receptor antagonist SCH-23390 (Hyttell 1983; lorio et al, 
1983) of the various effects of apomorphine on feeding confirm 
that these effects were mediated by D2 receptors. Although 
sulpiride has some affinity for alpha-2 adrenergic receptors 
(Hontanaro et al, 1982), the more potent alpha-2 antagonist 
yohimbine did not antagonize, the effects of systemic apomorphine 
on rate (Chapter 4). The fact that TBZ abolished all anorexic 
effects of a low dose of apomorphine (Expt. 5.1) strongly 
suggests that the relevant D2 receptors are presynaptlc rather 
than postsynaptic. Nhile SCH-23390 is a selective antagonist 
at D1 receptors (Hyttel 1983; lorio et al, 1983), this 
compound also blocks the behavioural stimulant effects
mediated by postsynaptic D2 receptors, suggesting that D1
and D2 receptors mediating behavioural stimulation may be
functionally linked (Breese and Mueller 1985; Christensen et al, 
1985). However, the sedative effects mediated by presynaptic D2 
receptors are not antagonized by SCH-23390 (lorio et al, 1983; 
Mereu et al, 1985). The fact that in the present study SCH-
23390 failed to reverse any of the effects of apomorphine on
feeding, supports the view that the receptors involved are 
located presynaptically.
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EXPERZHENT 5.3: DIS80CIATI0H OP TO« DA PATHWAYS mVOLVED TO 
AP<»IORPHIMB AND AMPHETAMINE-IMDDCED AWORBXTA
A final axparlMnt axaninad tha interaction between low doses 
of apoBorphine and aMphetaaine. The suppressant effects of 
anphetaaine on feeding are well-dociiaented and are known to be 
dependent on a stiaulatory action at central catecholaninergic 
synapses (Blundell and Lathan 1980; Cooper and Francis 1979; 
Sawanin and Garattini 1981), which is brought about by the 
release of transaitter fron presynaptic teninals (Stein 1964; 
Glowinski and Baldesaarini 1966; Fuxe and Hanson 1967 ). 
Microstructiiral studies of aaphetaaine anorexia concur in
showing that aaphetaaine suppresses food intake by decreasing the 
duration of eating, tdiilst concurrently Increasing the rate of 
eating (Blundell and Latham 1978, 1980). Using the methods
employed in the current study we have demonstrated that 
significant shifts to the shorter IRTs are detectable at doses of 
amphetamine as low as 0.125 mg/kg (Towell at al, 1987b).
A number of studies cited in the literature argue for t>oth a 
noradrenegic and dopaminergic component in the mediation of the 
effects of a low dose of amphetamine (Leibowitz 1982; Winner 
and Towell 1982) %ihile the effects of higher doses of 
amphetamine seem to be mediated by dopaminergic receptor systems 
(Lyon and Robbins 1975; Towell et al, 1987). However, it has 
also iMen reported that the dopamine receptor antagonist, 
pimozide, failed to reverse low dose amphetamine anorexia while 
abolishing the anorexia resulting from larger doses (Burridge and
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Blundell 1979). In contrast to this observation, it has been 
reported that piaozide reversed both low and high dose 
anphetaMine anorexia (Towell et al, 1987). In addition, the D1 
receptor antagonist SCH-23390 (but not the D2 receptor antagonist 
sulpiride) (Gilbert and Cooper 1985) and 6-OHDA lesions of the 
nigrostrlatal DA systea (Joyce and Iversen 1984) have also been 
found to attenuate the anorectic response to a low dose of 
anphetaaine, confiralng an involveaent of DA.
If aaphetaaine reduces feeding by Increasing DA release froa 
axon terainals, and apoaorphine reduces feeding by decreasing DA 
release, it alght k>e expected that the two drugs would tend to 
counteract one another. The present experiaent therefore exaained 
this interaction.
5.3.1 METHODS
Fifteen Individually housed rats (OLAC), aean weight 380g, 
were used in this experiaent. Testing for food reinforced door 
pressing, was carried out between 12.00 h and 14.00 h daily. 
Initially, test sessions were 30 aln in duration. When aniaals 
were performing asym>totlcally, 30 ain sessions were used on drug 
adainistratlon days, and 15 ain sessions were run on Intervening 
days. Miaraacological studies were initiated following the 
attainaent of asyaptotic performance.
Aig>hetaalne (0.5 ag/kg), apoaorphine (0.05 ag/kg), and 
vehicle treataents were adalnistered in a 2 • 2 factorial design. 
Aaphetaaine was given 30 ain and apoaorphine 10 ain before the
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sasaion. Each animal racalvad all four troataant 
combinations in a coimtar-balancad ordar, at two-day intarvals. 
Microstructural analysis was carriad out as dascrlbed in Chaptar
3. Tha 25th parcantlla rathar than tha madian IRT was calculated 
as this maasura was particularly sansitlva to amphatamina (Towall 
at al, 1987).
5.3.2 RESULTS
Apomorphina caused a 19% reduction in food intake (F(l,28) «
4.7, p<0.05), an affect similar in size to that seen at this dose 
in earlier studies (Chaptar 4; Hillnar at al, 1985). Unlike 
amphatamina, apomorphina caused a substantial decrease in eating 
rate (F(l,28) - 16.6, p<0.001), reflected in a rightward shift
in the IRT frequency distribution and a significant increase in 
the 25th percentile (F(l,28) - 25.9, p<0.001).
Amphetamine caused a reduction in food Intake (21%: F(l,28)
- 6.9, p<0.05) similar to that seen with apomorphine. However the 
• t t » c t u  of apomorphine and amphetamine were additive (Fig 5.3: 
inset): a^hetamlne reduced food Intake by 21% after vehicle 
treatment and by a further 22% in the presence of apomorphine 
(F(l,28) - 5.0, p<0.05), the interaction term being
insignificant (F(1,14) • 0.05, N.S.). Effects of the two drugs
on the shape of the IRT frequency distribution were also
additive (Fig 5.4), as were their effects on eating
(*pomorphlne/a«q>hetamine interaction: F(1 ,1 4 ) »
0.5, H.S.) and eating rate (apoaorphine/amphetanine
interaction: F(1,14) - 1.6, N.S.), (results not shown in detail).
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5.3.3 DISCUSSION
The results of the present study rather surprisingly 
demonstrate that the effects of aposorphine and asphetasine were 
additive. It is difficult to see how this paradox - sight be 
resolved if the two drugs are acting at a cosson site. However, 
it seess likely that the effects of apouorphine and asphetasine 
are mediated by different population of DA receptors: since
apomorphine anorexia is antagonized by the D2 receptor antagonist 
sulpiride but not by the D1 antagonist SCH-23390 (Expt. 5.2), 
while the reverse is true of amphetamine anorexia (Gilbert and 
Cooper 1985). A potential problem with this dichotomy as a 
possible explanation of the.apomorphine and amphetamine-induced 
changes in eating rate is that pimozide reversed the effects of 
both these DA agonists. Pimozide has been reported to have a high 
speclflcty for D2 receptors in that it selectively blocked the 
Inhibition of prolactin release by DA in the pituitary (Finder et 
al, 1976) and has fewer side effects (acute dystonia and tardive 
dyskinesia) compared to haloperidol %d\en administered in the 
clinic (Finder et al, 1976; Runplak et al, 1986). Nevertheless, 
pimozide is also aztong the ZK>st potent of drugs which inhibit 
dopamine-sensitive production of cyclic AMP in rat striatal 
homogenates (Miller et al, 1974). In addition, pimozide 
effectively reduced apomorphine and az^hetamlne-induced 
stereotypy (Janssen et al, 1968). These findings indicate that 
pimozide has also antagonistic actions at D1 receptor systems 
(Christensen et al, 1984), which may therefore provide an 
explanation for its antagonistic effects on both apomorphine and
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Mphetaaln«-Induced anorexias.
Furthereore, It seems likely that apomorphlne and amphetamine 
may reduce feeding by actions on different populations of DA 
neurons. The anorexic effects of apomorphlne may be reliably 
elicited from the VTA but not from the sxibstantla nigra (Winner 
et al, 1985). Amphetamine anorexia, by contrast, seems to be 
mediated by a system of fibres that originate In or around the 
substantia nigra (see Chapter 4, Introduction) and terminate In 
the lateral hypothalamus (McCabe et al, 1984). In addition, 6- 
OHDA lesions of the nlgrostrlatal sytem (Joyce and Iversen 1984) 
but not the nucleus accumbens (Koob et al, 1978) attenuated 
amphetamine-induced anorexia. The failure of amphetamine to 
antagonise apomorphlne anorexia would suggest that the DA system 
originating In the substantia nigra Is not Involved In 
apomorphlne anorexia thus supporting the hypothesis that It Is 
the mesollmblc DA system that Is responsible for the anorectic 
effects of apomorphlne.
5.4 GKNKRAI. DISCOSSIOM
The present series of experiments have demonstrated that 
following systemic apomorphlne, the ensuing reduction In eating 
rate Is mediated by:
1. Presynaptic DA receptors, since tetrabenazlne prevented the 
effects of both pre- and postsynaptic doses of apomorphine on 
eating rate.
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2. D2 receptors, as sulpiride (D2 receptor antagonist) but not 
SCH-23390 (D1 receptor antagonist) reversed the effects of a low 
dose of apoaorphine.
3. The mesoliabic DA systea, as aaphetaaine failed to attenuate 
the apoaorphlne-Induced reduction in eating rate.
Observations 1 and 2, do not need any futher clarification, 
however, the last of these findings (3), aay be open to different 
interpretations, in that presynaptlc D2 receptors in the caudate- 
putaaen could have contributed to the apoaorphlne response. This 
possibility reaalns open, because the DA systea iapllcated in 
a^phetaaine anorexia originates in the substantia nigra but 
terainates in the lateral, bypothalaaus (McCabe et al, 1984). 
Following 6-OHDA lesions of the caudate, aaphetaaine failed to 
reduce food intake (Joyce and Iversen 1984). However the 
destruction by 6-OHDA of the DA fibres originating in the 
substantia nigra could have also lead to the destruction of cell 
bodies of the fiber systea that projects to the lateral 
hypotbalaaus. The hypothalaaus seeas to have a high D1 receptor 
density (Damon et al, 1986) idiereas the caudate coaplex has a 
high density of both D1 (Dawson et al, 1986) and D2 (Gelhert and 
Waasley 1985) receptor sites, the precise location of which 
reaains an enigaa. Both the high D1 receptor density and 
the reversal by SCH-23390 of aaphetaaine anorexia (Gilbert and 
Cooper 1985) are consistent with an action in either the 
hypothalaaus or the caudate nucleus. These sites would not, on 
the other hand, appear to be involved in the actions of
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apoaorphine.
While the apoaorphine-induced reduction in eating rate is 
clearly aediated presynaptically, the position with respect to 
the apoaorphine-induced reduction in eating time is less
clearcut. Direct application of apoaorphine to the VTA resulted 
in a reduction in eating time and bout length (Wlllner et al, 
1985). However, systealc adainlstratlon of high doses of 
apoaorphine, in the presence or absence of tetrabenazine, also 
reduced eating tlae and bout length and also Increased gap length 
(experiment 5.1; Wlllner et al, 1985). This leaves open the 
question of %rttether the reduction in eating time following a low 
dose of apoaorphine is aediated pre or postsynaptically. This 
problem is resolved unambiguously by experiments described in the 
following chapter.
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CHAPTER 6
t he role o f dopamine autoreceptors in apomorphine anorexia
Presynaptlc inhibitory autoreceptors are selectively 
stinulated by low doses of DA agonists (Skirboll et al, 1979). 
Autoreceptor stimulation results in behavioural sedation (Di 
Chlara et al, 1976) and a concomittant reduction in food intake. 
The dopaminergic nature of this phenomenon is demonstrated by 
the attenuation of apomorphine anorexia following pretreatment 
with a variety of neuroleptic drugs (Chapter 4, 5; Hiliner et al, 
1985).
The rate and time reducing effects of a low dose of 
apomorphine are abolished' by the selective D2 antagonist 
sulpiride (Chapters 4 and 5) and the amine depleting drug, TBZ 
(Chapter 5). This would suggest that these effects of a low dose 
of apomorphine are mediated by presysnaptic DA autoreceptors. 
Administration of high doses of apomorphine also reduced eating 
rate and eating time. The reduction in rate following high doses 
of apomorphine was abolished by TBZ which would support the 
hypothesis that this effect of apomorphine was mediated
presynaptlcally. However, TBZ did not abolish the reduction of 
eating time by a high dose of apomorphine, indicating a 
P^stsynaptic effect. On the other hand, eating time was 
selectively reduced by direct application of apomorphine to 
presynaptlc receptors in the VTA suggesting a presynaptlc site of 
action (Winner et al, 1985).
112
The precise site at which aposorphine reduces both eating 
tiae and eating rate, aay be determined by central adsinistration 
procedures. The hypotheses examined in these experiments were 
that the reduction of eating time by apomorphine is mediated by 
presynaptic receptors in the VTA, while Injections of apomorphine 
to the nucleus accumbens would reduce eating rate via a 
separate population of DA autoreceptors located outside the VTA.
EXPERIMENT 6.1: THE ROLE OF DA CELL BODY ADTORECEPTORS
The aims of the present study were, firstly to substantiate 
the findings that administration of apomorphine to the VTA 
selectively reduced eating - time and secondly, to investigate 
whether systemic application of a low dose of apomorphine reduces 
eating time by an action at this site. The latter problem was 
investigated by administering sulpiride to the VTA. If 
apomorphine reduces eating time by an action on DA cell body 
autoreceptors in the VTA, but reduces eating rate by an action 
elsewhere, then the administration of sulpiride to the VTA should 
selectively antagonize the effect of systemic apomorphine on 
•«ting time while sparing the effect on eating rate.
6.1.1 METHODS 
Surgery and Drugs
Eight rats (NIMR), weighing 360-400g, were implanted 
bilaterally under pentobarbital anaesthesia with cannulae aimed 
at the VTA. The co-ordinates, chosen according to the atlas of 
Pellegrino and Cushman 1967, were: anterior +2.9 mm, depth -3 . 4
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■a and lataral or -1.2 u  for VTA. The cannulaa wera of 26 
gauga stainlass ataal (Arnold and Howall, liondon); injactions 
through than wara aada uaing a aicroayringa with a 33-gauge 
naadla (V.A. Howa, London). At the and of the axpariaent, cannula 
placaaenta wara verified histologically (Fig 6.1).
P e r i p h e r a l  i n j a c t i o n s  w a ra  B ad e  in  a  v o lu n e  o f  1 n l/ k g :  
a p o B o rp h in a  w as  i n j e c t e d  s u b c u t a n e o u s ly  in  t h e  s c r u f f  o f  th e  n ec k  
10 B in  p r i o r  t o  t e s t i n g  s e s s i o n s ;  s u l p i r i d e  w as  in je c t e d  
i n t r a p e r i t o n e a l l y  Ih  p r i o r  t o  t e s t i n g  s e s s i o n s .  A l l  i n t r a c r a n i a l  
t r e a t n a n t s  w a re  B ad e  up  t o  a  v o lu B e  w i t h  s o d iu B  p h o sp h a te  b u f f e r  
(pH  •  7 .0 )  an d  i n j e c t e d  a t  a  v o lu a e  o f  0 .4 4  u l ,  u s in g  a  
d i s p e n s e r  t o  d e l i v e r  tw o  0 .2 2  u l  p u l s e s ,  a f t e r  w h ich  a n l a a l s  
w a ra  iB iU M d ia t a ly  t a s t e d .  ^ p r o p r i é t é  v e h i c l e  s o lu t i o n s  w e re  
u s e d  f o r  c o n t r o l  i n j e c t i o n s .
Procedure
B e h a v io u r a l  t e s t i n g  w as  c a r r i e d  o u t  b e tw e e n  1 4 .0 0  and  1 6 .0 0  h 
d a i l y .  P r i o r  t o  s u r g e r y  a n i B a l s  w e re  g i v e n  e x t e n s iv e  t r a i n i n g  in  
f e e d in g  f t o B  a  p a l l e t  d i s p e n s e r ;  f o l l o w i n g  a  p o s t - o p e r a t i v e  
p e r i o d  o f  14 d a y s ,  p h a r s a c o l o g l c a l  s t u d i e s  w e re  n o t  
i n i t i a t e d  u n t i l  a n i s a l s  a s y a p t o t l c  p e r fo n u m c e  h ad  b e e n  
r e - e s t a b l i s h e d .  In  b o t h  p a r t s  o f  t h e  e x p e r im e n t  d ru g  
t r e a t s e n t s  w e re  p r e s e n t e d  in  a  c o u n t e r -b a la n c e d  o r d e r  w it h  
a  B in lB U B  o f  tw o  d r u g - f r e e  d a y s  b e tw e e n  t e s t s .  The d u r a t io n  o f  
t e s t  s e s s i o n s  w a s  30 B ln ;  on  o t h e r  d a y s ,  th e  s e s s io n  le n g t h  w as  
u s u a l l y  10 B in .
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In th« first part of tha axpariaant sight aniaals racaived 
apoaorphina a.c.(0.05 ag/kg), sulpirida i.p. ( l o  ag/kg) or i.c. 
(4.4 ug bilatarally), and tha appropriata vahicla injactions, in 
a 2 * 3 factorial dasign. In tha second part, which began after a 
14 day interval, five of tha aniaals racaived apoaorphina i.c. 
(4.4 ug bilatarally), sulpirida i.p.(lo ag/kg), or vahicla 
injections, in a 2 * 2 factorial dasign. The other three anlaals 
froa tha first part could not be retested owing to aovaaent of 
tha i^lant.
Measures of eating rate and eating tiae were derived from 
log siirvivor analysis of tha frequency distribution of inter- 
response tiaas, as described in Chapter 3. Microstructural 
P*i^*»«ters were subjected to analysis of variance, supplemented 
where appropriata by tests of simple main effects; Wilcoxon 
tests were used to assess effects of apoaorphlne on median IRT.
6.1.2 RESULTS
In earlier studies, mean food consu^>tion under control 
conditions in unoperated animals was of the order of 2 0 0 -2 50  
pellets, with substantially lower scores in operated animals, 
(Winner at al, 1985; see also earlier chapters). In the present 
®*P**’^*****t, performance in the first part was superior to that 
previously observed in VTA cannulated animals (mean pellet 
consumption + or - standard error - 157 + or - 1 1 ), and by the 
second part of the experiaent, following a further recovery 
P*i'foraance was in the lower end of the normal range (207 
+ or - 15). As, in each part of the experiment, the order of
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presentation of conditions was counter-Isa lanced, the changing 
baseline does not influence the interpretation of drug effects.
Systemic adninistration of apomorphine reduced food intake 
(Fig 6.2: P(l,21) - 7.6, p<0.05); by reducing both eating rate 
(Fig 6.2: F(l,21) - 14.2, pcO.OOl) and eating tine, although in 
this experiment, the latter did not reach statistical 
significance (Fig 6.2: F(l,21) - 0.5, p>0.05). Sulpiride did not 
significantly affect feeding when administered alone, either 
peripherally or centrally, but sulpiride did substantially 
*^^*"“*^* anorectic effects of apomorphine (Fig 6.2: F(l,28) 
“ 16.5, p<0.001; F(l,28) ” 13.2, p<0.001) respectively. With
peripheral sulpiride, attenuation of apomorphine anorexia was 
brought about by reversing the effects of apomorphine on both 
eating time and eating rate (Fig 6.2); after sulpiride 
pretreatment, apomorphine failed to alter either parameter 
(F(l,21) - 0.3, 0.3, respectively, p>0 .1 ). By contrast, central
sulpiride attenuated apomorphine anorexia by selectively 
increasing eating time (Fig 6.2: Apo vs Sul/Apo F(l,2l) - 4.8,
P<0.05), whilst sparing the effect of.apomorphine on eating rate 
(Fig 6.2: Veh vs Apo F(l,21) - 14.1, p< 0.001).
Unlike peripheral aponorphlne, central administration 
reduced food intake by a selective action on eating time (Fig 
6.2: F(l,8) “ 8.2, p<0.05); the rate of eating was unaffected
(Fig 6.2: F(l,8) « 0.1, p>0.05). As in the first part of the
experiment, sulpiride alone did not significantly affect feeding 
but sulpiride did attenuate the anorectic effect of central
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apoMorphine (Fig 6.2: F(i,8) -7.8, p<0.05), by blocking the
reduction of eating tiae (Fig 6.2: F(l,8) = 7.5, p<0.05).
As in earlier experiaents, systeaic apoaorphine, which caused 
a decrease in eating rate as assessed by aicrostructural 
paraaeters, also caused a rightward shift in the IRT frequency 
**^®^*'^bution (Fig 6.3), with a significant increase in aedian IRT 
(T(8) - 1, p<O.Ol); central apoaorphine, which did not decrease 
eating rate, did not change the shape of the curve (Fig 6.3), or 
significantly alter the awlian IRT (T(5) - 5, p>0.05). Systeaic
sulpiride blocked the effect of systeaic apoaorphine on eating 
rate, as assessed by aicrostructural analysis, and also blocked 
the rightward shift in the.IRT frequency distribution (Fig 6.3: 
T(8) - 13, p>0.05). However, central sulpiride, which spared the
effect of systeaic apoaorphine on eating rate, did not prevent 
the shift to longer IRTs (Fig 6.3: T(8) - 1, p<0.01).
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Fig. 6.2 The effect« of aponorphine and sulpiride on mean food intake, eating 
rate and eating tiae. In every panel, control scores are shown on the left and 
scores after apoanrphine on the right; error bars in the centre of the line joining 
control and apoeiorphine scores show the standard error of the difference between 
the two treataants. A, B and C show the effect of systeaic aponorphine with no 
pretreataent (A), systemic sulpiride (B) and central sulpiride (C) pretreatment 
respectively. D and E show the effect of central apoaorphine with systeaic vehicle 
(D) and sulpiride (E) pretreatment respectively. Stars show the significant effects 
of apofflorphine: One star, p <0.05; two stars, p <0.01; three stars, p <0.001.
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6.1.3 DISCUSSION
Th«s« expariaents confira that the VTA is the site at 
which apoaorphine reduces eating tiae, as suggested by the 
results of previous experiaents (Winner et al, 1985):
apoaorphine infusions into the VTA selectively reduced eating 
ti»«* In addition, sulpiride infusions into the VTA blocked the 
effect of systeaic apoaorphine on eating tine only. This effect 
of central sulpiride provides strong evidence that systeaic 
aponorphine reduces eating tiae through an action in the VTA.
In contrast to the clear effects on eating tiae, neither 
apoaorphine nor sulpiride infusions into the VTA had any
influence on eating rate,- even though this paraaeter is nore 
sensitive than eating tine to the effects of systeaic apoaorphine 
(Chapters 4,5). The fact that systeaic sulpiride did reverse the 
effect of apoaoridiine on eating rate, confiraing the findings in 
chapters 4 and 5, ljq;>lies that the effect of aponorphine on 
eating rate is aediated by another population of DA receptors 
which is located outside the VTA.
EXPERIMENT 6.2: ROLE OF DA AXON TERMINAL AUTORECEPTORS
The observation that TBZ abolished the rate reducing effects 
of apoaorphine suggests that this effect is aediated by 
presynaptic DA receptors. The indirectly acting DA agonist 
aaphetaaine, which increased the rate of eating in the 
aicrostructural paradiga, failed to attenuate the rate reducing 
effect of aponorphine: 6-OHDA lesions of the caudate (Joyce and
121
Iv«rs«n 1984) but not the accuadsens (Koob et al, 1978) attenuated 
the aMphetaaine-induced reduction in food Intake. It would appear 
froa these data that the rate reducing effects of apoaorphine are 
aediated by presynaptic DA receptors in the aesoliabic projection 
froa the VTA to the nucleus accuabens. A third and proalnent DA 
pathway originates in the VTA and teralnates in the frontal 
cortex; however, this systea seeas to be devoid of axon terainal 
autoreceptors (Bannon et al, 1982) and therefore is unlikely to 
be involved in this effect of apoaorphine. That 
apoaorphine infusions into the VTA did not have any effects on 
eating rate, effectively rules out the cell l>odies of the 
aesocortical projection as the" site of action.
The present experiaent therefore investigated the effect on 
^••ding of apoaorphina applied directly to the axon terainals of 
the aesoliabic projection in the nucleus accuabens. The problem 
Arises with direct Injections to this area is that unlike 
the VTA, the nucleus accuabens possesses both pre and 
postsynaptic receptor populations. However, stlaulatlon of 
presynaptic DA receptors results in behavioural sedation (Di 
Chiara et al, 1976) while stiaulatlon of postsynaptic DA
receptors results in behavioural activation (Kelly et al, 1975). 
In order to evaluate the contribution of presynaptic and
postsynaptic actions, apoaorphlne was adainistered at two doses 
and an attempt was made to relate the findings to effects on 
locomotor activity.
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6.2.1 METHODS 
Surgery and Drugs
Animals ware implanted bilaterally under pentobarbital 
anaesthesia with cannulae aimed at the nucleus accumbens. For 
•xperiments 6.2A and 6.2B the co-ordinates, chosen according 
to the atlas of Pellegrino and Cushman 1967, were:
anterior +8.0 mm, depth 0.0 - l.o mm and lateral + or - i.o 
“ 3.5 mm. The cannulae. were of 26 gauge stainless steel 
(Arnold and Howell, London); injections through them were made 
using a microsyringe with a 33-gauge needle (V.A. Howe,
London). At the end of the experiment, cannula placements were 
verified histologically (Fig 6.4). All cannulae were located 
within the nucleus accumbens or ventral striatum, and adjacent to 
the anterior commisure. As a number of cannulae were somewhat 
posterior to the nucleus accumbens, a more anterior placement (+
9.2 mm) was used for experiment 6.2C. These cannulae were all 
located within the nucleus accumbens (Fig. 6.4).
Sulpiride was injected intraperltoneally 1 hour prior to 
testing sessions. Intracranial injections of apomorphine were 
made bilaterally at a volume of 0.44 ul (two 0.22ul pulses) after 
which animals were immediately tested. Appropriate vehicle 
solutions were used for control injections.
Procedure
Behavioural testing was carried out between 14.00 and 16.00 h 
daily. Prior to surgery, the animals received extensive training 
in feeding from the pellet dispensers; following surgery,
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phanacologlcal studl** war* not Initiated \intil aniaala had re- 
attainad asyiq>totic parfonanca. In all axpariaants drug 
traatMnts wara praaantad in a countar-balancad order with a 
■iniauM of two drug-free daya between teste. Experiaents 6.2A, 
6.2B and 6.2C exaained the effects of central apoaorphine on 
feeding. The duration of feeding test sessions was 30 aln; on 
drug-free days, the session length was usually lo ain. In 
®J*P**^ *^*>t 6.2A eight aniaals received apoaorphine (4.4 ug 
i.c., bilaterally), sulpiride (10 ag/kg i.p.) and the 
appropriate vehicle injections in a 2 * 2 factorial design. In 
experlaent 6.2B twelve aniaals received apoaorphine (2.2 ug 
i.c., bilaterally), sulpiride (10 ag/kg) or vehicle 
injections in a 2 * 2 factorial design. In experiaent 6.2C, 
sixteen aniaals received three doses of apoaorphine (0.0, 2.2 and 
4.4ug i.c. * 2) through aore anteriorly placed cannulae. For all 
three experiaents, aeasures of eating rate, eating tine and 
other aicrostructural paraaeters were derived froa log 
survivor analysis of the frequency distribution of iRTs, as 
previously described.
Bxperiaent 6.2D used ten of the aniaals previously tested in 
experiaent 6.2B, following a drug-free period of eight days; 
experiaent 6.2E used fourteen aniaals previously tested in 
•>Q?*>^ iaent 6.2C, after a drug free period of ten days. The 
anlaals were tested in an open field; in the former 
•3q?eriaent the apparatus consisted of a square wooden enclosure 
(75 * 75 * 23ca), ruled in 12.5 cm squares, with a smoked
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p*rsp«x lid whil« in th* latter experiment the enclosure was 
constructed from grey perspex (75 * 75 * 18 cm), and eight
infrared beams at a height of 4.5 cm formed a 4 * 4 grid through 
which beam breaks were recorded automatically by a BBC
microcMputer. Animals were habituated to the apparatus during 
a series of five daily six-minute test sessions. Following 
habituation animals received three central injections of 
apraorphine (0, 2 .2 and. 4.4 ug) in a counter-balanced order.
iw the open-field commenced five minutes after the 
injection and lasted for six minutes; locomotor activity was 
assessed by the number of lines crossed (experiment 6.2D) or 
beams broken (experiment 6.'2E); in experiment 6.2D, the
incidence of rearing was also recorded.
6.2.2 RESULTS 
B;q;>eriment 6.2A
The administration of apomorphine (4.4 ug bilaterally) to 
the nucleus accumbens significantly reduced food intake (Fig 6.5:
“ 14.1, p<0.01), by reducing both eating rate and eating
(^^9 6.5; F(1,14) — 4.4 and 3.6 respectively; 0.0S<p<0.l).
Sulpiride (10 mg/kg) did not significantly affect feeding %rt»en 
administered alone, but did substantially attenuate the anorectic 
* ttm c t of apomorphine (Fig 6.5: interaction F(l,7) « 7.4, p<0.05). 
Effects of apomorphine on eating rate and eating time were both 
reversed by sulpiride pretreatment (Fig 6.5: interactions F(1,14)
” 6.1, p<0.05 and 3.9, 0.05<p<0.1 respectively).
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The effect of apoaoridiine on eating time was further 
analysed by computing the mean duration of feeding bouts and of 
gaps between feeding bouts. Apomorphins did not change the 
duration of feeding bouts (means V-Btandard error: control, 72 + 
/- 30; apomorphine, 67 +/- 28; T (8) - 0.1, p>0.1). However, 
apomori^lne did significantly increase the duration of gaps 
(control, 32 +/- 4; apomorphine, 46 +/“ 3; T (8) - 2.1, p<0.05). 
This effect is only seen with high ('postsynaptic*) doses of 
apomorphine on systemic administration (Expt. 5.1; Winner et al, 
1985).
Experiment 6.2B
Administration of apomorphine to the nucleus accumbens at 
a lower dose (2.2 ug) bilaterally produced a similar suppression 
of feeding (Fig 6.5: F(l,22) - 8.3, p<0.01). However, in this 
case, only eating rate was reduced (Fig 6.5: F(l,22) - 5.6 
p<0.05), whilst eating time remained unchanged (Fig 6.5: F(l,22)- 
0.4, p>0.1). As in experiment 6.2A, sulpiride by Itself did not 
significantly change any parameter of feeding, but after 
sulpiride pretreatment apomorphine failed to reduce food intake 
or eating rate (Fig 6.5: F(l,22) - 0.8 and 0.2 respectively, 
p>0.1). Consistent with the effects on eating rate, apomorphine 
also increased the median IRT (Fig 6.6: Hilcoxon T (12) = 13, 
p<0.05), and sulpiride pretreatment blocked this effect (Fig 6.6: 
T (12) - 39, p>0.1).
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Experia«nt 6.2C
Essentially slsilar effects of aposoxphine were observed 
using the sore anterior cannula placement (Fig. 6.7 A-C). Both 
doses of apoBorphine significantly reduced food intake (F(l,30) =
8.8, 16.3; pcO.Ol, 0.001). The lower dose of aposorphine (2.2 ug) 
significantly reduced eating rate (F(l,30) - 15.6; p<0.001) but
not eating time (F(l,30) - 1.1; H.S.); the higher dose (4.4 ug)
reduced both eating rate (P(l,30) - 5.9; p<0.05) and eating time
(F(l,30) - 12.9; p<0.01).
Experiment 6.2D,E
lo the open field (Fig 6.8) the lower dose of aponorphine 
significantly reduced locomotor activity (F(1,18) » 4.7, p<0.05)
and rearing (F(l,18) • 8.5, p<0.01). However, the higher dose did 
not significantly change either measure (F(1,18) - 0.4 and 0.0 
respectively, M.S.). The sane results were obtained in animals 
with more anterior cannula placements (experiment 6.2E: Fig 6.8): 
the lower dose of apomorphlne (2.2 ug) significantly reduced 
locomotor activity (F(l,26) - 8.5; p<0.01), but the higher dose
(4.4 ug) caused a non-significant increase (F(l,26) - 1.6; N.S.)
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10.2 0.2
9.6
8.2
8.8
Fig- 6.4 Serial sections through the rat brain derived from the atlas of Pellegrino 
and Cushman (1967). The nucleus accuadiens has been indicated by shading. Cannula 
i* shown by filled circles (experiment 6.2A) filled squares (experiment 
6.28) and filled triangles (experiment 6.2C). According to the atlas of Pellegrino 
and Cushman (1967) the nucleus accumbens extends from anterior 10.2 to anterior 
7.2; some authors consider sites posterior to 8.6 (approx.) to be in the ventral 
striatum (e.g. Eeckstead et al, 1979).
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6*5 The effects of centrel eponiorphine end syscenic sulpiride on mean 
food intake, eating rate and eating time. A and B show the effect of 4.« and 
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p < 0.01.
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6.2.3 DISCUSSION
According to Pollegrino and Cushnan (1967), the nucleus 
accuabens extends fro* anterior 10.2 to anterior 7.2; however, 
some authors consider sites posterior to 8.6 (approx) to be in 
the ventral striatua. Nevertheless, DA fibres froa the VTA appear 
to terminate in this area (Beckstead et al, 1979; Siaon et al, 
1979). Examination of the data did not reveal any differences in 
behavioural effects systestatically related to cannula placeaent. 
This was true for both feeding and locomotor behaviour.
The administration of the lower dose of apoaorphine to the 
nucleus accuabens/ventral striatua selectively reduced eating 
rate. The reversal of this effect by sulpiride confiras the 
was mediated by DA receptors. The observation that 
sulpiride has some affinity for alpha 2 adrenergic receptors 
(Montanaro et al, 1982) does not undermine this conclusion, as 
the more potent alpha 2 antagonist yohimbine did not antagonize 
the effect of aponorpbine on eating rate (Chapter 4). The fact 
that the reduction of eating rate by the lower dose of 
apomorphine was accompanied by behavioural sedation strongly 
suggests that at this dose apomorphine was acting 
presynaptlcally.
At the higher dose of apomorphine, the effect on feeding 
was less selective as both eating rate and eating time were 
reduced. Again, the reversal of these effects by sulpiride 
confirms the involvement of DA receptors in these phenomena. 
Earlier experiments have shown that systemic apomorphine alters
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the duration of gaps t>etween feeding tMuts only at high doses 
thought to act postsynaptlcally (Expt. 5,1; Hlllner et al, 1985). 
The decrease In eating tine caused by Intracranial 
adalnlstratlon of the higher dose of aponozphlne was brought by a 
selective Increase In the duration of gaps, it Is therefore 
suggested that stlnulatlon of postsynaptlc DA receptors night be 
responsible for this effect. An Involvenent of postsynaptlc DA 
receptors at the higher dpse of aponorphlne Is supported by the 
absence at this dose of sedative effects In the open field.
6.3 GEMKRAL DISCOSSION
The results of these experlnents conflm the anatonlcal 
sites at which a low dose of aponorphlne reduces eating tine and 
eating rate. The low dose of aponorphlne directly applied to the 
nucleus accunl>ens (or ventral strlatun) selectively reduced 
eating rate without Influencing eating tine. Sulpiride the 
specific D2 receptor antagonist reversed this effect of 
Aponorphlne. The sedative effect of this dose of aponorphlne was 
confirmed by the results of the open field study In which 
aponorphlne reduced loconotor activity.
Although a t  th e  h ig h e r  d ose, aponorphlne In fu s io n s  In to  th e  
n u cleu s accunbens reduced e a t in g  t i n e ,  t h i s  e f f e c t  I s  p rob ab ly  
n ot In vo lved  In th e  re d u c tio n  o f  e a t in g  t in e  by a low sy ste m ic  
dose aponorphlne, fo r  two reaso n s:
1. The reduction In eating tine following low doses of systemic 
aponorphine resulted from a reduction in bout length whereas the 
reduction in eating tine following high doses of apomorphine
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(i.c. or s.c.) was caused by a reduction in bout length and an 
increase in the gaps between bouts (gap length).
2. Sulpiride, the specific D2 antagonist reversed the effect of 
systesic apoaorphlne on eating tiae when adainistered directly to 
the VTA.
In that adainistration of a high dose of apoaorphine to the 
nucleus accuabens brought about siailar reductions in the 
aicrostructural paraaeters (reduction in eating tine, bout length 
and an Increase in gap length) to those seen following systemic 
adainistration of a high dose of apoaorphine, it nay be inferred 
that high doses of apoaorphine reduce eating tine by stimulating 
postsynaptic DA receptors in£he nucleus acc\inbens.
As a result of these findings it would appear that eating 
time and eating rate are differentially controlled by two 
populations of autoreceptors, located, respectively on cell 
bodies and axon terminals of nesolimbic DA neurons. This suggests 
that autoreceptors on DA cell bodies and axon terminals nay be 
•^i^^^J^^ntially involved in behaviour even though 
pharmacologically both populations are of the D2 subtype. The 
Implications of this dissociation are considered in Chapter 8.
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CHAPTER 7
CHANGES IN DA AUTORECEPTOR SENSITIVITY FOLLOWING 
ANTIDEPRESSANT TREATMENT
CHRONIC
Antidepressant drugs are traditionally considered to 
act at noradrenergic or serotonergic synapses. However, a 
reduction of central dopaeine turnover is a very robust finding 
in retarded depressions, and a nuaber of DA receptor agonist 
drugs aiq>ear to be effective as antidepressants (Winner 1983). 
There is also aore recent evidence that chronic treatment with 
antidepressant drugs or with electroconvulsive shock (ECS) causes 
a functional increase in dopaainergic transaisslon particularly 
in the aesoliablc systea. One way in which chronic antidepressant 
treatment or ECS may bring about an overall increase in 
aesollabic DA is by reducing the sensitivity of Inhibitory 
presynaptlc DA receptors. Serra et al (1979), have reported that 
snail doses of apoaorphine failed to elicit sedation in rats 
which had been chronically prtreated with laipraaine, 
aaitriptyllne or mianserin. In addition, the adnlnistration of 
aponoridiine failed to reduce DA synthesis in rats chronically 
treated with either antidepressant. The hypothesis that 
antidepressant treatment induces subsensitivity of DA 
autoreceptors is additionally supported by electrophysiological 
data. Chiodo and Antelnan (1980, 1982), found that apoaorphine 
administration selectively depressed the spontaneous activity of 
single DA cells in the pars coapacta of the substantia nigra and 
the VTA, but following repeated administration of imipraaine.
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a » i t r ip t y l in «  o r  Ip r in d o l« , th *  I n h ib ito r y  respon se to
apoaoridiine was s i g n i f i c a n t l y  a tte n u a te d .
However, these findings are controversial, in that a nunber 
of investigators have failed to observe DA autoreceptor 
subsensitivity following chronic antidepressant treatnent. 
Holconb at al (1982), failed to find any change in DA teminal 
autoreceptor sensitivity following chronic adninistration of 
inipranine or iprindole according to the saae schedule as used by 
Serra at al, (1979). In a recent biocheaical study it was 
reported that a nuaber of antidepressants failed to alter DOPAC 
and HVA levels in the rat striatua following the adainistration 
of low doses of apoaorphlne- (Diggory and Buckett 1984). Equally, 
Macneill and Gower (1982), were unable to find any change in 
apoaorphlne-induced inhibition of OA cell firing following 
chronic tricyclic antidepressant treataent. Indeed in one 
biocheaical study it was reported that DA autoreceptor 
sensitivity was actually increased by chronic ECS (Reches et al,
1984).
In view of the potential theoretical and clinical
significance of antidepressant effects on DA function, and the 
controversial nature of these observations, two experiaents were 
carried out using the effects of apoaorphine on the
aicrostructural analysis of feeding behaviour to assess DA 
autoreceptor function. The first experiaent exaained the
influence of DMI, aaitriptyline and aianserin on the effect of 
apoBorphine infusions to the VTA. The second experiaent examined
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the effects of systeaic apoaon^ine in an animal model of 
depression.
EXPERIMENT 7.1: EFFECTS OF CHRONIC ANTIDEPRESSANT TREATMENT ON 
DA CELL BODY AUTORECEPTORS
In previous chapters it has been demonstrated that 
microstructural analysis of the anorexic response to a low dose 
of apomorphine provides a sensitive behavioural assay of 
presynaptic dopamine receptor function and that the reduction of 
eating time by apomorphine appears to be mediated by DA cell body 
autoreceptors in the ventral tegmental area (VTA). Towell (1984), 
used these tools to assess- the effects of chronic treatment with 
the antidepressant DMI on DA autoreceptor function. In the first 
of two experiments apomorphine was administered systemically 
while in the second study apomorphine was directly applied to the 
VTA. DHI did not change the effect of apomorphine on eating rate 
in either study, thus ruling out an effect of antidepressant 
treatment on DA terminal autoreceptor function. In addition, no 
consistent effects on eating time were seen during the course of 
chronic treatment with DMI. However, during withdrawal from M!I 
there was an attenuation of the effect of apomorphine on eating 
time, indicating a subsensitivity of DA cell body autoreceptors, 
which was clearly apparent in both experiments.
The implications of these findings are important in relation 
the mechanism of clinical action of antidepressants, if DA 
autoreceptors were subsensitive during chronic DMI treatment,
138
then this effect might contribute to the clinical antidepressant 
action. However, if DA autoreceptors were subsensitive only 
following withdrawal of antidepressant treatment it would seen 
very unlikely that these effects would contribute to clinical 
improvements seen during treatment with antidepressant drugs.
The present experiment was a further attempt to clarify the 
status of DA cell body autoreceptors in the VTA during chronic 
DMI treatment. In addition to replicating these results of Towell 
(1984), the study also included two other antidepressants, the 
tricyclic antidepressant amitriptyline and the non-tricyclic 
antidepressant mianserin.
7.1.1 METHODS 
Surgery and Drugs
Forty-eight rats (Olac) weighing 3OOg at the start of the 
•xperiment were divided into four groups (n-12). Each group 
received either vehicle injections (distilled water), or Ml, 
amitriptyline or mianserin at a dose of 2.5 mg/kg i.p.. 
Injections were given between 17.00 and IS.OOh for forty-nine 
consecutive days. During the first forty days of treatment 
animals were run for thirty minutes daily in the operant 
chambers. The initiation of drug treatment was staggered over six 
consecutive days with two animals from each drug group commencing 
treatment on a given day. This treatment protocol allowed all 
animals to be implanted with cannulae on day 40 of drug 
treatment.
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Cannula* aia*d at the VTA war« iaplanted bilaterally under 
pentobazisital anaeathesla. The co-ordinates, chosen according to 
the atlas of Pellegrino and Cushman (1967), were: anterior 
■*-2.9mn, depth -3.4mm and lateral -f or - 1.2mm for VTA. The 
cannullae were of 26-gauge stainless steel (Arnold and Howell, 
London); injections through them were made using a microsyringe 
with a 33-gauge needle (V.A. Howe, London). At the end of the 
experiment, cannula placements were verified histologically (Fig 
7.1). Following surgery, animals were retrained in the operant 
chambers until an asymptotic performance was re-established.
Procedure
On the day following the final antidepressant treatment, and 
on days three, six and ten during withdrawal animals received 
apomorphine (2 * 4.4ug i.c.) directly before the start of the 
session. Vehicle injections %rere given on the day t>efore each 
apomorphine injection. All i.c. injections were made bilaterally 
at a volume of 0.44ul. Test sessions were thirty minutes in 
duration; on the intervening days, a ten minute session was run, 
with no drug treatments.
Measures of eating rate and eating time were derived from 
log survivor analysis of the frequency distribution of inter­
response times, as described in chapter 3. To assess any 
differential effect of antidepressant drugs on control 
performance, an initial set of analyses of variance were carried 
out on data derived from the four vehicle Injection sessions. 
Data were then transformed to represent the suppressive effect of
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•poaorphliM on food intako, by subtracting tha apoaorphlna scora 
fro* its pairad control scora. Thasa supprassion scores vara than 
subjected to analysis of variance. During tha course of the 
axpariaant, the nusbar of animals tasted fall, as soma of tha 
iiq>lants ware rejected (Fig 7.2). Rather than estimating scores 
for tha missing subjects (tihich would be necessary for a 2-way 
of variance), data for each of the four aponorphine 
tests were analysed separately by one-way analysis of variance.
appr^riate, analysis of variance was supplemented by tests 
of siiq;>le main effects.
7.1.2 RESULTS
None of the antidepressants tested significantly affected 
feeding scores on any of the four control days (max F(l,37) —
3.5, 4.0, 2.8; p > 0.05 for totals, time and rate respectively).
Over the four test days base line food intakes (mean +/- standard 
error) were: control: 170 +/- 15; amitriptyline: 156 +/- 1«; DMI: 
153 +/■ 15; and mianserin: 162 +/“ 14.
In control animals apomorphine reduced food intake on each 
of the four test days (mlnF(l,8)-6.0, p<o.05). Microstructural 
analysis revealed that the reduction of total food intake was 
mediated primarily by a decrease in eating time (minF(l,8)-5.3, 
pc0.05) with no significant changes in eating rate
(***^(1»^)•1» H.S.) These effects were of similar magnitude to
those observed in experiment 6 .1 .
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on th* first tsst day (day forty-nine of treatsent/ day one 
of withdrawal) none of the antidepressants significantly changed 
the reduction of total food intake by aposorphine. During 
withdrawal, however, all antidepressants attenuated aposorphine 
anorexia on all three test days (Fig 7.2), Taking each 
antidepressant separately, the effect of DMI was significant on 
all three withdrawal tests (F(l,37) - 4.9, p<0.05; F(l,34) - 8.7 , 
p<0.0 1; F(l,33) - 6.3, . p<O.OS, respectively). Asitrlptyline
significantly attenuated aposorphine anorexia on day six of 
withdrawal (F(l,34) - 8.3, p<0.01) whilst the effect of sianserin 
was significant on day three of withdrawal only (F(l,3 7) - 1 1 .9 ,
P<0.01).
The Blcrostructural analysis confirmed that these 
*"^^^*P*'******^"*P®>*®iphine interactions were mediated by effects 
on eating time rather than eating rate (Fig 7 .2). The 
apomorphine-induced reduction in eating time was attenuated 
during the withdrawal phase of chronic drug treatment. This 
effect reached significance on day three of withdrawal from 
mianserin treatment (F(l,37) - 14.9, p<0.00l), and on day six of
withdrawal from amitriptyline and DMI treatment (F(l,34) - 1 3 . 3  
and 5.6, p<0.00l and 0.05 respectively). On the final day of drug 
treatment, the suppression of eating rate was slightly increased 
by mianserin (F(l,34) - 6.2, p<0.05), but otherwise there were no 
significant effects of any antidepressant on eating rate.
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7.1.3 DISCUSSIOM
The assuaption underlying the present experinent was that 
anorexia caused by VTA infusions of apoaorphine, and in 
particular, the ap«M>rphine-induced suppression of eating tiae, 
aay be used to asssay the responsiveness of DA cell body 
autoreceptors in the VTA (Chapter 6). Hence the attenuation of 
these effects represents a reduction in DA autoreceptor 
responsiveness, nie present results confira previous observations 
that this phenoaenon is consistently seen during withdrawal from 
DHI not during chronic treataent, and extends this finding to 
aaitrlptyline and aianserin. In addition, DA autoreceptor 
subsensitivity was also absent on the first apoaorphine test, 
which was 17-21h after the final antidepressant injection. In a 
recent study (Scavone et al, 1986) chronic iaipraaine (14 days) 
attenuated the apoaorphine-lnduced reduction in locoaotor 
activity and DA synthesis, but as in the present experiaent, 
these effects were not observed until 48-72h following 
withdrawal.
The finding that DA autoreceptor subsensitivity only appears 
following withdraml froa chronic antidepressant treataent 
strongly suggests that this effect does not contribute 
significantly to the iag>roveaents seen in patients undergoing a 
course of antidepressant pretreataents. The question reaains of 
whether the effect observed was an antidepressant effect which 
for soae reason was aasked by the presence of antidepressants or 
the opposite, a rebound "depressant" effect. However, it should
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also bs notad that those data nay not be altogether relevant to 
the eechanise of clinical action of antidepressant drugs since 
this study was carried out in "normal" anisals. It could 
therefore be argued that the antidepressant effects were 
observed "in vacuo". In line with this hypothesis is the 
observation that antidepressants failed to alter wood in nonal 
subjects.
One way in which these Issues could potentially be resolved 
is to ask %ri>ether DA autoreceptor sensitivity is abnormal in 
depression, and if so, %rtiether the receptors are subsensitive or 
supersensitive. The following study examines this question in an 
animal model of depression.*
EXPERIMENT 7.2: EFFECTS OF CHRONIC DMI TREATMENT ON DA
AOTORECEPTOR SENSITIVITY W  M  ANIMAL MODEL 
OF DEPRESSION
The majority of animal models of depression suffer from two 
major dra«d>acks; they are of questionable validity, and of brief 
duration (Winner 1984). An exception is a paradigm described by 
Katz. In this behavioural model, animals were subjected
chronically and unpredlctably to a variety of stressors,
including electric shocks. Immersion in cold water and others. 
Following a week of such treataMnt, deficits in open field 
performance were apparent, which could be prevented by a wide 
range of antidepressant drugs, but not by drugs of other classes. 
Indeed, as found in the clinical situation, chronic stress also
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caused an incraasa in plasma cortlcostaroid lavals, and this 
affact too was ravarsad by antidaprassants (Katz 1981, 1984). 
This Bodal has a reasonably high dagraa of validity (Hillnar 
1984), and its prolonged duration aakas it suitable to examine 
the effects of chronic traataant with antidepressant drugs.
Most of the studies using this model have examined open 
field behaviour and cortlcostaroid lavals. However, in one study 
in which animals ware exposed to the chronic stress regime, it 
was noted that the subjects failed to Incraasa their fluid 
consum>tlon whan saccharin or sucrose were added to their 
drinking water (Katz 1982). This is a particularly relevant 
finding in that it implies a defective reward system, and models 
anhedonia «rtiich characterizes endogenous rather than reactive 
depression (Nelson and Chamey 1981). The suggestion that chronic 
unpredictable stress produces a state analogous to endogenous 
rather than reactive depression is further substantiated by 
elevated corticosteroid levels observed by Katz and co-workers 
(Katz 1984; Katz and Hersch 1981; Roth and Katz 1981), since 
elevated adrenocortical activity is a specific diagnostic 
marker for the endogenous sub type of depression (Carroll
1982); tdille Increased corticosterone levels are to be found 
in various other disorders such as Cushing's and 
Alzheimer's disease, within depression this effect seems to be 
specific to melancholia (Carrol 1982; Nlllner 1987).
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W* hav* d«v*lop«l a varalon of this aodal in %rttlch anhadonia 
is inducsd by sxpoaurs to ultra-aild atrsssors, such as periods 
of food or water deprivation and changes in teaperature, lighting 
or housing conditions. Rats subjected to this regiae showed 
substantial reductions in their preference for sweet solutions as 
aeasured in two-bottle tests; noraal behaviour was restored by 
chronic adainlstration of the tricyclic antidepressant 
DMI (Winner et al, 1987b). In the present study, these effects 
were replicated; in addition, DA autoreceptor sensitivity was 
exaained at regular Intervals during stress, Wtl treataent, and 
withdrawal.
7.2.1 METHODS 
Subjects
Forty eight aale Lister hooded rats (NIMR, Mill Hill, 
london), weighing approxiaately 300 g at the start of the 
experiaent were used. They were, with soae exceptions described 
below, individually housed and aalntained on a 12 h light/darA 
cycle, with food and water available ad libitua.
Fluid Consuaption Tests
^ before the start of the experiaent, aniaals were given a 
continuous 48 h exposure to two bottles, one containing a 1% 
sucrose solution and the other containing tap water. The bottles 
were counterbalanced across the left or right side of the feeding 
coapartaent; this procedure was adopted throughout the 
experiaent. Testing for fluid consuaption was carried out in the 
hoae cage 6 h into the light cycle, between 14.00 and
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15.00 h. Prior to tooting, animals wero food and water deprived 
for 23 h. Fluid consumption was recorded by reweighing preweighed 
bottles of test solution.
Feeding Tests
Consiimption of 45mg food pellets was measured in operant 
chambers as described in Chapter 3. Testing was carried out 
between 14.00 and 17.30 h, after 21 h food deprivation; test 
sessions were thirty minutes in duration. Measures of eating rate 
and eating time were derived from log survivor analysis of the 
frequency distribution of inter-response times, as described 
in Chapter 3.
Stress Regime
The stress protocol consisted of i. food and 2. water
3. continuous lighting, 4. cage tilt (30 deg), 5. 
paired housing, 6. soiled cage (loO ml of water spilled into 
bedding), 7. exposure to reduced temperature (lo deg c), 8.
intermittent white noise (85 db), 9. stroboscopic lighting (300
flashes/min), lo. exposure to em>ty water bottles following a 
period of water deprivation, li. restricted access to food 
(scattering of a few 45 mg precision pellets in the animal's hone 
c«9«)» 12. novel odours (e.g. fresh air deodorant), 13. presence
of foreign object in the home cage (e.g. piece of wood or 
intensity of some of the stressors was gradually 
Increased over the six weeks of testing (e.g. cage tilt increased 
30 to 50 deg; grouped housing Increased to four per cage). 
These procedures were scheduled over a one week period in such a
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way that at least one was In operation at any tiee, except during 
testing for fluid or food pellet consusption. Details of the 
scheduling of the stressors are shown Table 7.1.
Procedure
The animals were tested for their consumption of sucrose on 
Tuesday of each week (see Table 7.1). Following calculation of 
baseline intakes the animals were divided into two groups (n~24), 
matched for their sucrose and water consumption. One group was 
subjected to the stress regime, which was repeated for six 
consecutive weeks. Sucrose tests were readministered every 
Tuesday during the six weeks of stress, and for three further 
weeks. Every Thursday and Friday both groups of animals were 
tested in the pellet feeding procedure with vehicle injections on 
the Thursday and apomorphine injections (0.06 mg/kg s.c.) on the 
Friday. This dose of apomorphine was slightly higher than that 
used in ejqperiments described in Chapters 4-6, in order to ensure 
a consistent and significant reduction of eating tine throughout 
the three, three week phases (see )>elow). At the end of the third 
week of stress, the groups were again divided (n>12) and matched 
for 1 . sucrose and water consumption and 2. total pellet 
intakes. Each group received either DMI (5.0 mg/kg i.p.) or 
vehicle, for three weeks, according to a 2 * 2 factorial design. 
Testing was finally terminated three weeks into the withdrawal 
period so that the study was comprised of three, three week 
phases: phase 1. chronic stress, phase 2. chronic stress and DMI 
treatment, phase 3. withdrawal of both chronic stress and DMI.
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Analysis
All data war* analyzad by analysis of varlancs, supplsMnted 
by tssts of sliqila aaln *ffoots. For tho analysis of food 
consuoptlon, sating tlao and eating rate, the nine sets of data 
were treated as 3 3-week phases (stress, stress + DMI, withdrawal). 
These analyses therefore had the following 5 factors: 
•tress/control, OMI/vehlcle, apoeorphlne/vehlcle, phases (3), 
weeks (3).
For the analysis of fluid Intakes It was not convenient to
use the phases • weeks design as there were 4 test days In phase
1, but only 3 test days In each of phases 2 and 3. Sucrose
preference scores (defined as (sucrose consui^>tlon / total
consusptlon] * 100%) were therefore submitted to a 3-way
analysis, using the factors stress/control, DHZ/vehlcle and weeks
(10). The same design was used to analyze fluid consvog>tlon, with
the addition of a fourth factor, sucrose/water.
*
7.2.2 RESULTS 
Fluid Intakes
Application of the stress regime had no significant effects 
on water Intakes (F(l,88) - 0.02, M.S.) but substantially reduced 
the consumption of sucrose (F(l,88) - 52.5, p<0.00l) (Fig 7.3).
The effect was already apparent after one week of exposure to 
stress (F(l,440) — 13.9, p<0.001). Sucrose consumption in
vehicle-treated animals was even lower throughout the remainder 
of the stress period, and remained low for 2 weeks after 
termination of the stress regime (days 49, 56: F(l,440) = 20.0
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and 12.5, p<0.001). In the final test session, 3 weeks after 
termination of the stress regime, sucrose consumption in these 
animals %ras still lower than in unstressed controls (F(i,440) «
6.5, p<0.05), though sucrose preference was normal on this final
test (see below), owing to a small concomittant decrease in water 
consumption.
Unstressed animals administered Mil showed a small decrease 
in sucrose consumption after one week of treatment (day 28; 
F(l,440) - 9.8, p<0.01), but otherwise intakes of sucrose and 
water were unaffected by DMI in these animals, in stressed 
animals, DMI did not significantly alter fluid Intakes during the 
first 2 weeks of treatment'(days 28, 35; F(l,440) - o.03, o.oi,
H.S.), but an increase in sucrose consumption was seen after 3 
weeks of MCI (day 42), compared to vehicle treated stressed 
animals. This difference was not quite significant (F(i,440) -
2.9, p>0.05), owing to an uncharacteristic rise in sucrose 
consumption in the vehicle treated group. However, large and 
significant differences in sucrose consul^>tion iMtween MCI and 
vehicle treated stressed animals were maintained throughout the 
withdrawal period (days 49, 56, 63: F(l,440) - 22.8, 25.2, 1 3 .4,
p<0.001).
The effects of stress and DMI were confirmed in analysis of 
sucrose preference scores (Fig 7.4). Sucrose preference was 
significantly reduced by 3 weeks of stress (F(l,440) = 9.1,
p<0.01), remained low after 3 weeks of vehicle treatment 
(F(l,440) - 7.2, p<0.01), but was restored to a level not
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significantly different fron that of unstressed anisals by 3 
weeks of DMI treat»»nt (F(l,440) - 1 .1 , n .S.). Sucrose preference 
in vehicle treated stressed animals had returned to nomal by the 
final test session, 3 weeks after termination of the stress 
regime (F(l,440) - 0.4, N.S.), though as noted above, sucrose 
consumption was still abnormally low at this time.
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Food Consvuiptlon
A prollainary analysis of food Intake scores showed that on 
control days (i.e., those on %rhich aponorphlne was not
administered), neither stress nor DMI significantly affected 
consumption in any of the 3 phases of the experiment; the 
stress * DMI interactions were also non-significant. The 4 sets 
of data were therefore combined, for clarity of presentation 
(Fig 7.5A).
In vehicle treated, unstressed animals, apomorphine 
significantly reduced pellet consumption on every trial (min 
F(l,220) " 13.4, p<0.001). However, this effect was substantially 
*^^**"**ted in stressed animals. Higher pellet consumption in 
animals (ie. a smaller suppression of feeding by 
apomorphine) was first seen in the third week of phase 1 (day 1 7 : 
F(l,220) >12.0, p<0.001), and continued, invehióle treated
animals, throughout phase 2 (F(1,132) - 7.1, p<0.01). Attenuation 
OÍ aifect of ap<»orphlne continued through the first 2 weeks
of phase 3 (though not significant in week 7: F(l,220) - i.i,
N.S.; week 8: F(l,220) « 4.2, p<0.05), only returning to normal
in the final week (F(l,220) - 2.7, H.S.).
DMI had a biphasic effect in unstressed animals, enhancing 
the effect of apomorphine in phase 2 (F(1,132) - io.7, p<0.01),
but attenuating the effect of apomorphine in phase 3 (F(1,132) - 
5.0, p<0.05). The phase 2 enhancement was greatest in week 4 
(F(l,220) « 21.3, p<0.001), substantially smaller in week 5 
(F(1,220) - 3.5, p<0.05), and absent by week 6 (F(l,220) = 0.1,
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N.S.). Slailarly, th* phase 3 attenuation was apparent in weeks 7 
(F(l,220) - 7.5, p<0.01) and 8 (F(l,220) - 5.6, p<0.05), but 
absent in week 9 (F(l,220) - 0.2, N.S.).
In stressed aniaals DHI enhanced the effect of apoaorphine 
throughout phase 2 (F(1,132) - 12.1, p<0.001): pellet intakes of 
DMI treated aniaals were lower than those of vehicle treated 
animals not only in weeks 4 and 5, but also in week 6 (F(l,220) « 
7.1, 4.2, 6.4, p<0.05). In the final week of phase 2, therefore, 
stress attenuated the effect of aponorphine in vehicle treated 
animals (F(l,220) - 5.5, p<0.05), but not in M I  treated animals 
(F(l,220) - 0.02, H.S.).
Examination of microstructural parameters of feeding showed 
that the interactions of both stress and DMI with apomorphine 
were effected primarily by changes in eating time rather than in 
eating rate. Apomorphine significantly reduced eating rate (Fig 
7.5B) in all 4 groups, in all 3 phases of the experiment (min 
^(^»132) • 12.5, p<0.001). However, with a single exception (week 
6 in DMl-treated animals: F(l,220) - 7.2, p<0.01), all effects of 
stress and DMI on eating rate were non-significant.
By contrast, effects of stress and M I  on eating time (Fig 
7.5C) were similar to effects on total food Intake (Fig 7.5A), 
and if anything, more dramatic. While apomorphine consistently 
reduced eating time in vehicle treated, unstressed animals 
(F(1,44) - 10.5, p<0.01), this effect was totally abolished in 
vehicle treated stressed animals between weeks 3 and 8 inclusive:
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on Most of these tests apoaorphine actually caused a non­
significant increase in eating tiee (max F(l,220) - 2.7, N.S.). 
The noxaal reduction in eating time returned in the final test, 
three weeks after temination of the stress regiae (F(l,220) « 
7.0, p<0.01). Siailarly, in DHI-treated unstressed aniaals, 
apoaorphine failed to reduce eating tiae during the withdrawal 
phase (phase 3) of the experiaent (F(1,132) - 0.6, M.S.).
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7.2.3 DISCUSSION
In unstressed aniaals, DMI had a biphasic effect on 
aponorphine anorexia, initially enhancing the suppression of food 
intake and eating tlse, but attenuating the effect after 
withdrawal. These results replicate our earlier observations 
(Expt. 7.1, Towell 1984; Towell et al, 1986) and imply that 
during withdrawal fros OKI, DA cell body autoreceptors in the VTA 
are subsensitive. However, an exactly comparable attenuation of 
apomorphine anorexia was also seen in stressed animals. In 
vehicle-treated stressed animals, this effect was present 
throughout the stress period; idiile in DMI-treated stressed 
animals, attenuation of the apomorphine effect disappeared 
at exactly the time their sucrose preference was begining to 
recover. These observations argue strongly against the hypothesis 
that ^ e  theraputlc action of tricyclic antidepressant treatment 
results from the Inhibltlbn of DA autoreceptor function.
7.3 GENERAL DISCUSSION
Generalization for the results of experiment 7.2 to the 
clinical situation depends on the assumption that the animal 
model used to assess DA autoreceptor function is a valid one. The 
reduction in sucrose preference may reflect an underlying 
"anhedonia"; however, this behavioural deficit is open to other 
interpretations. The deficits in sucrose consumption may for 
example have occurred as a result of stress-induced decrements in 
caloric regulation. However, this explanation is ruled out by the 
observation that chronic stress produced deficits in both caloric
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(«ucros«) and non-calorio (aaccharln) solutions (Millner at al, 
1987b). It is also possibla, that chronic strass sight changa the 
perceived stiwilus properties of the sweet drinlcs to sake then 
less palatable. -There are however, no grounds, theoretical or 
e^lrical for believing this to be the case. A third possibility 
is that chronic stress sosehow liq;>alrs the anlsals* ability to 
drink. This does not appear to be so, as saline consusption was 
unaffected by stress, even though total fluid intakes in 
unstressed saline-consuslng anisals were as high as in the 
sucrose-consuslng control group (Hillner et al, 1987). it seess 
likely then, that the deficit in sucrose and saccharin 
preference is accounted for by a reduction in their rewarding 
properties than by sensory or eotor changes. We have exaained the 
possibility that this effect nay be secondary to a stress-induced 
increase in blood glucose levels: if anything blood glucose 
levels were slightly lower in stressed anleals (Winner et al, 
1987b).
Acute pretreatMnt with DHI has been found to enhance the 
effect of apoaorphlne adeinistered peripherally or centrally 
(Experlaent 7.2; Towell 1984). The eechaniss of these 
interactions is obscure. Tricyclics are known to potentiate the 
effects of high doses of apoaorphine such as stereotyped 
behaviour (Mange and Brand 1971; Molander and Randrup 1976) and 
changes in blood pressure (Kadzielawa and Poplelarskl 1 9 7 1). 
These effects of apoaorphine seen to be aediated by DA systeas as 
the potentiation of apoaorphine stereotypy by tricyclics was
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unaffected by pharaacological treataents which abolish na 
transalssion (Molander and Randrup 1976). There is also evidence 
that neither changes in the Metabolise of apoeorphine, nor the 
cholinergic effects of tricyclics, sake a significant 
contribution (Molander and Randrup 1976; Rurak and Helzacka
1985). It is now accepted that tricyclics do in fact inhibit DA 
uptake (Halaris et al, 1975; Hytell 1978; Willner 1983), but 
it is unclear %rtiy this effect should enhance DA receptor 
stimulation by aponorphine. Consequently, there is as yet no 
satisfactory explanation for the synergistic effects of 
apoMorphine and tricyclic antidepressants at postsynaptic or 
presynaptic DA receptors.
Following prolonged DMI treatnent the enhancement of the 
apomorphine effects were greatly reduced. However, central 
administration of apomorphine provided no evidence that these 
effects of apomorphine were actually attenuated during chronic 
antidepressant treatment. Taken together, the present experiments 
(Expt 7.1 and 7.2) do not support the hypothesis that DA 
autoreceptors become subsensitive during the course of treatment 
with antidepressant drugs. The observation that DA autoreceptors 
on cell body/soma of the mesollmbic DA system are not 
subsensitive during chronic DMI does not in itself exclude 
the hypothesis of an increased DA output following 
chronic antidepressant treatment since such an effect could 
result from a desensitization of DA terminal autoreceptors. 
However, Holcomb et al, (1982) failed to observe any
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Chang«* in Oh taniinal autor«c«ptor rasponsivanass following 
chronic DMI. This in turn is consistant with the prasent 
finding (Exparlnant 7.2), that chronic DMI treatment failed 
to alter the reduction of eating rate by a low systemic dose of 
apomorphine. The evidence adduced in earlier chapters indicates 
that DA axon terminal autoreceptors mediate this effect.
In contrast to the acute and chronic effects of ntl the two 
experiments were consistant in confirming an attenuation of DA 
cell body autoreceptor responsiveness during withdrawal from 
chronic antidepressant treatment, which appears to be maximal 
after 6-7 days of withdrawal. Mhlle this conclusion may be drawn 
unambiguosly from the present model, this would not be the case, 
however in other behavioural models. In other models, therefore, 
it may be argued that the apparent absence of the sedative 
component may in fact have resulted from an Increase in 
responsiveness of DA postsynaptic receptors (see eg. Serra et al,
1979). Chronic treatment with tricyclic and atypical 
antidepressants has been shown to enhance apomorphine and 
amphetamine-induced locomotor activity (Spyraki and Fibiger 
1981), indicating that postsynaptic receptors in the mesolimblc 
DA system have become supersensitIve. It should be noted however, 
that apomorphlne in the present behavioural paradigm reduces food 
intake both at low doses which act at presynaptic DA receptors, 
and also at high doses which stimulate postsynaptic DA receptors 
(Chapter 5: Winner et al, 1985). Therefore any increase in 
postsynaptic DA receptor sensitivity brought about by chronic
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antideprasMnt traatMnt would further reduce food intake. This 
effect was not observed in this study and hence rules out any 
contribution of an increased responsiveness of postsynaptic DA 
receptors following chronic antidepressant treatsent to the 
attenuation of apoeorphine anorexia. The effect say interpreted 
unaebiguosly as a decrease in responsiveness of cell body 
autoreceptors.
It is at present unclear how to interpret the finding that 
DA autoreceptors are subsensitive in stressed anisals displaying 
reduced sucrose preference. As DA autoreceptors are inhibitory 
(Skirboll et al, 1979), subsensitivity isplies an increase in the 
activity of aesolisbic DA neurons. However, this conclusion is 
not easily reconciled with a decrease in the consueption of a 
highly rewarding solution since a considerable literature 
indicates that such an effect would involve a decrease in 
■esollabic DA activity (Hillner 1983; Wise 1982). It is 
possible, however that autoreceptor subsensitivity develops to 
coapensate for chronically increased levels of dendritic DA 
release (Geffen et al, 1976). If this were the case, then 
autoreceptor subsensitivity sight coexist with reduced DA 
turnover in teminal areas, since axonal and dendritic release of 
DA appear to be Inversely related (Nieoullon et al, 1978, 1979).
Whatever the significance of a reduced DA autoreceptor 
sensitivity in stressed aniaals, the fact of its coexistence with 
a reduced sucrose preference strongly suggests that when the same 
effect is seen during withdrawal from antidepressant drugs, it is
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CHAPTER 8
COMCUDIMG DISC088ION 
8.1 80HMARY COMCLD8ION8
Th* aajor findings of ths prsssnt study nay b« sunarissd as 
follows:
1. Low dosas (<0.1ng/kg) of aponorphine reduce food intake in the 
■icrostructural paradlg« by reducing both the tine spent eating 
and the rate of food consuaption. These effects of apoaorphlne 
are mediated by central DA receptors of the D2 subtype.
2. ^maorphlne reduced eating tlae by selectively stieulatlng 
cell body autoreceptors in the VTA. Apoaorphlne reduced eating 
rate by selectively stiaulating axon terainal autoreceptors in 
the nucleus accuaSaens, one of the sites at which DA projections 
originating in the VTA terminate.
3. Using the apoaorphine-lnduced reductions of eating tine and 
•Ating rate to index DA autoreceptor function, chronic 
antidepressant treatment did not change the sensitivity of these 
receptors. However, following withdrawal, cell body autoreceptors 
were deemed to be subsensitive as there was an attenuation of the 
response to apomorphine on eating time.
4. This effect of antidepressant pretreatment does not appear to 
be relevant to the clinical action of these drugs.
The implications and detailed basis of these conclusions are now 
discussed.
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8.2 APOMORPHINE AMOREXIA
In th« ■Icrostructural paradign, apoaorphlna reduced food 
intake by reducing eating tine and eating rate. These effects of 
apoeorphlne were reversed by central DA anatagonists but not by 
the peripheral DA antagonist domperldone, or antagonists of other 
neurotransaitter systens (Chapter 4). This result, in effect, 
would suggest a hoaogenous interaction of apoaorphlne with 
central receptor systeas. Indeed, the DA receptor involved in 
both of the responses to apoaorphlne is of the D2 subtype, as 
both effects were reversed by sulpiride but not SCH-23390 
(Chapter 5). That these receptors are located presynapticaly was 
deaonstrated following TBZ pretreataent. TBZ, which reduces DA 
availability by destroying teralnal stores. Inhibited the actions 
of low doses of apoaorphine on eating tiae and eating rate. 
However, TBZ pretreataent failed to attenuate the reduction in 
eating tiae following a higher dose of apoaorphine, «ihlch laplies 
that at this dose apoaorphina acts postsynaptically.
The observation that the reductions in food intake following 
apoaorpbine were prevented by TBZ, argues strongly against a 
postsynaptic site of action and in turn rules out the involveaent 
of a special population of postsynaptic D2 receptors that are 
unusually sensitive to low doses of apoaorphine. The existence of 
such a receptor population has been hypothesized by Gessa et al, 
(1985), on the basis that, in SCH-23390 pretreated aniaals, both 
low and high doses of apoaorphine elicited a sedative response, 
%diich was antagonized by the D2 receptor antagonist, sulpiride. 
Presysnaptic DA receptors are several tiaes more sensitive to DA
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agonists (Skirboll et al, 1979), and following high doses of 
apoaorphine stisulation of these receptors by endogenous DA is 
■asked by the stinulation of postsynaptic receptors by the 
exogenous agonist (Hachtel et al, 1979). The fact that SCH-23390 
unmasked the inhibitory response of a high dose of aponorphine 
would suggest that at this dose, SCH-23390 blocked the 
postsynaptic response but spared the presynaptic response (which 
is assumed to be mediated by D2 receptors). The findings reported 
by Cessa and colleagues are fully consistent with this 
formulation. There are no empirical data to support the notion of 
a hypersensitive population of sedative postsynaptic D2 
receptors. Dawson et al, (1986), however, using autoradiogarphy 
techniques, reported that not only are there postsynaptic D2 and 
D1 receptors but also subpopulations of presynaptic 02 and D1 in 
various brain areas. The finding that SCH-23390 did not attenuate 
the effects of a presynaptic dose of apomorphine, shows that 
"presysnaptic" D1 receptors are not involved in this response.
niat the responses to low doses of apomorphine on eating time 
and eating rate were mediated by presysnaptic DA receptors was 
confirmed by local administration procedures (Chapter 6). 
Apomorphine directly applied to the VTA resulted in a selective 
reduction of eating time; central administration of sulpiride to 
the VTA reversed the reduction in eating time but not eating rate 
following systemic apomorphine. In direct contrast to these 
findings, aposorphlne infusions into the nucleus accumbens 
produced a reduction in eating rate but not eating tine, and
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behavioural sedation. Higher, non-sedative doses of apoaorphine 
adainlstered to the nucleus accuiO>ens resulted in sisilar 
reductions in eating tlae and eating rate to those seen following 
administration of high systemic doses of apomorphine (Chapters 5 
and 6). This in turn would suggest that both low and high doses 
of apomorphine reduce food Intake by reducing eating time and 
eating rate. The pharmacological mechanisms by which these 
effects are brought about, are however, quite different; low dose 
effects are the result of the stimulation of presysnaptlc DA 
receptors %mile the additional effects of high doses are brought 
about by an interaction of apomorphine with postsynaptic DA 
receptors.
Behavlourally, the observation that both low and high doses 
of apomorphine reduce eating time would suggest that DA agonists 
* ■i*ilar effects on feeding behaviour. On close examination 
<lAta however, low doses of apomorphine appear to reduce 
eating time by reducing the length of feeding bouts whereas high 
doses also increase the latency to onset and the intervals 
between feeding bouts. The reduction in eating time following low 
doses of apomorphine results from a reduction in the impulse- 
induced release of DA into the synaptic terminal, in that 
reductions in DA availability result in a general decrease in 
behavioural activity (Benlnger 1983; Heyman et al, 1986; Wlllner 
et al, 1987; Wise 1982), this would then explain why animals on 
apomorphine spend less time feeding. On the contrary, stimulation 
of postsynaptic DA receptors results in an increase in 
behavioural activity which in turn, from the above deductions,
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ought to Incroase «ating tia*. Howavar, incraasing doses of Dh 
agonists are )cnown to induce hyperactivity and stereotyped 
behaviours that are incospatible with feeding l>ehaviour (Lyons 
and Robbins 1975). Following the adsinistration of high doses of 
apoMorphine the animals were not sedated and rearing behaviour 
was also in evidence, which would suggest that the aniaals spent 
less time feeding due to response competition. This effect of 
apomorphine was effectively picked up by the microstructural 
analysis of feeding in that an increase in the inter-bout 
intervals was observed. Similarly, Stable and Ungerstedt (1986a), 
using an automated holel>oard apparatus, noted that incraasing 
doses of apomorphine reduced exploratory behaviour monotonlcally. 
The pre and postsynaptic effects of apomorphine could be reliably 
differentiated by the measurement of a number of behavioural 
characteristics including, activity, forward locomotion, rearing, 
hole exploration and comer-restricted behaviour. Low doses of 
apomorphina reduced most variables measured, however, they 
reported that the reduction of exploratory behaviour at higher 
doses involved qualitative change in the pattern of behaviour. 
The use of multivariate statistics demonstrated that a breakpoint 
may be determined for the transition from one typical pattern to 
the next; with increasing doses of apomorphine the change 
occurred at doses between 0.1 and 0.2 mg/kg.
reduction of eating rate by apomorphine, appears to be 
caused by the stimulation of axon terminal autoreceptors. These 
receptors reduce DA availability in the synaptic terminal by
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inhibiting it« r«l«a«« by an interaction with calciu« gating 
Mchaniau (G«ff«n «t al, 1976; Korf «t al, 1976; Roth at al,
1983). Bahaviourally, thi« affect of aponorphina on DA axon 
tarainal autoracaptor«, may ba intarpratad as a reduction in the 
effort the animals are prepared to sustain while feeding. The 
mesolinbic DA system has for some time been implicated in the 
activating aspects of positively reinforced behaviours (Beninger 
1983). In addition, it has been proposed that the VTA is a site 
through irtiich biologically significant stimuli converge and 
influence the firing rate of the mesolimbic DA neurons (Mogenson 
and Yim 1981). The information arriving at the nucleus accnimbens 
is then influenced by inputs from other brain areas (eg 
amygdala), believed to be involved with motivational behaviour, 
before being relayed to the motor system. Typically neuroleptic 
P*^ *^^*®^*** animals fail to maintain responding for food or 
saccharin reinforcements beyond the first few trials (Geary and 
Smith 1985; Towell at al, 1987a; Wise et al, 1978). The 
performance decrement that results following administration of DA 
antagonists in positively reinforced procedures, has been 
Interpreted as an inability to sustain effort (Neill and Justice 
1981). In a similar way, animals on apomorphine were capable of 
responding but did so less vigorously while responding for food 
reinforcement.
It is therefore suggested that the reduction of eating time 
by apomorphine following the stimulation of cell body 
autoreceptors, resulted from a decrease in the firing rate of the 
mesolimbic DA system which in turn caused a reduction in response
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■alntainanc*. On th* othar hand, tha stlnulation of axon terainal 
autoracaptors by apoaorphina raducad tha affort axpandad by 
aniaals whlla raaponding for food, which was raflactad by a 
raductlon In tha rata of consumption.
Tha hypothasis that DA autoracaptors subsarva diffarent 
bahavioural functions is difficult to raconcila physiologically. 
Ona potantially ralavant diffarance batwean axon terminal and 
call body autoracaptor action is that tha stimulation of cell 
body autoracaptors may altar the pattern of firing. A 
characteristic of DA neurons is that they have two active nodes, 
a single spiking and a Srarst firing node (Bunney et al, 1984). In 
addition, it seams that tha activity of these neurons is 
interchangeable in tha freely moving, undrugged animal (Freeman 
at al, 1985). Since bursting activity is highly correlated 
with an augmented DA release, it is tempting to speculate that as 
a result of this activity tha affects of othar inputs into the 
nucleus accumbans are diminished in order to maintain tha animals 
•ttantion to tha currently ongoing )>ahaviour. Amphetamine 
administration which results in a augmentation of DA release, 
produces response parsarvaratlon in tha attentional switching 
modal (Evandan and Robbins 1983, 1985), first described by 
Kristofferson (1967), to measure attentional switching in humans. 
In addition, 6-OHDA lesions of tha nucleus accumbans antagonized 
tha aiQ>hatanlna induced performance deficits in this paradigm 
(Robbins at al, 1986). Apomorphina in the mlcrostructural 
paradigm reduced eating time by selectively stimulating DA cell
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body autorocoptora. Thia action of apoaorphina aay have resulted 
in an inhibition of bursting activity of these neurons and the 
concraitant augaented OA release, which was observed in the 
paradiga by a reduction in response aaintainance.
As well as reducing eating tine apoaorphine also reduced 
eating rate, in this case by a selective stiaulation of DA axon 
teminal autoreceptors. This effect of apoaorphine is potentially 
aore difficult to resolve. The reduction in the release of 
endogenous DA that results froa the stlnulation of these 
autoragulatory receptors aay be aore significant with respect to 
the single spike aode than the bursting node. It is possible that 
the rate of ongoing behaviour is deteralned by a niniaal level of 
DA in the synaptic teralnal that is aaintalned by single spiking 
activity. This is supported by the observation that axon terainal 
autoreceptors do not becoae functional until DA levels in the 
synaptic cleft are such that reuptake aechanlsas are saturated 
(Cubeddu et al, 1983).
This accoiint of the function of aesoliabic DA neurons has 
little or no eapirical data to support it. However, it does 
provide for a nuaber of testable predictions. Firstly, using 
extracellular recording techniques it should be possible to show 
that the stiaulation of cell body autoreceptors selectively 
reduces the nuaber or frequency of spike trains. Secondly, 
if the fluctuation in DA release is aonitored froa aoaent to 
aoaent, stiaulation of axon teralnal autoreceptors should 
decrease the release of DA by single spikes, but not aaxiaal
176
concentrations that result following a burst of spikes. It must
stressed again, that these assuaptions are highly speculative. 
The second of the two hypotheses is not currently testable in 
that the preparations used to Monitor DA in vivo have an 
insufficiently fine teaporal resolution; with in vivo dialysis 
the tiae required to collect Measurable saaples is in the order 
of 20 ain while electrical events occur in Milliseconds 
(Zetterstroa and Ungerstedt 1984; Zetterstroa et al, 1 9 8 5). 
However, the first hypothesis is currently testable and we are 
hoping to carry out the appropriate electrophysiological studies 
in the near future.
8.3 DOPAMINE AND ANTIDEPRESSANT FONCTION
Since the recognition by Randrup et al, (1975), that DA 
systeas aight be involved in the pathogenisis of depression, a 
plethora of literature has evolved around the aechanisas by idilch 
antidepressant drugs aay Increase DA efficacy. The hypothesis 
•N**ined in this thesis was that antidepressants exert their 
effects by reducing the sensitivity of DA autoreceptors and thus 
Increasing DA output. No evidence for this hypothesis was 
forthcoaing froa the experiaents described in Chapter 7.
Acute antidepressant pretreataent, consistently resulted (in 
®t**<iie8), in an aapliflcation of the apoaorphine response 
(®^>^i****^ 7.1; Towell 1984). The aechanisa by idiich this effect 
is brought about is not )cnown, but it nay result froa the 
Increase in DA levels following the inhibition of DA uptake by 
antidepressants (Hytell 1979). This in turn would lead to an
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lncr«as* in tha stimulation of da autoracaptors, and an 
anhancsMnt of tha apowirphina raaponsa on acuta administration. 
Similarly, changas in tha sansitivity of postsyanptic DA 
racaptors following chronic antidaprassant traatmant, wars only 
apparant following amphatamina administration. Antidaprassant 
P*"*^"®***"^ in tha potantiation of amphatamina-inducad 
hyparactivity but had no affacts on basal actvity lavala. 
(Spyraki and Fibigar 1981).
Howavar, chronic antidaprassant traatmant did not cause any 
changas in tha sansitivity of DA autoracaptors as datarminad by 
tha rasponsa to low dosas of apomorphina. This rasult is a 
furthar addition to tha body of growing avidanca that if 
antidapraasants affactivaly incraasa DA afficacy in tha clinical 
situation, tha machanism of action is not a raduction in the 
sansitivity of DA autoracaptors (Spyraki and Fibigar 1981; 
Spyraki at al, 1987).
Finally, both typical and atypical antidaprassants reduced 
tha sansitivity of DA call body autoracaptors following 
withdrawal from traatmant. Scavona at al, (1987), also raported 
that 72 h following tha last antidaprassant injaction, animals 
fallad to respond to a sedative dose of apomorphine in the 
locomotor activity paradigm. This rasult, in affect, should 
remove any remaining uncertainties as to tha clinical relevance 
of a raduction in tha sansitivity of prasynaptic DA racaptors 
since improvements in depressive symptomology are manifested 
during chronic antidepressant treatment rather than withdrawal.
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A consistent finding in the literature is the observation 
that postsynaptic receptors in the aesoliabic DA systea becoae 
supersensitive during chronic treataent with antidepressant drugs 
(Spyraki and Fibiger 1981; Spyraki et al, 1987; Winner 1987). in 
studies using the locoaotor activity paradiga, this effect could 
be aisinterpreted as a decrease in autoreceptor sensitivity (see 
eg Serra et al, 1979). However, supersensitivity of postsynaptic 
DA receptors would be deaonstrated in the aicrostructural 
paradiga by a further reduction in food intake. In effect, the 
findings reported showed the contrary; following withdrawal of 
chronic antidepressant treataent there was an attenuation of the 
effect of apoaorphine on food intake. Using this particular 
paradiga, therefore, unaablguous conclusions aay be drawn in 
*^ *^ *^ ®^** the effects of antidepressant pretreataents on DA 
autoreceptor sensitivity.
However, the problea inherent in all these types of studies 
is that the effects of antidepressant pretreataents were 
aonitored in noraal aniaals. Indeed, the findings that receptor 
sensitivity aay change over tiae, has resulted in the general 
acceptance that receptor systeas are dynaaic rather than static 
and therefore function hoaeostatically. Thus a reduction in 
transaltter output aay be reaedled by an increase in the 
sensitivity of postsynaptic receptors and an Increase in the 
release of transaltter nay l>e overcone by a down regulation of 
these receptors. Effects observed with antidepressant 
pretreataents in nomal aninals night therefore reflect this 
systea of operation in action. Bearing in mind these receptor
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th« results of studies in nonal animals provide 
only limited insight into the mechanisms by tihich antidepressant 
drugs may alleviate depressive episodes in the clinical 
situation.
8.4 DOPAMIME AMD STRESS
It has been postulated that antidepressants may work by 
*^*^®^^**9 the process of adaptation to stress. Stone (1979), 
observed that the induction of stress or the inception of 
chronic treatment with antidepressants, both resulted in a 
reduction in the sensitivity of beta adrenergic receptors, mie 
mechanism by which these treatments cause the subsensitivity of 
beta adrenergic receptors ls.some\diat different. Antidepressants 
increase NA In the synaptic terminal by inhibiting its uptake 
(^ **^ *^*®** *1» 1969; Maitre et al, 1982) whereas stress reduced 
the activity of monoamine oxidase, the enzyme that degrades 
monoamines Intraneuronally (Welch and Welch 1970); the overall 
result however, is an increase in intrasynaptic NA 
concentrations.
Acute stress is found to decrease both NA and DA levels by 
increasing the utilization and synthesis of these catechoalmines. 
It would appear that these adaptive changes occur in order to 
keep pace with immediate enviromental demands and therefore, 
assure adequate supplies of transmitter. Exposure to a number of 
stressful stimuli may result in a excessive stimulation of 
neuronal systems which may then result in a down regulation of 
postsynaptic receptors (eg beta adrenergic receptors) in order to
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■Iniaize the potential hazards of over stieulation. However, 
following repeated exposure to uncontrollable stress there coses 
a point when demand outstrips supply (Anisnan and Sklar 1 9 7 9; 
Weiss et al, i960, 1981; Willner 1985) and then reductions in 
transmitter levels become apparent. The reduction in amine levels 
may then be held responsible for mediating the debilitating 
effects of stress on performance. The analogy that is 
consequential to these observations is that following 
antidepressant pretreatmeht, the reduction in sensitivity of DA 
autoreceptors may result from acute Increases in DA levels. 
DA autoreceptor subsensitivity was not observed in normal animals 
except during withdrawal from treatment but in stressed animals a 
reduction in sensitivity of DA autoreceptors has been 
demonstrated (Antelman and Chlodo 1984). These observations 
would seem to suggest that it is not a good idea to co^are 
neurochemical adaptatloM to stress with ones resulting from 
antidepressant treatments in normal animals. On reflection, even 
though the initial changes seem to Involve an Increase in 
transmitter availability, subsequently, the similarities cease to 
exist. It may therefore be advisable to look at the mechanism by 
which antidepressants influence DA receptor function in a 
framework that models the affective disorder in question.
Evidence is accumulating that chronic low grade stress nay be 
important factor in the development of depression (Aneshensel and 
Stone 1982; Jahoda 1979); in particular a specific relationship 
to endogenous depression has been postulated (Hillner 1985,
1987). One of the characteristic features of this subtype of
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d«Pí'«**ion Is a dacraass in tha parforaance of rawarded 
bahavlours. In that a raductlon in DA decraasas rasponding 
for l e s s  (Koob at al, 1 9 7 8 » Moganson at al, 1 9 7 9 ) as well as in 
other positively reinforced tasics, it follows that a decrease 
in DA fiuiction nay be a good candidate to sediata sosa of the 
major dysfunctions seen in depression. We have developed a 
potential anisal sodal of depression in which a reduction in 
sucrose preference has been brought about by exposure to ultra- 
mild, relatively naturalistic stressors. This effect was 
interpreted as a gradual development of anhedonia through the 
course of several weeks of exposure to the stress regime. Animals 
in this model when "depressed”, displayed a reduction in DA 
autoreceptor sensitivity determined by the apomorphine response. 
This result would seem surprising in light of the evidence that a 
reduction in the sensitivity of these receptors would mean an 
increase in DA output.
However, an Increase in DA transmission is not easily 
reconciled with the low preference for a highly rewarding 
solution. In other studies, we have deannstrated that drugs that 
block the action of endogenous DA, decreased sucrose preference 
in two bottle preference tests (Towell et al, 1987a). As 
described in Chapter 7, it is possible that the down regulation 
of cell body autoreceptors represent a homeostatic compensation 
for chronically increased levels of dendritic DA release (Geffen 
et al, 1976). Alternatively, DA autoreceptor subsensitivity may 
be secondary to the increased cholinergic activity that results 
from exposure to inescapable stressors (Aprison et al, 1975;
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Fink«lst«ln *t al, 1984; Roaano and Shih 1983). The fibre system 
that seems to sustain ICSS, originates in the lateral 
hypothalamus and the substantia innominata and terminates on DA 
cells in the VTA (Gallistel et al, 1981). The substantia 
innominata also receives a cholinergic input from the aidbrain 
(Lewis and Schute 1978) and the inhibition of these neurons 
may result in a reduction in the stimulation of mesolimbic DA 
neurons, and might perhaps be responsible for a reduced 
sensitivity of cell body autoreceptors.
8.5 DOPAMIMB. DBPRKSSION AHD AMTTnRPRFSgaur FQNCTION
We have suggested that with the use of a valid animal model 
of depression (Winner et al, 1987) it may be possible to study 
the idiysiological effects of antidepressant agents on a
clinically relevant time scale, in the chronic stress model, the 
typical antidepressant DMI, did attenuate the anhedonic deficits 
on chronic treatment. However, this effect did not result from a 
down regulation of DA autoreceptors. This observation casts 
serious doubts over the assumption that chronic antidepressant 
pretreatments increase DA efficacy by reducing the sensitivity of 
presysnaptic DA receptors. It nay be that the reversal of the 
sucrose deficits in this model by DMI, result from a change in 
the sensitivity of postsynaptlc DA receptors. This line of 
inquiry is currently under investigation.
It must be said however, that in our attempts to understand 
complex disease states such as depression, animals models
have proved to be valuable on the understanding that they too
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»rm  limited in the amount of intonation they can provide. No 
model can seriously pretend to coee up with all the 
necessary answers. However, unlike biocheeical assays, 
behavioural Models provide data that provide infornation about 
the overall functioning of neurotransaitter systems.
Finally, theories of depression should now incorporate a role 
for the aesolinbic DA system in the endogenous subtype of 
depression. The animal literature also reflects this point as 
there is a significant amount of evidence to suggest that there 
is more than a casual relationship between a reduction in DA 
function and endogenous depression. The DA autoreceptor 
hypothesis of antidepressant action should be discarded and the 
focal point of future research switched to the mechanisms by 
which antidepressant drugs are able to sensitize postsynaptic DA 
However, as far as presynaptlc DA receptors are 
concerned, an effort should be made to understand how different 
behaviours may arise following the stimulation of cell body or 
axon terminal DA autoreceptors on the same population of DA 
neurons.
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